title,url,time_published,summary,ticker,relevance_score,ticker_sentiment_score,ticker_sentiment_label
Insulet  ( PODD )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2037037/insulet-podd-gains-as-market-dips-what-you-should-know,2023-01-09 23:15:25,"Insulet (PODD) closed the most recent trading day at $296.27, moving +1.35% from the previous trading session.",PODD,0.705377,0.243961,Somewhat-Bullish
Market Takes Big Step; These 9 Stocks Flash Buy Signals,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-takes-big-step-9-stocks-flash-buy-signals/,2023-01-08 13:49:00,Market Takes Big Step. These 9 Stocks Flash Buy Signals Investor's Business Daily ...,PODD,0.063876,0.002014,Neutral
"Market Takes Big Step, These 9 Stocks Flash Buy Signals",https://www.investors.com/market-trend/stock-market-today/market-rally-takes-big-step-9-stocks-flash-buy-signals-tesla-ev-price-war/,2023-01-06 23:21:00,"Dow Jones futures will open on Sunday evening, along with S&P 500 futures and Nasdaq futures. The stock market rally attempt had a strong finish Friday, with the major indexes moving sharply higher on the December jobs report and ISM services index.",PODD,0.065032,0.002017,Neutral
20 Great Stock Ideas For 2023 From Top-Performing Fund Managers,https://www.forbes.com/sites/sergeiklebnikov/2023/01/04/20-great-stock-ideas-for-2023-from-top-performing-fund-managers/,2023-01-04 11:30:00,Forbes spoke with ten top fund managers. Here are their best stock ideas for the coming year.,PODD,0.009663,0.172278,Somewhat-Bullish
Insulin Pump Market is expected to grow from USD 4.8 billion in 2022 to USD 16.06 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30250692/insulin-pump-market-is-expected-to-grow-from-usd-4-8-billion-in-2022-to-usd-16-06-billion-by-2030-,2023-01-02 16:30:00,"Pune India, Jan. 02, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the insulin pump market is operating and is ...",PODD,0.025569,0.120249,Neutral
Insulet  ( PODD )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2041696/insulet-podd-gains-as-market-dips-what-you-should-know,2023-01-19 23:15:19,"Insulet (PODD) closed at $292.38 in the latest trading session, marking a +1.11% move from the prior day.",PODD,0.720339,0.205956,Somewhat-Bullish
Futures Rise Ahead Of Wholesale Inflation Report; Tesla Extends Gains,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-ahead-of-key-inflation-report-united-airlines-jumps-on-earnings-tesla-stock-races-higher/,2023-01-18 13:25:00,Dow Jones Futures Rise Ahead Of Key Inflation Report. Tesla Stock ... Investor's Business Daily ...,PODD,0.122737,0.143141,Neutral
Ulta Beauty  ( NASDAQ:ULTA )  Downgraded by StockNews.com to Hold,https://www.etfdailynews.com/2023/01/18/ulta-beauty-nasdaqulta-downgraded-by-stocknews-com-to-hold-2/,2023-01-18 08:48:42,"Ulta Beauty ( NASDAQ:ULTA - Get Rating ) was downgraded by equities researchers at StockNews.com from a ""buy"" rating to a ""hold"" rating in a research report issued on Wednesday. Other equities research analysts also recently issued research reports about the stock. Robert W.",PODD,0.06211,0.140062,Neutral
Azure Power Global  ( NYSE:AZRE )  Coverage Initiated by Analysts at StockNews.com,https://reporter.am/2023/01/18/azure-power-global-nyseazre-coverage-initiated-by-analysts-at-stocknews-com.html,2023-01-18 08:16:44,Azure Power Global ( NYSE:AZRE ) Coverage Initiated by Analysts at ... Armenian Reporter ...,PODD,0.082393,0.126238,Neutral
"Bio-Techne  ( NASDAQ:TECH )  Upgraded to ""Buy"" by StockNews.com",https://reporter.am/2023/01/18/bio-techne-nasdaqtech-upgraded-to-buy-by-stocknews-com.html,2023-01-18 08:16:44,"Bio-Techne ( NASDAQ:TECH - Get Rating ) was upgraded by analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a note issued to investors on Wednesday.",PODD,0.055364,0.083853,Neutral
"Bio-Techne  ( NASDAQ:TECH )  Upgraded to ""Buy"" by StockNews.com",https://www.etfdailynews.com/2023/01/18/bio-techne-nasdaqtech-upgraded-to-buy-by-stocknews-com/,2023-01-18 08:16:44,"Bio-Techne ( NASDAQ:TECH - Get Rating ) was upgraded by investment analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a research report issued on Wednesday. A number of other brokerages have also recently commented on TECH. Robert W.",PODD,0.054114,0.083764,Neutral
"Equity Bancshares  ( NASDAQ:EQBK )  Lifted to ""Buy"" at StockNews.com",https://reporter.am/2023/01/18/equity-bancshares-nasdaqeqbk-lifted-to-buy-at-stocknews-com.html,2023-01-18 08:16:44,"Equity Bancshares ( NASDAQ:EQBK - Get Rating ) was upgraded by StockNews.com from a ""hold"" rating to a ""buy"" rating in a research report issued on Wednesday. EQBK stock opened at $32.68 on Wednesday. Equity Bancshares has a 12 month low of $28.06 and a 12 month high of $38.04.",PODD,0.048523,0.101225,Neutral
BlackLine  ( NASDAQ:BL )  Upgraded to Hold by StockNews.com,https://reporter.am/2023/01/18/blackline-nasdaqbl-upgraded-to-hold-by-stocknews-com.html,2023-01-18 08:16:42,"BlackLine ( NASDAQ:BL - Get Rating ) was upgraded by stock analysts at StockNews.com from a ""sell"" rating to a ""hold"" rating in a note issued to investors on Wednesday. Several other brokerages have also recently commented on BL. Robert W.",PODD,0.050465,0.118304,Neutral
"BlackLine  ( NASDAQ:BL )  Upgraded to ""Hold"" by StockNews.com",https://www.etfdailynews.com/2023/01/18/blackline-nasdaqbl-upgraded-to-hold-by-stocknews-com/,2023-01-18 08:16:42,"BlackLine ( NASDAQ:BL - Get Rating ) was upgraded by research analysts at StockNews.com from a ""sell"" rating to a ""hold"" rating in a research report issued on Wednesday. Several other analysts have also recently weighed in on the stock. Robert W.",PODD,0.049939,0.118218,Neutral
Almaden Minerals  ( NYSE:AAU )  Earns Sell Rating from Analysts at StockNews.com,https://www.etfdailynews.com/2023/01/18/almaden-minerals-nyseaau-earns-sell-rating-from-analysts-at-stocknews-com-6/,2023-01-18 08:10:46,Almaden Minerals ( NYSE:AAU ) Earns Sell Rating from Analysts at ... ETF Daily News ...,PODD,0.231332,0.210737,Somewhat-Bullish
Adams Resources & Energy  ( NYSE:AE )  Downgraded by StockNews.com,https://www.etfdailynews.com/2023/01/18/adams-resources-energy-nyseae-downgraded-by-stocknews-com/,2023-01-18 08:10:46,Adams Resources & Energy ( NYSE:AE ) Downgraded by StockNews ... ETF Daily News ...,PODD,0.197413,0.02159,Neutral
Ashford  ( NYSE:AINC )  Earns Buy Rating from Analysts at StockNews.com,https://www.etfdailynews.com/2023/01/18/ashford-nyseainc-earns-buy-rating-from-analysts-at-stocknews-com-2/,2023-01-18 08:10:45,Ashford ( NYSE:AINC ) Earns Buy Rating from Analysts at StockNews ... ETF Daily News ...,PODD,0.21686,0.232892,Somewhat-Bullish
StockNews.com Begins Coverage on Ashford  ( NYSE:AINC ) ,https://reporter.am/2023/01/18/stocknews-com-begins-coverage-on-ashford-nyseainc.html,2023-01-18 08:10:42,"Stock analysts at StockNews.com assumed coverage on shares of Ashford ( NYSE:AINC - Get Rating ) in a research note issued on Wednesday. The brokerage set a ""buy"" rating on the stock.",PODD,0.21686,0.232892,Somewhat-Bullish
"Commercial Vehicle Group  ( NASDAQ:CVGI )  Raised to ""Strong-Buy"" at StockNews.com",https://www.etfdailynews.com/2023/01/18/commercial-vehicle-group-nasdaqcvgi-raised-to-strong-buy-at-stocknews-com/,2023-01-18 08:08:49,"Commercial Vehicle Group ( NASDAQ:CVGI ) Raised to ""Strong-Buy ... ETF Daily News ...",PODD,0.088472,0.111613,Neutral
Investar  ( NASDAQ:ISTR )  Upgraded at StockNews.com,https://www.etfdailynews.com/2023/01/18/investar-nasdaqistr-upgraded-at-stocknews-com/,2023-01-18 08:08:49,"Investar ( NASDAQ:ISTR - Get Rating ) was upgraded by investment analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a research note issued to investors on Wednesday. Separately, Piper Sandler decreased their target price on shares of Investar to $23.00 in a research report on ...",PODD,0.071784,0.102623,Neutral
Fifth Third Bancorp  ( NASDAQ:FITB )  Rating Increased to Hold at StockNews.com,https://www.etfdailynews.com/2023/01/18/fifth-third-bancorp-nasdaqfitb-rating-increased-to-hold-at-stocknews-com/,2023-01-18 08:08:49,Fifth Third Bancorp ( NASDAQ:FITB ) Rating Increased to Hold at ... ETF Daily News ...,PODD,0.043979,0.220592,Somewhat-Bullish
Ellington Residential Mortgage REIT  ( NYSE:EARN )  Stock Rating Upgraded by StockNews.com,https://www.etfdailynews.com/2023/01/18/ellington-residential-mortgage-reit-nyseearn-stock-rating-upgraded-by-stocknews-com/,2023-01-18 08:08:48,Ellington Residential Mortgage REIT ( NYSE:EARN ) Stock Rating ... ETF Daily News ...,PODD,0.062926,0.185195,Somewhat-Bullish
"StockNews.com Upgrades Boeing  ( NYSE:BA )  to ""Hold""",https://www.etfdailynews.com/2023/01/18/stocknews-com-upgrades-boeing-nyseba-to-hold/,2023-01-18 08:08:48,"Boeing ( NYSE:BA - Get Rating ) was upgraded by investment analysts at StockNews.com from a ""sell"" rating to a ""hold"" rating in a research report issued to clients and investors on Wednesday. BA has been the topic of several other reports.",PODD,0.049424,0.125116,Neutral
Advaxis  ( NASDAQ:ADXS )  Coverage Initiated by Analysts at StockNews.com,https://www.etfdailynews.com/2023/01/18/advaxis-nasdaqadxs-coverage-initiated-by-analysts-at-stocknews-com/,2023-01-18 08:08:48,Advaxis ( NASDAQ:ADXS ) Coverage Initiated by Analysts at ... ETF Daily News ...,PODD,0.204072,0.024622,Neutral
China Automotive Systems  ( NASDAQ:CAAS )  Upgraded at StockNews.com,https://www.etfdailynews.com/2023/01/18/china-automotive-systems-nasdaqcaas-upgraded-at-stocknews-com/,2023-01-18 08:08:48,China Automotive Systems ( NASDAQ:CAAS ) Upgraded at ... ETF Daily News ...,PODD,0.100729,0.108644,Neutral
Townsquare Media  ( NYSE:TSQ )  Cut to Hold at StockNews.com,https://www.etfdailynews.com/2023/01/18/townsquare-media-nysetsq-cut-to-hold-at-stocknews-com/,2023-01-18 08:08:47,"Townsquare Media ( NYSE:TSQ - Get Rating ) was downgraded by equities research analysts at StockNews.com from a ""buy"" rating to a ""hold"" rating in a research report issued on Wednesday. Several other equities analysts also recently commented on the stock.",PODD,0.086556,0.188915,Somewhat-Bullish
TEGNA  ( NYSE:TGNA )  Downgraded by StockNews.com,https://reporter.am/2023/01/18/tegna-nysetgna-downgraded-by-stocknews-com.html,2023-01-18 08:08:47,"TEGNA ( NYSE:TGNA - Get Rating ) was downgraded by StockNews.com from a ""buy"" rating to a ""hold"" rating in a report issued on Wednesday. TGNA opened at $19.86 on Wednesday. The stock has a market cap of $4.43 billion, a PE ratio of 8.21 and a beta of 0.66.",PODD,0.074692,0.138403,Neutral
Huntington Ingalls Industries  ( NYSE:HII )  Upgraded by StockNews.com to Buy,https://www.etfdailynews.com/2023/01/18/huntington-ingalls-industries-nysehii-upgraded-by-stocknews-com-to-buy/,2023-01-18 08:08:47,Huntington Ingalls Industries ( NYSE:HII ) Upgraded by StockNews ... ETF Daily News ...,PODD,0.063091,0.077175,Neutral
"CVB Financial  ( NASDAQ:CVBF )  Upgraded to ""Hold"" at StockNews.com",https://www.etfdailynews.com/2023/01/18/cvb-financial-nasdaqcvbf-upgraded-to-hold-at-stocknews-com/,2023-01-18 08:08:47,"CVB Financial ( NASDAQ:CVBF ) Upgraded to ""Hold"" at StockNews ... ETF Daily News ...",PODD,0.059488,0.092999,Neutral
Cemtrex  ( NASDAQ:CETX )  Receives New Coverage from Analysts at StockNews.com,https://www.etfdailynews.com/2023/01/18/cemtrex-nasdaqcetx-receives-new-coverage-from-analysts-at-stocknews-com/,2023-01-18 08:08:47,Cemtrex ( NASDAQ:CETX ) Receives New Coverage from Analysts at ... ETF Daily News ...,PODD,0.128135,0.189495,Somewhat-Bullish
Primo Water  ( NASDAQ:PRMW )  Rating Lowered to Buy at StockNews.com,https://www.etfdailynews.com/2023/01/18/primo-water-nasdaqprmw-rating-lowered-to-buy-at-stocknews-com/,2023-01-18 08:08:47,Primo Water ( NASDAQ:PRMW ) Rating Lowered to Buy at ... ETF Daily News ...,PODD,0.126119,0.084003,Neutral
Eastern  ( NASDAQ:EML )  Earns Buy Rating from Analysts at StockNews.com,https://www.etfdailynews.com/2023/01/18/eastern-nasdaqeml-earns-buy-rating-from-analysts-at-stocknews-com/,2023-01-18 08:08:46,Eastern ( NASDAQ:EML ) Earns Buy Rating from Analysts at ... ETF Daily News ...,PODD,0.071784,0.071989,Neutral
StockNews.com Downgrades CenterPoint Energy  ( NYSE:CNP )  to Sell,https://www.etfdailynews.com/2023/01/18/stocknews-com-downgrades-centerpoint-energy-nysecnp-to-sell/,2023-01-18 08:08:46,"CenterPoint Energy ( NYSE:CNP - Get Rating ) was downgraded by StockNews.com from a ""hold"" rating to a ""sell"" rating in a research report issued on Wednesday. CNP has been the subject of a number of other reports.",PODD,0.064449,0.175293,Somewhat-Bullish
StockNews.com Initiates Coverage on U.S. Global Investors  ( NASDAQ:GROW ) ,https://www.etfdailynews.com/2023/01/18/stocknews-com-initiates-coverage-on-u-s-global-investors-nasdaqgrow/,2023-01-18 08:08:46,StockNews.com Initiates Coverage on U.S. Global Investors ... ETF Daily News ...,PODD,0.131643,0.118161,Neutral
China Automotive Systems  ( NASDAQ:CAAS )  Upgraded at StockNews.com,https://reporter.am/2023/01/18/china-automotive-systems-nasdaqcaas-upgraded-at-stocknews-com.html,2023-01-18 08:08:46,China Automotive Systems ( NASDAQ:CAAS ) Upgraded at ... Armenian Reporter ...,PODD,0.102449,0.109176,Neutral
Sify Technologies  ( NASDAQ:SIFY )  Coverage Initiated at StockNews.com,https://www.etfdailynews.com/2023/01/18/sify-technologies-nasdaqsify-coverage-initiated-at-stocknews-com-2/,2023-01-18 08:08:45,Sify Technologies ( NASDAQ:SIFY ) Coverage Initiated at StockNews ... ETF Daily News ...,PODD,0.09439,0.130695,Neutral
New Residential Investment  ( NYSE:NRZ )  Research Coverage Started at StockNews.com,https://www.etfdailynews.com/2023/01/18/new-residential-investment-nysenrz-research-coverage-started-at-stocknews-com/,2023-01-18 08:08:45,New Residential Investment ( NYSE:NRZ ) Research Coverage ... ETF Daily News ...,PODD,0.07887,0.143576,Neutral
"Lakeland Bancorp  ( NASDAQ:LBAI )  Upgraded to ""Hold"" at StockNews.com",https://reporter.am/2023/01/18/lakeland-bancorp-nasdaqlbai-upgraded-to-hold-at-stocknews-com.html,2023-01-18 08:08:45,"Lakeland Bancorp ( NASDAQ:LBAI ) Upgraded to ""Hold"" at ... Armenian Reporter ...",PODD,0.07157,0.10887,Neutral
"Pearson  ( NYSE:PSO )  Raised to ""Buy"" at StockNews.com",https://reporter.am/2023/01/18/pearson-nysepso-raised-to-buy-at-stocknews-com.html,2023-01-18 08:08:45,"Pearson ( NYSE:PSO - Get Rating ) was upgraded by StockNews.com from a ""hold"" rating to a ""buy"" rating in a research note issued to investors on Wednesday.",PODD,0.069495,0.105429,Neutral
"Bio-Rad Laboratories  ( NYSE:BIO )  Downgraded to ""Hold"" at StockNews.com",https://www.etfdailynews.com/2023/01/18/bio-rad-laboratories-nysebio-downgraded-to-hold-at-stocknews-com/,2023-01-18 08:08:45,"Bio-Rad Laboratories ( NYSE:BIO ) Downgraded to ""Hold"" at ... ETF Daily News ...",PODD,0.065866,0.095145,Neutral
StockNews.com Lowers CenterPoint Energy  ( NYSE:CNP )  to Sell,https://reporter.am/2023/01/18/stocknews-com-lowers-centerpoint-energy-nysecnp-to-sell.html,2023-01-18 08:08:45,"CenterPoint Energy ( NYSE:CNP - Get Rating ) was downgraded by analysts at StockNews.com from a ""hold"" rating to a ""sell"" rating in a research report issued to clients and investors on Wednesday.",PODD,0.063763,0.175233,Somewhat-Bullish
"Brunswick  ( NYSE:BC )  Upgraded by StockNews.com to ""Buy""",https://www.etfdailynews.com/2023/01/18/brunswick-nysebc-upgraded-by-stocknews-com-to-buy/,2023-01-18 08:08:45,"Brunswick ( NYSE:BC - Get Rating ) was upgraded by research analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a research report issued on Wednesday. Several other analysts have also weighed in on the company.",PODD,0.06179,0.106021,Neutral
Avinger  ( NASDAQ:AVGR )  Coverage Initiated at StockNews.com,https://www.etfdailynews.com/2023/01/18/avinger-nasdaqavgr-coverage-initiated-at-stocknews-com/,2023-01-18 08:08:45,"Research analysts at StockNews.com initiated coverage on shares of Avinger ( NASDAQ:AVGR - Get Rating ) in a research note issued on Wednesday. The firm set a ""sell"" rating on the medical device company's stock. Shares of NASDAQ AVGR opened at $1.26 on Wednesday.",PODD,0.128135,0.153033,Somewhat-Bullish
StockNews.com Lowers Costamare  ( NYSE:CMRE )  to Hold,https://www.etfdailynews.com/2023/01/18/stocknews-com-lowers-costamare-nysecmre-to-hold/,2023-01-18 08:08:44,"Costamare ( NYSE:CMRE - Get Rating ) was downgraded by analysts at StockNews.com from a ""buy"" rating to a ""hold"" rating in a research note issued to investors on Wednesday.",PODD,0.084423,0.077804,Neutral
"Lakeland Bancorp  ( NASDAQ:LBAI )  Upgraded to ""Hold"" at StockNews.com",https://www.etfdailynews.com/2023/01/18/lakeland-bancorp-nasdaqlbai-upgraded-to-hold-at-stocknews-com/,2023-01-18 08:08:44,"Lakeland Bancorp ( NASDAQ:LBAI ) Upgraded to ""Hold"" at ... ETF Daily News ...",PODD,0.078611,0.109946,Neutral
GSK  ( NYSE:GSK )  Cut to Buy at StockNews.com,https://reporter.am/2023/01/18/gsk-nysegsk-cut-to-buy-at-stocknews-com.html,2023-01-18 08:08:44,"GSK ( NYSE:GSK - Get Rating ) was downgraded by equities research analysts at StockNews.com from a ""strong-buy"" rating to a ""buy"" rating in a research report issued to clients and investors on Wednesday. A number of other analysts have also commented on the company.",PODD,0.073321,0.168551,Somewhat-Bullish
"Sterling Infrastructure  ( NASDAQ:STRL )  Lowered to ""Buy"" at StockNews.com",https://www.etfdailynews.com/2023/01/18/sterling-infrastructure-nasdaqstrl-lowered-to-buy-at-stocknews-com/,2023-01-18 08:08:44,"Sterling Infrastructure ( NASDAQ:STRL ) Lowered to ""Buy"" at ... ETF Daily News ...",PODD,0.050572,0.103783,Neutral
Fifth Third Bancorp  ( NASDAQ:FITB )  Rating Increased to Hold at StockNews.com,https://reporter.am/2023/01/18/fifth-third-bancorp-nasdaqfitb-rating-increased-to-hold-at-stocknews-com.html,2023-01-18 08:08:44,Fifth Third Bancorp ( NASDAQ:FITB ) Rating Increased to Hold at ... Armenian Reporter ...,PODD,0.043738,0.220501,Somewhat-Bullish
Advaxis  ( NASDAQ:ADXS )  Coverage Initiated by Analysts at StockNews.com,https://reporter.am/2023/01/18/advaxis-nasdaqadxs-coverage-initiated-by-analysts-at-stocknews-com-2.html,2023-01-18 08:08:44,Advaxis ( NASDAQ:ADXS ) Coverage Initiated by Analysts at ... Armenian Reporter ...,PODD,0.204072,0.024622,Neutral
"Gold Fields  ( NYSE:GFI )  Raised to ""Buy"" at StockNews.com",https://www.etfdailynews.com/2023/01/18/gold-fields-nysegfi-raised-to-buy-at-stocknews-com/,2023-01-18 08:08:44,"Gold Fields ( NYSE:GFI - Get Rating ) was upgraded by stock analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a research report issued to clients and investors on Wednesday.",PODD,0.139265,0.168194,Somewhat-Bullish
Evoke Pharma  ( NASDAQ:EVOK )  Research Coverage Started at StockNews.com,https://reporter.am/2023/01/18/evoke-pharma-nasdaqevok-research-coverage-started-at-stocknews-com.html,2023-01-18 08:08:44,Evoke Pharma ( NASDAQ:EVOK ) Research Coverage Started at ... Armenian Reporter ...,PODD,0.132368,0.100497,Neutral
Evoke Pharma  ( NASDAQ:EVOK )  Research Coverage Started at StockNews.com,https://www.etfdailynews.com/2023/01/18/evoke-pharma-nasdaqevok-research-coverage-started-at-stocknews-com/,2023-01-18 08:08:44,Evoke Pharma ( NASDAQ:EVOK ) Research Coverage Started at ... ETF Daily News ...,PODD,0.130926,0.099941,Neutral
Avinger  ( NASDAQ:AVGR )  Coverage Initiated at StockNews.com,https://reporter.am/2023/01/18/avinger-nasdaqavgr-coverage-initiated-at-stocknews-com-2.html,2023-01-18 08:08:44,"Equities research analysts at StockNews.com started coverage on shares of Avinger ( NASDAQ:AVGR - Get Rating ) in a report issued on Wednesday. The brokerage set a ""sell"" rating on the medical device company's stock. Shares of AVGR opened at $1.26 on Wednesday.",PODD,0.130926,0.15463,Somewhat-Bullish
Townsquare Media  ( NYSE:TSQ )  Cut to Hold at StockNews.com,https://reporter.am/2023/01/18/townsquare-media-nysetsq-cut-to-hold-at-stocknews-com.html,2023-01-18 08:08:43,"Townsquare Media ( NYSE:TSQ - Get Rating ) was downgraded by stock analysts at StockNews.com from a ""buy"" rating to a ""hold"" rating in a research note issued on Wednesday.",PODD,0.084722,0.188207,Somewhat-Bullish
"Pearson  ( NYSE:PSO )  Raised to ""Buy"" at StockNews.com",https://www.etfdailynews.com/2023/01/18/pearson-nysepso-raised-to-buy-at-stocknews-com/,2023-01-18 08:08:43,"Pearson ( NYSE:PSO - Get Rating ) was upgraded by investment analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a research note issued on Wednesday. A number of other research analysts have also recently issued reports on the company.",PODD,0.071145,0.105582,Neutral
"Magic Software Enterprises  ( NASDAQ:MGIC )  Upgraded by StockNews.com to ""Strong-Buy""",https://www.etfdailynews.com/2023/01/18/magic-software-enterprises-nasdaqmgic-upgraded-by-stocknews-com-to-strong-buy/,2023-01-18 08:08:43,Magic Software Enterprises ( NASDAQ:MGIC ) Upgraded by ... ETF Daily News ...,PODD,0.066784,0.116472,Neutral
GSK  ( NYSE:GSK )  Downgraded by StockNews.com,https://www.etfdailynews.com/2023/01/18/gsk-nysegsk-downgraded-by-stocknews-com/,2023-01-18 08:08:43,"GSK ( NYSE:GSK - Get Rating ) was downgraded by equities researchers at StockNews.com from a ""strong-buy"" rating to a ""buy"" rating in a research note issued on Wednesday. A number of other analysts also recently issued reports on the stock.",PODD,0.065685,0.167382,Somewhat-Bullish
Activision Blizzard  ( NASDAQ:ATVI )  Stock Rating Lowered by StockNews.com,https://www.etfdailynews.com/2023/01/18/activision-blizzard-nasdaqatvi-stock-rating-lowered-by-stocknews-com/,2023-01-18 08:08:43,Activision Blizzard ( NASDAQ:ATVI ) Stock Rating Lowered by ... ETF Daily News ...,PODD,0.062597,0.100034,Neutral
"Commercial Vehicle Group  ( NASDAQ:CVGI )  Raised to ""Strong-Buy"" at StockNews.com",https://reporter.am/2023/01/18/commercial-vehicle-group-nasdaqcvgi-raised-to-strong-buy-at-stocknews-com.html,2023-01-18 08:08:42,"Commercial Vehicle Group ( NASDAQ:CVGI ) Raised to ""Strong-Buy ... Armenian Reporter ...",PODD,0.074692,0.109025,Neutral
InterContinental Hotels Group  ( NYSE:IHG )  Upgraded at StockNews.com,https://reporter.am/2023/01/18/intercontinental-hotels-group-nyseihg-upgraded-at-stocknews-com.html,2023-01-18 08:08:42,InterContinental Hotels Group ( NYSE:IHG ) Upgraded at StockNews ... Armenian Reporter ...,PODD,0.062761,0.165136,Somewhat-Bullish
InterContinental Hotels Group  ( NYSE:IHG )  Upgraded at StockNews.com,https://www.etfdailynews.com/2023/01/18/intercontinental-hotels-group-nyseihg-upgraded-at-stocknews-com/,2023-01-18 08:08:42,InterContinental Hotels Group ( NYSE:IHG ) Upgraded at StockNews ... ETF Daily News ...,PODD,0.058615,0.165,Somewhat-Bullish
RPC  ( NYSE:RES )  Rating Increased to Buy at StockNews.com,https://www.etfdailynews.com/2023/01/18/rpc-nyseres-rating-increased-to-buy-at-stocknews-com/,2023-01-18 08:08:42,"RPC ( NYSE:RES - Get Rating ) was upgraded by StockNews.com from a ""hold"" rating to a ""buy"" rating in a research note issued to investors on Wednesday. NYSE:RES opened at $9.57 on Wednesday. The business's 50-day moving average price is $9.09 and its 200 day moving average price is $8.24.",PODD,0.052112,0.07788,Neutral
New Relic  ( NYSE:NEWR )  Stock Rating Upgraded by StockNews.com,https://www.etfdailynews.com/2023/01/18/new-relic-nysenewr-stock-rating-upgraded-by-stocknews-com/,2023-01-18 08:08:42,"New Relic ( NYSE:NEWR - Get Rating ) was upgraded by research analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a research note issued on Wednesday. Several other equities research analysts also recently weighed in on NEWR. Robert W.",PODD,0.049629,0.102205,Neutral
Ampio Pharmaceuticals  ( NYSE:AMPE )  Coverage Initiated by Analysts at StockNews.com,https://reporter.am/2023/01/18/ampio-pharmaceuticals-nyseampe-coverage-initiated-by-analysts-at-stocknews-com-2.html,2023-01-18 08:08:42,Ampio Pharmaceuticals ( NYSE:AMPE ) Coverage Initiated by ... Armenian Reporter ...,PODD,0.16849,0.10225,Neutral
Primo Water  ( NASDAQ:PRMW )  Rating Lowered to Buy at StockNews.com,https://reporter.am/2023/01/18/primo-water-nasdaqprmw-rating-lowered-to-buy-at-stocknews-com.html,2023-01-18 08:08:42,Primo Water ( NASDAQ:PRMW ) Rating Lowered to Buy at ... Armenian Reporter ...,PODD,0.126784,0.084212,Neutral
Acuity Brands  ( NYSE:AYI )  Upgraded at StockNews.com,https://www.etfdailynews.com/2023/01/18/acuity-brands-nyseayi-upgraded-at-stocknews-com/,2023-01-18 07:38:46,StockNews.com upgraded shares of Acuity Brands ( NYSE:AYI - Get Rating ) from a buy rating to a strong-buy rating in a research note published on Tuesday morning. Other equities analysts have also issued research reports about the stock.,PODD,0.04076,0.135222,Neutral
Laredo Petroleum  ( NYSE:LPI )  Research Coverage Started at StockNews.com,https://www.etfdailynews.com/2023/01/18/laredo-petroleum-nyselpi-research-coverage-started-at-stocknews-com/,2023-01-18 07:38:45,Laredo Petroleum ( NYSE:LPI ) Research Coverage Started at ... ETF Daily News ...,PODD,0.058472,0.200006,Somewhat-Bullish
Schlumberger  ( NYSE:SLB )  Upgraded to Buy at StockNews.com,https://reporter.am/2023/01/18/schlumberger-nyseslb-upgraded-to-buy-at-stocknews-com.html,2023-01-18 07:38:45,StockNews.com upgraded shares of Schlumberger ( NYSE:SLB - Get Rating ) from a hold rating to a buy rating in a research report sent to investors on Tuesday morning.,PODD,0.047654,0.131745,Neutral
StockNews.com Lowers United Microelectronics  ( NYSE:UMC )  to Buy,https://www.etfdailynews.com/2023/01/18/stocknews-com-lowers-united-microelectronics-nyseumc-to-buy/,2023-01-18 07:38:44,"StockNews.com downgraded shares of United Microelectronics ( NYSE:UMC - Get Rating ) from a strong-buy rating to a buy rating in a research report report published on Tuesday morning. Separately, Bank of America started coverage on United Microelectronics in a research note on Monday, January ...",PODD,0.092927,0.238156,Somewhat-Bullish
"StockNews.com Upgrades Kimball Electronics  ( NASDAQ:KE )  to ""Buy""",https://www.etfdailynews.com/2023/01/18/stocknews-com-upgrades-kimball-electronics-nasdaqke-to-buy/,2023-01-18 07:38:44,StockNews.com upgraded shares of Kimball Electronics ( NASDAQ:KE - Get Rating ) from a hold rating to a buy rating in a research note released on Tuesday. NASDAQ KE opened at $24.46 on Tuesday. The business has a 50 day moving average price of $23.20 and a two-hundred day moving average price ...,PODD,0.07446,0.208413,Somewhat-Bullish
ARMOUR Residential REIT  ( NYSE:ARR )  Upgraded at StockNews.com,https://www.etfdailynews.com/2023/01/18/armour-residential-reit-nysearr-upgraded-at-stocknews-com/,2023-01-18 07:38:44,StockNews.com upgraded shares of ARMOUR Residential REIT ( NYSE:ARR - Get Rating ) to a sell rating in a research note released on Tuesday. Several other equities analysts have also issued reports on ARR. B.,PODD,0.067158,0.216337,Somewhat-Bullish
Chipotle Mexican Grill  ( NYSE:CMG )  Upgraded by StockNews.com to Buy,https://www.etfdailynews.com/2023/01/18/chipotle-mexican-grill-nysecmg-upgraded-by-stocknews-com-to-buy/,2023-01-18 07:38:44,Chipotle Mexican Grill ( NYSE:CMG ) Upgraded by StockNews.com ... ETF Daily News ...,PODD,0.059636,0.126001,Neutral
StockNews.com Upgrades Amgen  ( NASDAQ:AMGN )  to Strong-Buy,https://www.etfdailynews.com/2023/01/18/stocknews-com-upgrades-amgen-nasdaqamgn-to-strong-buy/,2023-01-18 07:38:43,StockNews.com upgraded shares of Amgen ( NASDAQ:AMGN - Get Rating ) from a buy rating to a strong-buy rating in a report issued on Tuesday morning. Other equities analysts have also issued research reports about the stock.,PODD,0.050572,0.041997,Neutral
Clearfield  ( NASDAQ:CLFD )  Upgraded to Hold by StockNews.com,https://www.etfdailynews.com/2023/01/18/clearfield-nasdaqclfd-upgraded-to-hold-by-stocknews-com/,2023-01-18 07:38:42,StockNews.com upgraded shares of Clearfield ( NASDAQ:CLFD - Get Rating ) from a sell rating to a hold rating in a research note released on Tuesday morning. Other equities research analysts have also issued reports about the stock. Cowen began coverage on shares of Clearfield in a report on ...,PODD,0.066784,0.15142,Somewhat-Bullish
Big Lots  ( NYSE:BIG )  Upgraded at StockNews.com,https://www.etfdailynews.com/2023/01/18/big-lots-nysebig-upgraded-at-stocknews-com/,2023-01-18 07:38:42,"StockNews.com upgraded shares of Big Lots ( NYSE:BIG - Get Rating ) from a sell rating to a hold rating in a research report released on Tuesday morning. Several other equities analysts have also commented on BIG. Credit Suisse Group assumed coverage on shares of Big Lots in a report on Monday, ...",PODD,0.058472,0.106989,Neutral
Corcept Therapeutics  ( NASDAQ:CORT )  Rating Lowered to Buy at StockNews.com,https://www.etfdailynews.com/2023/01/18/corcept-therapeutics-nasdaqcort-rating-lowered-to-buy-at-stocknews-com/,2023-01-18 07:38:42,Corcept Therapeutics ( NASDAQ:CORT ) Rating Lowered to Buy at ... ETF Daily News ...,PODD,0.053509,0.004001,Neutral
"Futures Drop Ahead Of Manufacturing, Inflation Data",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-drop-ahead-of-manufacturing-inflation-data-goldman-sachs-falls-on-earnings-miss/,2023-01-17 13:17:00,"Dow Jones futures dropped Tuesday morning ahead of New York regional manufacturing data, and another round of key inflation numbers due out Wednesday. Fourth-quarter earnings season continues Tuesday, with results from Dow Jones stock Goldman Sachs ( GS ) and Morgan Stanley ( MS ) .",PODD,0.130571,0.125975,Neutral
Market Breaks Past Resistance; Tesla's Painful Transition,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-clears-resistance-tesla-big-transition/,2023-01-15 21:40:00,Dow Jones Futures Due: Market Rally Clears Resistance. Tesla's ... Investor's Business Daily ...,PODD,0.102712,0.060245,Neutral
"Investing Action Plan: Netflix, Schlumberger Earnings; Will Oil Top $80?",https://www.investors.com/research/investing-action-plan/stock-market-investing-action-plan-netflix-slb-earnings-will-oil-top-80/,2023-01-13 23:13:00,"Investing Action Plan: Netflix, Schlumberger Earnings. Will Oil Top ... Investor's Business Daily ...",PODD,0.087397,0.089626,Neutral
Insulet  ( PODD )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2039331/insulet-podd-stock-sinks-as-market-gains-what-you-should-know,2023-01-13 23:00:22,"Insulet (PODD) closed the most recent trading day at $305.89, moving -0.13% from the previous trading session.",PODD,0.568148,0.2575,Somewhat-Bullish
Market Breaks Past Resistance; Tesla's Painful Transition,https://www.investors.com/market-trend/stock-market-today/market-rally-breaks-through-resistance-5-stocks-in-buy-areas-teslas-painful-transition/,2023-01-13 22:30:00,Market Rally Breaks Past Resistance. Tesla's Painful Transition ... Investor's Business Daily ...,PODD,0.108076,0.061253,Neutral
Novo Nordisk's Home Field Diabetes Advantage Just Deepened,https://www.investors.com/news/technology/nvo-stock-jumps-after-novo-nordisk-expands-diabetes-lead-over-pfizer-eli-lilly/,2023-01-13 15:58:00,NVO Stock Jumps After Novo Nordisk Expands Diabetes Lead Over ... Investor's Business Daily ...,PODD,0.092213,0.0,Neutral
How This IBD Stock Of The Day Built A 'Moat' To Keep Out Rivals,https://www.investors.com/research/ibd-stock-of-the-day/podd-stock-how-insulet-built-several-moats-to-fend-off-rivals/,2023-01-12 18:05:00,PODD Stock: How Insulet Built Several 'Moats' To Fend Off Rivals Investor's Business Daily ...,PODD,0.644033,0.41416,Bullish
Insulet  ( PODD )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2045091/insulet-podd-stock-sinks-as-market-gains-what-you-should-know,2023-01-26 23:00:21,"In the latest trading session, Insulet (PODD) closed at $286.13, marking a -1.23% move from the previous day.",PODD,0.591019,0.222563,Somewhat-Bullish
"As Per The Home Healthcare Equipment Market Forecast, The Rise In The Ageing Population Will Drive Market Growth As Per The Business Research Company's Home Healthcare Equipment Global Market Report 2023",https://www.benzinga.com/pressreleases/23/01/g30589113/as-per-the-home-healthcare-equipment-market-forecast-the-rise-in-the-ageing-population-will-drive-,2023-01-26 16:30:00,"LONDON, Jan. 26, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's research on the home healthcare equipment market forecasts the rise in the ageing population to propel the growth of the home healthcare equipment market going forward.",PODD,0.0428,-0.052565,Neutral
Insulet  ( PODD )  Dips More Than Broader Markets: What You Should Know,https://www.zacks.com/stock/news/2044431/insulet-podd-dips-more-than-broader-markets-what-you-should-know,2023-01-25 23:15:22,"Insulet (PODD) closed the most recent trading day at $289.70, moving -0.68% from the previous trading session.",PODD,0.658003,0.196476,Somewhat-Bullish
Global Wearable Patches Market Report 2022-2031: Lucrative Opportunities in Deployments of an End-to-End Platform for Services,https://www.prnewswire.com/news-releases/global-wearable-patches-market-report-2022-2031-lucrative-opportunities-in-deployments-of-an-end-to-end-platform-for-services-301729654.html,2023-01-25 10:50:00,Global Wearable Patches Market Report 2022-2031: Lucrative ... PR ...,PODD,0.039289,0.110798,Neutral
Diabetes Care Devices Market will value USD 56.9 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30552821/diabetes-care-devices-market-will-value-usd-56-9-billion-by-2030-greyviews,2023-01-24 17:00:00,"Pune India, Jan. 24, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the diabetes care devices market is operating and ...",PODD,0.024724,0.090593,Neutral
The benefits and risks of personal medical monitoring on the internet,https://www.cnbc.com/2023/01/21/the-benefits-and-risks-of-personal-medical-monitoring-on-the-internet.html,2023-01-21 14:46:43,"Personal medical devices for conditions such as diabetes and sleep apnea are connecting to the internet, introducing privacy, hacking and health risks.",PODD,0.029472,0.073099,Neutral
Insulet  ( PODD )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2051269/insulet-podd-stock-sinks-as-market-gains-what-you-should-know,2023-02-07 23:00:22,"Insulet (PODD) closed at $289.36 in the latest trading session, marking a -0.96% move from the prior day.",PODD,0.578355,0.214492,Somewhat-Bullish
INTERIM REPORT FOR Q1 2022/23,https://www.globenewswire.com/news-release/2023/02/07/2602585/0/en/INTERIM-REPORT-FOR-Q1-2022-23.html,2023-02-07 06:00:00,"Ambu delivers solid performance for Q1 2022/23. The company posts 4% organic revenue growth for the quarter and continues to progress its new ZOOM IN strategy and global transform­ation program. Financial guidance maintained for the fiscal year 2022/23, with organic revenue growth at 5-8% and ...",PODD,0.045054,0.049284,Neutral
Insulet  ( PODD )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2048021/insulet-podd-outpaces-stock-market-gains-what-you-should-know,2023-02-01 23:00:17,"Insulet (PODD) closed the most recent trading day at $290.53, moving +1.12% from the previous trading session.",PODD,0.664604,0.415424,Bullish
Boston Scientific  ( BSX )  Lags Q4 Earnings Estimates,https://www.zacks.com/stock/news/2047498/boston-scientific-bsx-lags-q4-earnings-estimates,2023-02-01 12:55:05,"Boston Scientific (BSX) delivered earnings and revenue surprises of -4.26% and 0.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?",PODD,0.138066,0.0,Neutral
3 Growth Stocks That Have Delivered 10X Returns Over the Past Decade,https://www.fool.com/investing/2023/02/14/growth-stocks-delivered-10x-returns-over-decade/,2023-02-14 15:11:54,Are these stocks still good buys today?,PODD,0.333685,0.30912,Somewhat-Bullish
Insulet  ( PODD )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2053698/insulet-podd-outpaces-stock-market-gains-what-you-should-know,2023-02-13 23:00:21,"Insulet (PODD) closed the most recent trading day at $298.61, moving +1.28% from the previous trading session.",PODD,0.655824,0.361234,Bullish
Insulet  ( PODD )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2052872/insulet-podd-to-report-q4-earnings-whats-in-the-cards,2023-02-10 14:26:00,"In Drug Delivery, Insulet (PODD) is expected to have faced higher manufacturing costs in Q4.",PODD,0.422493,0.306459,Somewhat-Bullish
DexCom  ( DXCM )  Q4 2022 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/02/09/dexcom-dxcm-q4-2022-earnings-call-transcript/,2023-02-10 02:30:47,"DXCM earnings call for the period ending December 31, 2022.",PODD,0.004646,0.134985,Neutral
"Is Insulet  ( PODD )  a Solid Growth Stock? 3 Reasons to Think ""Yes""",https://www.zacks.com/stock/news/2059973/is-insulet-podd-a-solid-growth-stock-3-reasons-to-think-yes,2023-02-28 17:45:04,Insulet (PODD) could produce exceptional returns because of its solid growth attributes.,PODD,0.50605,0.370118,Bullish
Insulet  ( PODD )  Upgraded to Buy: What Does It Mean for the Stock?,https://www.zacks.com/stock/news/2059950/insulet-podd-upgraded-to-buy-what-does-it-mean-for-the-stock,2023-02-28 17:00:08,"Insulet (PODD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.",PODD,0.364275,0.311471,Somewhat-Bullish
Teladoc Health  ( TDOC )  Down 8.1% Since Q4 Earnings Release,https://www.zacks.com/stock/news/2059369/teladoc-health-tdoc-down-81-since-q4-earnings-release,2023-02-27 15:42:00,"Teladoc Health's (TDOC) fourth-quarter results bear the brunt of escalating expenses. Management expects 2023 revenues within $2,550-$2,675 million, way higher than the 2022 figure.",PODD,0.109455,0.060579,Neutral
"Insulet  ( PODD )  Q4 Earnings Beat Estimates, Margins Down",https://www.zacks.com/stock/news/2058923/insulet-podd-q4-earnings-beat-estimates-margins-down,2023-02-24 16:59:00,Insulet's (PODD) Q4 performance benefits from record quarterly U.S. and Total Omnipod new customer starts.,PODD,0.40062,0.283309,Somewhat-Bullish
Insulet  ( PODD )  Q4 Earnings and Revenues Beat Estimates,https://www.zacks.com/stock/news/2058361/insulet-podd-q4-earnings-and-revenues-beat-estimates,2023-02-23 22:15:05,"Insulet (PODD) delivered earnings and revenue surprises of 129.17% and 11.91%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?",PODD,0.407844,0.147526,Neutral
"S&P 500 Breaks Final Support; Watch JPMorgan, These Stocks",https://www.investors.com/market-trend/stock-market-today/what-to-do-as-sp-500-breaks-final-support-watch-jpmorgan-these-bank-stocks/,2023-03-10 23:48:00,"S&P 500 Breaks Final Support. Watch JPMorgan, These Stocks Investor's Business Daily ...",PODD,0.07031,0.0,Neutral
Insulet  ( PODD )  Stock Moves -0.97%: What You Should Know,https://www.zacks.com/stock/news/2064421/insulet-podd-stock-moves--097-what-you-should-know,2023-03-10 22:00:11,"Insulet (PODD) closed at $280.36 in the latest trading session, marking a -0.97% move from the prior day.",PODD,0.680677,0.157064,Somewhat-Bullish
U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems,https://investingnews.com/u-s-fda-clears-abbott-s-freestyle-libre-r-2-and-freestyle-libre-r-3-sensors-for-integration-with-automated-insulin-delivery-systems/,2023-03-06 12:20:51,- Abbott ( NYSE: ABT ) today announced that the U.S. Food and Drug Administration ( FDA ) has cleared its FreeStyle Libre 2 and FreeStyle Libre 3 integrated continuous glucose monitoring ( iCGM ) system sensors for integration with automated insulin delivery ( AID ) systems.,PODD,0.066784,0.142377,Neutral
U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems,https://www.prnewswire.com/news-releases/us-fda-clears-abbotts-freestyle-libre-2-and-freestyle-libre-3-sensors-for-integration-with-automated-insulin-delivery-systems-301763020.html,2023-03-06 12:00:00,U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 ... PR ...,PODD,0.050044,0.142212,Neutral
Insulet  ( PODD )  Stock Moves -1.05%: What You Should Know,https://www.zacks.com/stock/news/2067605/insulet-podd-stock-moves--105-what-you-should-know,2023-03-17 22:00:24,"In the latest trading session, Insulet (PODD) closed at $309.09, marking a -1.05% move from the previous day.",PODD,0.614479,0.128803,Neutral
Insulet  ( PODD )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2067037/insulet-podd-gains-but-lags-market-what-you-should-know,2023-03-16 22:15:20,"In the latest trading session, Insulet (PODD) closed at $312.36, marking a +1.45% move from the previous day.",PODD,0.628473,0.317043,Somewhat-Bullish
3 Reasons Why Growth Investors Shouldn't Overlook Insulet  ( PODD ) ,https://www.zacks.com/stock/news/2066920/3-reasons-why-growth-investors-shouldnt-overlook-insulet-podd,2023-03-16 16:45:05,Insulet (PODD) could produce exceptional returns because of its solid growth attributes.,PODD,0.510302,0.337696,Somewhat-Bullish
Insulet Joins Elite List Of Stocks With 95-Plus Composite Rating,https://www.investors.com/ibd-data-stories/insulet-joins-elite-list-of-stocks-with-95-plus-composite-rating-3/,2023-03-16 08:00:00,"Insulet ( PODD ) saw its IBD SmartSelect Composite Rating rise to 96 Thursday, up from 94 the day before. X The revised score means the stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength. Insulet is currently forming a consolidation, with a ...",PODD,0.651499,-0.107845,Neutral
"AMD, Chipotle Headline This IBD Screen Of The Day",https://www.investors.com/research/amd-stock-nears-latest-buy-point-chipotle-boasts-rising-profit-estimates/,2023-03-15 18:29:58,AMD Stock Nears Latest Buy Point. Chipotle Boasts Rising Profit ... Investor's Business Daily ...,PODD,0.216215,0.146479,Neutral
Heska Shows Rising Relative Strength; Still Shy Of Key Threshold,https://www.investors.com/ibd-data-stories/heska-shows-rising-relative-strength-still-shy-of-key-threshold/,2023-03-15 08:00:00,Heska Shows Rising Relative Strength. Still Shy Of Key Threshold Investor's Business Daily ...,PODD,0.350564,0.0,Neutral
Stocks To Watch: Integer Holdings Sees RS Rating Rise To 82,https://www.investors.com/ibd-data-stories/stocks-to-watch-integer-holdings-sees-rs-rating-rise-to-82/,2023-03-15 08:00:00,"Integer Holdings ( ITGR ) had its Relative Strength ( RS ) Rating upgraded from 74 to 82 Wednesday. X As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength.",PODD,0.327366,0.0,Neutral
GLUCOTRACK PROVIDES SHAREHOLDER UPDATE,https://www.globenewswire.com/news-release/2023/03/14/2626845/0/en/GLUCOTRACK-PROVIDES-SHAREHOLDER-UPDATE.html,2023-03-14 14:00:00,"Rutherford, NJ, March 14, 2023 ( GLOBE NEWSWIRE ) -- GlucoTrack, Inc. ( Nasdaq: GCTK ) ( ""GlucoTrack"" or the ""Company"" ) , a medical device and digital health platform company focused on diabetes and prediabetes, announced today that Paul V.",PODD,0.03642,0.110414,Neutral
"Company News for Mar 14, 2023",https://www.zacks.com/stock/news/2065310/company-news-for-mar-14-2023,2023-03-14 13:24:00,"Companies In The News Are: SGEN, PFE, PODD, SIVB, ILMN, PNC.",PODD,0.535653,0.016606,Neutral
"Dow Jones Rises With Gold, Bitcoin Amid Bank Sell-Off; Analysts See Rate Freeze In March",https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-as-gold-bitcoin-rise-amidst-bank-run-fears-analysts-see-rate-hike-pause-as-banks-crater/,2023-03-13 17:10:31,"Dow Jones Rises With Gold, Bitcoin Amid Bank Sell-Off. Analysts ... Investor's Business Daily ...",PODD,0.109705,-0.202145,Somewhat-Bearish
"Stocks making the biggest moves midday: First Republic Bank, Moderna, Newmont, Illumina and more",https://www.cnbc.com/2023/03/13/stocks-moving-big-midday-frc-mrna-nem-prvb.html,2023-03-13 16:56:32,These are the stocks posting the largest moves midday.,PODD,0.134968,0.095609,Neutral
Abbott  ( ABT )  to Pair CGM Sensors & AID System on FDA Clearance,https://www.zacks.com/stock/news/2064906/abbott-abt-to-pair-cgm-sensors-aid-system-on-fda-clearance,2023-03-13 16:41:00,Abbott Laboratories (ABT) receives FDA clearance for the integration of its iCGM system sensors with automated insulin delivery (AID) systems.,PODD,0.047371,0.165625,Somewhat-Bullish
We're adding to 3 stocks in Monday's volatile market and putting 4 more on our buy list,https://www.cnbc.com/2023/03/13/were-adding-to-3-stocks-in-mondays-volatile-market-and-putting-4-more-on-our-buy-list.html,2023-03-13 16:02:42,"In keeping with Jim Cramer's commentary Sunday evening, the Club is putting some of its cash to work.",PODD,0.102231,0.16429,Somewhat-Bullish
Futures Loom: FDIC Ready For Monday After SVB Collapse?,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fdic-ready-after-svb-financial-collapse-watch-these-bank-stocks/,2023-03-12 16:38:10,Futures: FDIC Ready For Monday After SVB Collapse? Investor's Business Daily ...,PODD,0.058188,0.0,Neutral
Insulet  ( PODD )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2072160/insulet-podd-gains-but-lags-market-what-you-should-know,2023-03-29 22:15:18,"Insulet (PODD) closed at $312.90 in the latest trading session, marking a +0.52% move from the prior day.",PODD,0.622414,0.336652,Somewhat-Bullish
"Insulet  ( PODD )  Benefits From Omnipod 5 Launch, Expansion",https://www.zacks.com/stock/news/2071409/insulet-podd-benefits-from-omnipod-5-launch-expansion,2023-03-28 15:24:00,Insulet (PODD) witnesses continued uptake of Omnipod through the U.S. pharmacy channel.,PODD,0.515543,0.451043,Bullish
Insulet  ( PODD )  is a Top-Ranked Growth Stock: Should You Buy?,https://www.zacks.com/stock/news/2071338/insulet-podd-is-a-top-ranked-growth-stock-should-you-buy,2023-03-28 13:45:03,"Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",PODD,0.616842,0.358122,Bullish
"The Zacks Analyst Blog Highlights Comfort Systems, Hershey, Wynn Resorts, Insulet and Lattice Semiconductor",https://www.zacks.com/stock/news/2070622/the-zacks-analyst-blog-highlights-comfort-systems-hershey-wynn-resorts-insulet-and-lattice-semiconductor,2023-03-27 10:50:00,"Comfort Systems, Hershey, Wynn Resorts, Insulet and Lattice Semiconductor are included in this Analyst Blog.",PODD,0.186378,0.025264,Neutral
Fed Policy Pause & Yellen's Assurance Buoy Wall Street: 5 Picks,https://www.zacks.com/stock/news/2070077/fed-policy-pause-yellens-assurance-buoy-wall-street-5-picks,2023-03-24 13:01:00,"Thanks to the Fed's willingness to pause its interest rate hikes, it's prudent for investors to place their bets on growth stocks like Comfort Systems USA (FIX), Hershey (HSY), Wynn Resorts (WYNN), Insulet (PODD), and Lattice Semiconductor (LSCC).",PODD,0.151222,0.070957,Neutral
Insulet  ( PODD )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2069922/insulet-podd-stock-sinks-as-market-gains-what-you-should-know,2023-03-23 22:15:22,"In the latest trading session, Insulet (PODD) closed at $311.49, marking a -1.16% move from the previous day.",PODD,0.537474,0.336056,Somewhat-Bullish
"Global Tubeless Insulin Pump Market Predicted to Garner a Revenue of $2,837.6 Million and Rise at a CAGR of 23.4% over the Analysis Timeframe 2019-2026 [95-Pages] | Explained by Research Dive",https://www.benzinga.com/pressreleases/23/04/g31725410/global-tubeless-insulin-pump-market-predicted-to-garner-a-revenue-of-2-837-6-million-and-rise-at-a,2023-04-10 13:02:00,"New York, USA, April 10, 2023 ( GLOBE NEWSWIRE ) -- According to a report published by Research dive, the global tubeless insulin pump market is envisioned to generate a revenue of $2,837.6 million, growing at a striking CAGR of 23.4% throughout the forecast timeframe from 2019 to 2026.",PODD,0.069697,0.116816,Neutral
Quest Diagnostics  ( DGX )  Advances Access to Transplant Services,https://www.zacks.com/stock/news/2076056/quest-diagnostics-dgx-advances-access-to-transplant-services,2023-04-10 10:47:00,Quest Diagnostics' (DGX) upgrade to advanced diagnostics and support services is likely to feature personalized patient access to service centers and mobile phlebotomists.,PODD,0.218325,0.080515,Neutral
Teleflex Shows Improved Relative Price Performance; Still Shy Of Benchmark,https://www.investors.com/ibd-data-stories/teleflex-shows-improved-relative-price-performance-still-shy-of-benchmark/,2023-04-10 07:00:00,Teleflex Shows Improved Relative Price Performance. Still Shy Of ... Investor's Business Daily ...,PODD,0.31482,0.0,Neutral
Zimmer Biomet Holdings Scores Relative Strength Rating Upgrade; Hits Key Threshold,https://www.investors.com/ibd-data-stories/zimmer-biomet-holdings-scores-relative-strength-rating-upgrade-hits-key-threshold/,2023-04-10 07:00:00,Zimmer Biomet Holdings Scores Relative Strength Rating Upgrade ... Investor's Business Daily ...,PODD,0.306963,0.0,Neutral
5 S&P 500 Stocks Showing Strength As Recession Fears Rise,https://www.investors.com/news/5-sp-500-stocks-showing-strength-as-recession-fears-rise/,2023-04-07 17:14:00,"S&P 500 medical stocks Cardinal Health ( CAH ) , Vertex Pharmaceuticals ( VRTX ) , Merck ( MRK ) , Intuitive Surgical ( ISRG ) and Insulet ( PODD ) are in focus this week. Medical stocks are coming into favor again - with companies involved in biotech, pharmaceuticals, medical products and ...",PODD,0.214937,0.082914,Neutral
"Action Plan: Bank Earnings In Focus; Delta, UnitedHealth On Tap",https://www.investors.com/research/investing-action-plan/jpmorgan-big-bank-earnings-get-special-attention-delta-unitedhealth-due/,2023-04-06 16:55:00,JPMorgan and other bank earnings On Tap Investor's Business Daily ...,PODD,0.090134,0.0,Neutral
Select Medical  ( SEM )  Buys Richmond Post-Acute Care Facility,https://www.zacks.com/stock/news/2075741/select-medical-sem-buys-richmond-post-acute-care-facility,2023-04-06 16:00:00,Select Medical (SEM) acquires the Vibra Hospital of Richmond to provide enhanced critical illness recovery care across Virginia.,PODD,0.222838,0.139515,Neutral
Boston Scientific  ( BSX )  Hits 52-Week High: What's Driving It?,https://www.zacks.com/stock/news/2075403/boston-scientific-bsx-hits-52-week-high-whats-driving-it,2023-04-06 13:05:00,Boston Scientific (BSX) outperforms the industry and the S&P 500 due to several new acquisitions and the long-term growth prospects of the WATCHMAN device.,PODD,0.135857,0.034407,Neutral
Cardiovascular Systems  ( CSII )  Finishes ECLIPSE Trial Enrollment,https://www.zacks.com/stock/news/2074814/cardiovascular-systems-csii-finishes-eclipse-trial-enrollment,2023-04-05 13:11:00,Cardiovascular Systems' (CSII) ECLIPSE clinical trial data is likely to help physicians form an optimal treatment plan for patients with severely calcified coronary arteries.,PODD,0.259727,0.094528,Neutral
Insulet  ( PODD )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2074587/insulet-podd-gains-as-market-dips-what-you-should-know,2023-04-04 22:15:20,"Insulet (PODD) closed the most recent trading day at $319.91, moving +0.34% from the previous trading session.",PODD,0.670742,0.148103,Neutral
3 Reasons Growth Investors Will Love Insulet  ( PODD ) ,https://www.zacks.com/stock/news/2074454/3-reasons-growth-investors-will-love-insulet-podd,2023-04-04 16:45:05,"Insulet (PODD) possesses solid growth attributes, which could help it handily outperform the market.",PODD,0.514619,0.40889,Bullish
Here's Why You Should Retain Amedisys  ( AMED )  Stock for Now,https://www.zacks.com/stock/news/2074160/heres-why-you-should-retain-amedisys-amed-stock-for-now,2023-04-04 12:43:00,Amedisys's (AMED) share price is likely to grow following an impressive fourth-quarter 2022 performance and new partnerships.,PODD,0.135347,0.034337,Neutral
Bruker Corporation  ( BRKR )  Hits 52-Week High: What's Driving It?,https://www.zacks.com/stock/news/2073617/bruker-corporation-brkr-hits-52-week-high-whats-driving-it,2023-04-03 12:53:00,Bruker Corporation (BRKR) outperforms the industry and the S&P 500 due to impressive quarterly results and segmental prospects.,PODD,0.153145,0.036919,Neutral
Myriad Genetics  ( MYGN )  Gets Permit to Expand Tumor Testing,https://www.zacks.com/stock/news/2080924/myriad-genetics-mygn-gets-permit-to-expand-tumor-testing,2023-04-19 12:53:00,Myriad Genetics (MYGN) and Intermountain Precision Genomics receive the New York State Clinical Laboratory Permit to offer solid tumor testing to patients in all 50 U.S. states.,PODD,0.217346,0.080229,Neutral
Insulet Readies Breakout And Primes 56% Growth Ahead,https://www.investors.com/research/breakout-stocks-technical-analysis/insulet-joins-sp-500-as-podd-stock-gets-ready-to-spring-higher-with-q1-earnings-due/,2023-04-19 12:01:00,Insulet Joins S&P 500 And Gets Ready To Pump Up New Breakout ... Investor's Business Daily ...,PODD,0.806749,0.334839,Somewhat-Bullish
"Insulet's  ( PODD )  New Omnipod, Strategic Moves Drive Growth",https://www.zacks.com/stock/news/2080596/insulets-podd-new-omnipod-strategic-moves-drive-growth,2023-04-18 16:28:00,"Insulet (PODD) has been progressing well with respect to its four-pillar strategy, where the first two pillars include expanding access and awareness and delivering consumer-focused innovation.",PODD,0.444401,0.371336,Bullish
Diabetes Devices Market to Reach Over USD 90.2 Bn by 2031 with 6.0% of CAGR | TMR Study,https://www.benzinga.com/pressreleases/23/04/g31843569/diabetes-devices-market-to-reach-over-usd-90-2-bn-by-2031-with-6-0-of-cagr-tmr-study,2023-04-17 21:30:00,"Wilmington, Delaware, United States, April 18, 2023 ( GLOBE NEWSWIRE ) -- The global diabetes devices market was valued at USD 50.5 Bn in 2021 and is anticipated to reach USD 90.2 Bn by 2031. Increase in prevalence of diabetes has led to rise in demand for diabetes care devices and diabetes ...",PODD,0.038468,0.062437,Neutral
Abbott  ( ABT )  Gets FDA Clearance for FreeStyle Libre 3 Reader,https://www.zacks.com/stock/news/2079480/abbott-abt-gets-fda-clearance-for-freestyle-libre-3-reader,2023-04-17 12:05:00,Abbott (ABT) receives the FDA clearance for a standalone reader to be used for the FreeStyle Libre 3 iCGM system.,PODD,0.230235,0.083999,Neutral
Walgreens  ( WBA )  Declares Partnership With Prothena Corporation,https://www.zacks.com/stock/news/2078721/walgreens-wba-declares-partnership-with-prothena-corporation,2023-04-14 11:30:00,"Walgreens (WBA) collaborates with Prothena Corporation to support patient awareness, participation and representation in a clinical trial of Prothena's Alzheimer's drug candidate, PRX012.",PODD,0.22861,0.083524,Neutral
BRKR's Canopy Biosciences Partners With Enable Medicine,https://www.zacks.com/stock/news/2078009/brkrs-canopy-biosciences-partners-with-enable-medicine,2023-04-13 11:37:00,BRKR's Canopy Biosciences collaborates with Enable Medicine to bring advanced spatial analysis pipelines to the Canopy CellScape System for high-plex spatial biology.,PODD,0.256314,0.091603,Neutral
Illumina  ( ILMN )  Partners With Henry Ford Health for NGS Test,https://www.zacks.com/stock/news/2077349/illumina-ilmn-partners-with-henry-ford-health-for-ngs-test,2023-04-12 12:01:00,Illumina (ILMN) collaborates with Henry Ford Health to conduct a series of studies that is likely to focus on the genetic drivers of cardiovascular disease.,PODD,0.222327,0.081685,Neutral
Henry Schein  ( HSIC )  Acquires Majority Stake in Biotech Dental,https://www.zacks.com/stock/news/2076729/henry-schein-hsic-acquires-majority-stake-in-biotech-dental,2023-04-11 11:33:00,Henry Schein (HSIC) announces that the completion of the Biotech Dental partnership brings forth the company's several important solutions to customers.,PODD,0.211652,0.032699,Neutral
Insulet  ( PODD )  Expected to Beat Earnings Estimates: Can the Stock Move Higher?,https://www.zacks.com/stock/news/2086052/insulet-podd-expected-to-beat-earnings-estimates-can-the-stock-move-higher,2023-04-27 14:02:54,Insulet (PODD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,PODD,0.262994,0.161881,Somewhat-Bullish
"Align Technology  ( ALGN )  Q1 Earnings Beat, Margins Contract",https://www.zacks.com/stock/news/2085712/align-technology-algn-q1-earnings-beat-margins-contract,2023-04-27 12:13:00,Align Technology (ALGN) delivers better-than-expected revenues and earnings in the first quarter of 2023 but suffers significant foreign currency woes.,PODD,0.142144,0.003762,Neutral
"The Zacks Analyst Blog Highlights BioRad Laboratories, Henry Schein, Insulet, Abbott and LabCorp",https://www.zacks.com/stock/news/2085609/the-zacks-analyst-blog-highlights-biorad-laboratories-henry-schein-insulet-abbott-and-labcorp,2023-04-27 09:48:00,"BioRad Laboratories, Henry Schein, Insulet, Abbott and LabCorp are included in this Analyst Blog.",PODD,0.218254,0.0,Neutral
"Illumina  ( ILMN )  Q1 Earnings Beat Estimates, Margins Contract",https://www.zacks.com/stock/news/2084868/illumina-ilmn-q1-earnings-beat-estimates-margins-contract,2023-04-26 13:26:00,"Illumina's (ILMN) Q1 revenues decline year over year, reflecting the impact of Covid-19 monitoring headwinds and the transition of its high-throughput customers to NovaSeq X.",PODD,0.123844,0.003498,Neutral
"SurModics  ( SRDX )  Reports Q2 Loss, Tops Revenue Estimates",https://www.zacks.com/stock/news/2084763/surmodics-srdx-reports-q2-loss-tops-revenue-estimates,2023-04-26 12:25:13,"SurModics (SRDX) delivered earnings and revenue surprises of 18.37% and 4.63%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?",PODD,0.139265,0.0,Neutral
3 MedTech Stocks Likely to Beat Estimates in Q1 Earnings,https://www.zacks.com/stock/news/2084748/3-medtech-stocks-likely-to-beat-estimates-in-q1-earnings,2023-04-26 12:14:00,"MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how BIO, HSIC and PODD are poised ahead of their earnings releases.",PODD,0.19661,0.0,Neutral
STERIS  ( STE )  Set to Post Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2083979/steris-ste-set-to-post-q4-earnings-whats-in-the-cards,2023-04-25 12:51:00,"STERIS' (STE) fourth-quarter fiscal 2023 results are likely to reflect an impressive performance across the Healthcare and AST segments, with a gradual improvement in the supply chain.",PODD,0.208644,0.074957,Neutral
BioRad Laboratories  ( BIO )  to Post Q1 Earnings: What's in Store?,https://www.zacks.com/stock/news/2083202/biorad-laboratories-bio-to-post-q1-earnings-whats-in-store,2023-04-24 10:59:00,"Bio-Rad Laboratories' (BIO) first-quarter 2023 results are likely to reflect an impressive performance across its Life Science segment, with a gradual reduction in backlogs and an improvement in the supply chain.",PODD,0.248343,0.086198,Neutral
Why Insulet  ( PODD )  is Poised to Beat Earnings Estimates Again,https://www.zacks.com/stock/news/2082929/why-insulet-podd-is-poised-to-beat-earnings-estimates-again,2023-04-21 16:10:12,Insulet (PODD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,PODD,0.413199,0.418769,Bullish
"Option Trading: Insulet Butterfly Taps Into Stock's Leadership, Potential Rally",https://www.investors.com/research/options/option-trading-insulet-butterfly-taps-into-stocks-leadership-potential-rally/,2023-04-21 14:13:00,Option Trading: Insulet Butterfly Taps Into Stock's Leadership ... Investor's Business Daily ...,PODD,0.208914,0.266522,Somewhat-Bullish
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names,https://www.zacks.com/stock/news/2082636/looking-for-stocks-with-positive-earnings-momentum-check-out-these-2-medical-names,2023-04-21 12:50:07,Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.,PODD,0.402403,0.386585,Bullish
Should You Invest in the First Trust Health Care AlphaDEX ETF  ( FXH ) ?,https://www.zacks.com/stock/news/2093125/should-you-invest-in-the-first-trust-health-care-alphadex-etf-fxh,2023-05-10 10:20:07,Sector ETF report for ...,PODD,0.134968,0.071604,Neutral
3 Top Stocks to Buy Now for Stellar Earnings Growth,https://www.zacks.com/stock/news/2092090/3-top-stocks-to-buy-now-for-stellar-earnings-growth,2023-05-09 10:44:00,"Stocks such as Franklin Electric (FELE), Insulet (PODD) & Wingstop (WING) have striking earnings growth and positive estimate revisions.",PODD,0.11123,0.127648,Neutral
"Abbott  ( ABT )  EPD Business Grows Strong, Macro Issues Stay",https://www.zacks.com/stock/news/2091614/abbott-abt-epd-business-grows-strong-macro-issues-stay,2023-05-08 14:45:00,"Abbott (ABT) continues to make good progress, increasing manufacturing production and recovering market share in the Nutrition business.",PODD,0.161349,0.038188,Neutral
"Zacks Industry Outlook Highlights Stryker, Boston Scientific, Zimmer Biomet and Insulet",https://www.zacks.com/stock/news/2091489/zacks-industry-outlook-highlights-stryker-boston-scientific-zimmer-biomet-and-insulet,2023-05-08 12:36:00,"Stryker, Boston Scientific, Zimmer Biomet and Insulet are part of the Zacks Industry Outlook article.",PODD,0.125569,0.162739,Somewhat-Bullish
Here's Why Investors Should Retain Syneos Health  ( SYNH )  for Now,https://www.zacks.com/stock/news/2091382/heres-why-investors-should-retain-syneos-health-synh-for-now,2023-05-08 12:24:00,Syneos Health's (SYNH) share price movement is expected to be favorable due to the strength of the company's Syneos One portfolio and several value-added partnership deals.,PODD,0.09186,0.04617,Neutral
Two AI Plays Lead 5 Stocks Near Buy Points,https://www.investors.com/news/amd-stock-ai-play-and-new-sp-500-member-lead-5-stocks-near-buy-points/,2023-05-06 13:19:00,"AMD Stock, AI Play And New S&P 500 Member Lead 5 Stocks Near ... Investor's Business Daily ...",PODD,0.326403,0.082176,Neutral
PODD Stock Breaks Out; Building Materials Stock Surges Past Buy Point,https://www.investors.com/stock-lists/new-highs/new-highs-diabetes-stock-breaks-out-cement-maker-surges-past-buy-point/,2023-05-05 18:34:00,New Highs: Diabetes Stock Breaks Out. Cement Maker Surges Past ... Investor's Business Daily ...,PODD,0.7887,0.249996,Somewhat-Bullish
"Insulet  ( PODD )  Q1 Earnings Beat Estimates, Sales View Up",https://www.zacks.com/stock/news/2091100/insulet-podd-q1-earnings-beat-estimates-sales-view-up,2023-05-05 17:21:00,"Omnipod 5 continues to be a driving force of Insulet's (PODD) strong U.S. growth, representing almost 95% of U.S. new customer starts in the first quarter.",PODD,0.423843,0.357646,Bullish
4 Medical Products Stocks to Capitalize on the Industry's Recovery,https://www.zacks.com/commentary/2090763/4-medical-products-stocks-to-capitalize-on-the-industrys-recovery,2023-05-05 13:59:00,"Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should lend support to the Zacks Medical-Products industry. SYK, BSX, ZBH and PODD are well-poised to gain from the favorable factors.",PODD,0.107688,0.150783,Somewhat-Bullish
"Insulet Reports Better-Than-Expected Q1 Earnings As Omnipod 5 Launch Gains Momentum, Lifts Guidance - Insulet  ( NASDAQ:PODD ) ",https://www.benzinga.com/news/earnings/23/05/32234024/insulet-reports-better-than-expected-q1-earnings-as-omnipod-5-launch-gains-momentum-lifts-guidance,2023-05-05 13:16:56,"Insulet Corporation PODD reported Q1 sales of $358.10 million Thursday, beating the consensus of $330.84 million. Total Omnipod revenue came in at $357.6 million, up 32.7% year-over-year. Insulet rolled out its next-generation Omnipod 5 in August 2022.",PODD,0.868812,0.505714,Bullish
Futures: Apple Rises On Earnings; Two Cathie Wood Stocks Jump,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-apple-earnings-top-draftkings-soars-jobs-report-pacwest-bancorp/,2023-05-04 21:51:00,"Dow Jones Futures: Apple Earnings Top, DraftKings Soars After ... Investor's Business Daily ...",PODD,0.081276,-0.031748,Neutral
Insulet  ( PODD )  Q1 Earnings and Revenues Top Estimates,https://www.zacks.com/stock/news/2090368/insulet-podd-q1-earnings-and-revenues-top-estimates,2023-05-04 21:15:11,"Insulet (PODD) delivered earnings and revenue surprises of 155.56% and 8.45%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?",PODD,0.395012,0.30484,Somewhat-Bullish
Buy These 5 Stocks Ahead of Earnings Releases This Week,https://www.zacks.com/stock/news/2089710/buy-these-5-stocks-ahead-of-earnings-releases-this-week,2023-05-04 09:41:00,"We have narrowed our search to five stocks that are set to report earnings results this week. These are: PODD, BKNG, BILL, JCI and COLD.",PODD,0.200134,0.154633,Somewhat-Bullish
Here's Why You Should Retain National Vision  ( EYE )  Stock Now,https://www.zacks.com/stock/news/2087896/heres-why-you-should-retain-national-vision-eye-stock-now,2023-05-02 12:02:00,National Vision's (EYE) share price is likely to grow following the company's efforts to expand remote capabilities and investments in doctor recruiting and retention efforts.,PODD,0.098389,0.06213,Neutral
DraftKings  ( DKNG )  to Report Q1 Earnings: What's in Store?,https://www.zacks.com/stock/news/2087639/draftkings-dkng-to-report-q1-earnings-whats-in-store,2023-05-01 18:03:00,DraftKings' (DKNG) first-quarter 2023 performance is likely to have benefited from the robust demand for mobile sports betting and expansion efforts in new states.,PODD,0.192183,0.060841,Neutral
Live updates: First Republic JP Morgan acquisition,https://edition.cnn.com/business/live-news/stocks-first-republic-banking/index.html,2023-05-01 14:39:00,The latest on JPMorgan Chase takeover of First Republic Bank: Live updates CNN International ...,PODD,0.023169,-0.085771,Neutral
BellRing Brands  ( BRBR )  Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release,https://www.zacks.com/stock/news/2087501/bellring-brands-brbr-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q2-release,2023-05-01 14:00:58,BellRing Brands (BRBR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,PODD,0.173958,0.079448,Neutral
Alcon  ( ALC )  to Report Q1 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2087398/alcon-alc-to-report-q1-earnings-whats-in-the-cards,2023-05-01 13:17:00,"Amid persistent supply-chain headwinds, Alcon's (ALC) first-quarter top-line results are likely to reflect the commercial execution of new product launches across its segments and contributions from strategic alliances.",PODD,0.157483,0.049486,Neutral
Is First Trust Health Care AlphaDEX ETF  ( FXH )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2095603/is-first-trust-health-care-alphadex-etf-fxh-a-strong-etf-right-now,2023-05-16 10:20:06,Smart Beta ETF report for ...,PODD,0.116631,0.061379,Neutral
Dow Jones Near Session Lows. TSLA Falls After Musk Names NBCUniversal Exec Linda Yaccarino As Twitter Chief.,https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-on-weakening-sentiment-teslas-musk-names-nbcuniversal-ad-chief-linda-yaccarino-as-twitter-chief/,2023-05-12 17:56:00,Dow Jones Near Session Lows. TSLA Falls After Musk Names ... Investor's Business Daily ...,PODD,0.215574,0.108071,Neutral
Medtronic's EOflow Acquisition Will Not Impact Insulet's Omnipod' Insulin Pump In Near or Medium Term: Analyst - Insulet  ( NASDAQ:PODD ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/05/32592955/medtronics-eoflow-acquisition-will-not-impact-insulets-omnipod-insulin-pump-in-near,2023-05-26 12:49:21,"Thursday, Medtronic Plc MDT agreed to acquire Korea-based EOflow Co Ltd, manufacturer of the EOPatch device - a tubeless, wearable, and fully disposable insulin delivery device. The total consideration would be KRW 971 billion ( $738 million ) .",PODD,0.686739,0.121575,Neutral
Medtronic  ( MDT )  Q4 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/05/25/medtronic-mdt-q4-2023-earnings-call-transcript/,2023-05-25 19:00:18,"MDT earnings call for the period ending March 31, 2023.",PODD,0.00402,0.086605,Neutral
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF  ( RYH ) ?,https://www.zacks.com/stock/news/2099430/should-you-invest-in-the-invesco-sp-500-equal-weight-health-care-etf-ryh,2023-05-25 10:20:06,Sector ETF report for ...,PODD,0.130217,0.070327,Neutral
Is Invesco S&P 500 Equal Weight Health Care ETF  ( RYH )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2098841/is-invesco-sp-500-equal-weight-health-care-etf-ryh-a-strong-etf-right-now,2023-05-24 10:20:06,Smart Beta ETF report for ...,PODD,0.118064,0.067312,Neutral
Here's Why You Should Retain Insulet  ( PODD )  Stock for Now,https://www.zacks.com/stock/news/2098375/heres-why-you-should-retain-insulet-podd-stock-for-now,2023-05-23 12:25:00,Investors continue to be optimistic about Insulet (PODD) on the robust performance of Omnipod 5.,PODD,0.552001,0.289305,Somewhat-Bullish
HAE or PODD: Which Is the Better Value Stock Right Now?,https://www.zacks.com/stock/news/2098078/hae-or-podd-which-is-the-better-value-stock-right-now,2023-05-22 15:40:13,HAE vs. PODD: Which Stock Is the Better Value Option?,PODD,0.626443,0.638179,Bullish
ESLOY or PODD: Which Is the Better Value Stock Right Now?,https://www.zacks.com/stock/news/2107147/esloy-or-podd-which-is-the-better-value-stock-right-now,2023-06-12 15:40:12,ESLOY vs. PODD: Which Stock Is the Better Value Option?,PODD,0.616447,0.490151,Bullish
ESLOY vs. PODD: Which Stock Is the Better Value Option?,https://www.zacks.com/stock/news/2114317/esloy-vs-podd-which-stock-is-the-better-value-option,2023-06-28 15:40:12,Investors looking for stocks in the Medical - Products sector might want to consider either EssilorLuxottica Unsponsored ADR ( ESLOY Quick QuoteESLOY - ) or Insulet ( PODD Quick QuotePODD - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look ...,PODD,0.661016,0.55769,Bullish
Stocks With Rising Relative Strength: Insulet,https://www.investors.com/ibd-data-stories/stocks-with-rising-relative-strength-insulet/,2023-06-27 07:00:00,"The Relative Strength ( RS ) Rating for Insulet ( PODD ) headed into a higher percentile Tuesday, as it got a lift from 66 to 73. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",PODD,0.636698,0.484492,Bullish
Here's Why You Should Retain Insulet  ( PODD )  Stock for Now,https://www.zacks.com/stock/news/2111427/heres-why-you-should-retain-insulet-podd-stock-for-now,2023-06-21 18:03:00,Investors are optimistic about Insulet (PODD) owing to strength in Omnipod 5 and its focus on market expansion.,PODD,0.451494,0.347507,Somewhat-Bullish
Insulet  ( PODD )  Launches the Omnipod 5 AID System in the UK,https://www.zacks.com/stock/news/2111213/insulet-podd-launches-the-omnipod-5-aid-system-in-the-uk,2023-06-21 13:48:00,Insulet (PODD) commercializes its revolutionary Omnipod 5 AID System in the United Kingdom.,PODD,0.353898,0.334741,Somewhat-Bullish
"France $3.39 Bn Diabetes Markets to 2028: Insulin Pump, CGM, Self-Monitoring Blood Device and Company Analysis",https://www.prnewswire.com/news-releases/france-3-39-bn-diabetes-markets-to-2028-insulin-pump-cgm-self-monitoring-blood-device-and-company-analysis-301870998.html,2023-07-06 15:30:00,"DUBLIN, July 6, 2023 /PRNewswire/ -- The ""France Diabetes Market, Size, Forecast 2023-2028, By Insulin Pump, CGM, Self-Monitoring Blood Device and Company Analysis"" report has been added to ResearchAndMarkets.com's offering.",PODD,0.038969,-0.078115,Neutral
8 S&P 500 Stocks Make The Cut In Goldman's 'Rule Of 10' Screens,https://www.investors.com/news/sp-500-stocks-8-make-the-cut-in-goldmans-rule-of-10-screens/,2023-07-05 11:45:00,"Looking for steady long-term earnings and sales growth? ServiceNow ( NOW ) , Chipotle Mexican Grill ( CMG ) , Fortinet ( FTNT ) , Cadence Design Systems ( CDNS ) , Intuit ( INTU ) , Paycom Software ( PAYC ) , Insulet ( PODD ) and Aptiv ( APTV ) appear in Goldman Sachs' ""Rule of 10"" stock screens ...",PODD,0.331765,0.247528,Somewhat-Bullish
"Wearable Bioelectronics Skin Patches Market to reach USD 14.8 billion in 2031, expanding at a CAGR of 11.5%: TMR Report",https://www.benzinga.com/pressreleases/23/07/g33106889/wearable-bioelectronics-skin-patches-market-to-reach-usd-14-8-billion-in-2031-expanding-at-a-cagr-,2023-07-04 14:30:00,"Wilmington, Delaware, United States, July 04, 2023 ( GLOBE NEWSWIRE ) -- The global wearable bioelectronics skin patches market is projected to flourish at a CAGR of 11.5% from 2023 to 2031. As per the report published by TMR, a valuation of US$ 14.8 billion is anticipated for the market in 2031.",PODD,0.041682,0.076844,Neutral
"These stocks could be the next Magnificent Seven market leaders, says Goldman Sachs.",https://www.marketwatch.com/story/these-stocks-could-be-the-next-magnificent-seven-market-leaders-says-goldman-sachs-5ea8a4e6,2023-07-03 11:36:00,"Our call of the day, from a team at Goldman Sachs led by chief U.S. equity strategist David Kostin has some fresh ideas on how to find big market outperformers.",PODD,0.149424,0.085564,Neutral
Should You Invest in the First Trust Health Care AlphaDEX ETF  ( FXH ) ?,https://www.zacks.com/stock/news/2121063/should-you-invest-in-the-first-trust-health-care-alphadex-etf-fxh,2023-07-14 10:20:04,Sector ETF report for ...,PODD,0.129516,0.070142,Neutral
DexCom  ( DXCM )  Q2 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/07/28/dexcom-dxcm-q2-2023-earnings-call-transcript/,2023-07-28 05:00:57,"DXCM earnings call for the period ending June 30, 2023.",PODD,0.004803,0.017524,Neutral
ZBH or PODD: Which Is the Better Value Stock Right Now?,https://www.zacks.com/stock/news/2125511/zbh-or-podd-which-is-the-better-value-stock-right-now,2023-07-21 15:40:14,ZBH vs. PODD: Which Stock Is the Better Value Option?,PODD,0.680677,0.566286,Bullish
Is First Trust Health Care AlphaDEX ETF  ( FXH )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2124252/is-first-trust-health-care-alphadex-etf-fxh-a-strong-etf-right-now,2023-07-20 10:20:09,Smart Beta ETF report for ...,PODD,0.119532,0.067655,Neutral
Insulet  ( PODD )  Tops Q2 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2133864/insulet-podd-tops-q2-earnings-and-revenue-estimates,2023-08-08 21:15:10,"Insulet (PODD) delivered earnings and revenue surprises of 58.33% and 3.26%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?",PODD,0.401331,0.119663,Neutral
Insulet lifts sales growth forecast on strong demand for insulin pumps,https://www.reuters.com/business/healthcare-pharmaceuticals/insulet-lifts-sales-growth-forecast-strong-demand-insulin-pumps-2023-08-08/,2023-08-08 21:04:00,"Aug 8 ( Reuters ) - Insulet Corp ( PODD.O ) on Tuesday raised its annual revenue growth forecast and beat second-quarter profit and revenue estimates, on strong demand for its tubeless insulin pumps that are more convenient to use compared to traditional devices.",PODD,0.227007,0.359602,Bullish
Here's Why You Should Retain Insulet  ( PODD )  Stock for Now,https://www.zacks.com/stock/news/2133521/heres-why-you-should-retain-insulet-podd-stock-for-now,2023-08-08 12:20:00,Investors continue to be optimistic about Insulet (PODD) on the strength of the Omnipod 5 AID system.,PODD,0.535653,0.270795,Somewhat-Bullish
"Minerva Surgical, Inc.  ( UTRS )  Reports Q2 Loss, Misses Revenue Estimates",https://www.zacks.com/stock/news/2131351/minerva-surgical-inc-utrs-reports-q2-loss-misses-revenue-estimates,2023-08-02 21:25:16,"Minerva Surgical, Inc. (UTRS) delivered earnings and revenue surprises of 44.44% and 3.80%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?",PODD,0.138066,0.0,Neutral
8 Stocks Thrive In August - As The Rest Of The S&P 500 Withers,https://www.investors.com/etfs-and-funds/sectors/sp500-stocks-thrive-in-august-as-the-rest-of-the-withers/,2023-08-02 12:00:00,August isn't a great month for the S&P 500 - it's actually on average the third-worst month of the year. But savvy investors can still pick up some big gains in the challenging month.,PODD,0.235252,0.302113,Somewhat-Bullish
"Where to Invest $5,000 for the Next 20 Years",https://www.fool.com/investing/2023/08/02/where-to-invest-5000-for-the-next-20-years/,2023-08-02 10:59:00,These are high-growth opportunities investors should focus on for the long haul.,PODD,0.244723,0.168122,Somewhat-Bullish
"JP Morgan Bullish On Insulet, Forecasts Robust Pump Market with Long Runway for Growth - Insulet  ( NASDAQ:PODD ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/08/33897946/jp-morgan-bullish-on-insulet-forecasts-robust-pump-market-with-long-runway-for-grow,2023-08-17 18:14:06,J.P. Morgan reiterates its Overweight rating on Insulet Corp PODD after it hosted several investor meetings with Insulet's CFO Wayde McMillan and Head of Investor Relations Deb Gordon. With shares trading at ~8-9x NTM EV/Sales vs. what has historically been solidly double-digits for Insulet.,PODD,0.608634,0.442378,Bullish
Insulin Patients Can Find Discounts With Amazon's New Automated Coupon System,https://www.kiplinger.com/personal-finance/health-insurance/insulin-patients-can-find-discounts-with-amazons-new-automated-coupon-system,2023-08-16 21:36:53,Amazon Pharmacy said it will now automatically apply manufacturer-sponsored coupons on more than 15 of the most prescribed insulin and diabetes care brand-name products to eligible customers for a price starting at $35 a month.,PODD,0.079921,0.0,Neutral
"Amazon's Boon for Diabetes Patients, Streamlining Pharmacy Discounts - Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/news/23/08/33857951/amazons-boon-for-diabetes-patients-streamlining-pharmacy-discounts,2023-08-15 16:41:43,Amazon.Com Inc's AMZN online pharmacy launched a new initiative on Tuesday to streamline the process for diabetes patients seeking discounts on their medications. The program automatically applies manufacturer-sponsored coupons to over 15 insulin and diabetes drugs.,PODD,0.116348,0.087101,Neutral
"Amazon Pharmacy Announces Coupons For Insulin- Revolutionizing Medication Access, Yet Again",https://www.forbes.com/sites/saibala/2023/08/15/amazon-pharmacy-announces-coupons-for-insulin--revolutionizing-medication-access-yet-again/,2023-08-15 11:08:24,"With a commitment to improving patient care and a tech-forward mindset, Amazon Pharmacy is powerful force of innovation.",PODD,0.05387,0.193812,Somewhat-Bullish
Amazon Pharmacy automates discounts to help insulin patients get pledged prices,https://www.reuters.com/business/retail-consumer/amazon-pharmacy-automates-discounts-help-insulin-patients-get-pledged-prices-2023-08-15/,2023-08-15 11:05:00,Aug 15 ( Reuters ) - Amazon.com ( AMZN.O ) said on Tuesday its online pharmacy will automatically apply manufacturer-sponsored coupons to more than 15 insulin and diabetes medicines to help patients access discounts pledged by the drug industry.,PODD,0.08687,0.214015,Somewhat-Bullish
Amazon Pharmacy Launches $35 Insulin Coupons As Transparency Takes Hold,https://www.forbes.com/sites/brucejapsen/2023/08/15/amazon-pharmacy-launches-35-insulin-coupons-amid-transparency-debate/,2023-08-15 11:00:00,"Amazon Pharmacy is rolling out coupons that ""automatically"" reduce customer costs for insulin to as low as $35 a month on more than a dozen diabetes care brands.",PODD,0.089462,0.165028,Somewhat-Bullish
This Is What Whales Are Betting On Insulet - Insulet  ( NASDAQ:PODD ) ,https://www.benzinga.com/markets/options/23/08/33840848/this-is-what-whales-are-betting-on-insulet,2023-08-14 18:01:02,"A whale with a lot of money to spend has taken a noticeably bullish stance on Insulet. Looking at options history for Insulet PODD we detected 10 strange trades. If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations ...",PODD,0.871674,0.187846,Somewhat-Bullish
Insulet Unusual Options Activity - Insulet  ( NASDAQ:PODD ) ,https://www.benzinga.com/markets/options/23/08/33721749/insulet-unusual-options-activity,2023-08-10 19:16:44,"Someone with a lot of money to spend has taken a bearish stance on Insulet PODD. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",PODD,0.856646,0.162243,Somewhat-Bullish
Synaptive Medical Announces Timothy J. Scannell as New Chair of Board of Directors,https://www.benzinga.com/pressreleases/23/08/g33721439/synaptive-medical-announces-timothy-j-scannell-as-new-chair-of-board-of-directors,2023-08-10 19:05:44,"TORONTO, Aug. 10, 2023 ( GLOBE NEWSWIRE ) -- Synaptive Medical, a global medical device and technology company solving surgical, imaging and data challenges, is pleased to announce the appointment of Timothy J. Scannell as the new Chair of the Board of Directors, effective June 20, 2023.",PODD,0.102013,0.0,Neutral
"Insulet  ( PODD )  Q2 Earnings Beat, Sales Growth View Raised",https://www.zacks.com/stock/news/2134385/insulet-podd-q2-earnings-beat-sales-growth-view-raised,2023-08-09 15:03:00,"Insulet's (PODD) Omnipod 5 gains market share in the second quarter within the diabetes technology market as the only FDA-approved fully disposable, pod-based automated insulin delivery system.",PODD,0.417611,0.467144,Bullish
Check Out What Whales Are Doing With PODD - Insulet  ( NASDAQ:PODD ) ,https://www.benzinga.com/markets/options/23/08/34051537/check-out-what-whales-are-doing-with-podd,2023-08-25 20:45:50,"Someone with a lot of money to spend has taken a bullish stance on Insulet PODD. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",PODD,0.792512,0.215586,Somewhat-Bullish
MDT or PODD: Which Is the Better Value Stock Right Now?,https://www.zacks.com/stock/news/2139786/mdt-or-podd-which-is-the-better-value-stock-right-now,2023-08-23 15:40:05,MDT vs. PODD: Which Stock Is the Better Value Option?,PODD,0.68471,0.519717,Bullish
"Benzinga's Top Ratings Upgrades, Downgrades For August 21, 2023",https://markets.businessinsider.com/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-august-21-2023-1032570447,2023-08-21 15:31:25,"Wolfe Research upgraded the previous rating for ArcBest Corp ( NASDAQ:ARCB ) from Peer Perform to Outperform. ArcBest earned $1.54 in the second quarter, compared to $4.30 in the year-ago quarter. The current stock performance of ArcBest shows a 52-week-high of $122.86 and a 52-week-low of $68.01.",PODD,0.186259,0.07316,Neutral
"NVIDIA To Rally Over 80%? Here Are 10 Other Analyst Forecasts For Monday - Deere  ( NYSE:DE ) , Cogent Comms Hldgs  ( NASDAQ:CCOI ) ",https://www.benzinga.com/news/23/08/33962357/nvidia-to-rally-over-80-here-are-10-other-analyst-forecasts-for-monday,2023-08-21 13:01:55,"Credit Suisse lowered the price target for The Walt Disney Company DIS from $126 to $122. Credit Suisse analyst Douglas Mitchelson maintained an Outperforn rating. Disney shares gained 0.4% to $86.27 in pre-market trading. B of A Securities boosted Palo Alto Networks, Inc.",PODD,0.366061,0.238023,Somewhat-Bullish
Insider Buys: 3 CEOs Scooping Up Shares,https://www.zacks.com/commentary/2146221/insider-buys-3-ceos-scooping-up-shares,2023-09-07 18:29:00,"These 3 CEOs have put their money where their mouths are, recently stepping up and acquiring shares. Given their confidence, should investors follow them into their trades?",PODD,0.385455,0.273441,Somewhat-Bullish
Why Insulet Stock Is Sinking Today,https://www.fool.com/investing/2023/09/07/why-insulet-stock-is-sinking-today/,2023-09-07 16:34:57,Comments from Insulet's CEO at a major healthcare conference rattled investors.,PODD,0.859085,0.165636,Somewhat-Bullish
This Is What Whales Are Betting On Insulet - Insulet  ( NASDAQ:PODD ) ,https://www.benzinga.com/markets/options/23/09/34326879/this-is-what-whales-are-betting-on-insulet,2023-09-07 16:31:52,"Someone with a lot of money to spend has taken a bearish stance on Insulet PODD. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",PODD,0.8362,0.061256,Neutral
Insulet shares slump on concerns of sales hit from new diabetes drugs,https://www.reuters.com/business/healthcare-pharmaceuticals/insulet-shares-slump-concerns-sales-hit-new-diabetes-drugs-2023-09-07/,2023-09-07 16:02:00,Sept 7 ( Reuters ) - Insulet Corp's ( PODD.O ) shares hit an over three-year low on Thursday on concerns that strong demand for a new class of diabetes drugs that also aid in weight loss could hit sales of its insulin pumps.,PODD,0.342487,-0.146172,Neutral
Is It Time to Buy the S&P 500's 3 Worst-Performing August Stocks?,https://www.fool.com/investing/2023/09/07/is-it-time-to-buy-the-sp-500s-3-worst-performing-a/,2023-09-07 13:56:00,The S&P 500 had a rare decline last month.,PODD,0.213048,-0.01786,Neutral
How Dexcom Allayed Concerns Of A Weight-Loss Bloodbath,https://www.investors.com/news/technology/dexcom-stock-leads-a-medtech-rally-how-it-allayed-concerns-of-a-weight-loss-bloodbath/,2023-09-06 18:13:00,"Dexcom ( DXCM ) stock helped lead a medical surge Wednesday after the company allayed concerns that popular weight-loss drugs like Wegovy would tamp down usage of its diabetes devices. Instead, the inverse appears to be true, Dexcom said in a presentation Tuesday.",PODD,0.196344,0.313165,Somewhat-Bullish
More Than A Third Of S&P 500 Stocks Get Kicked Out In Nine Years,https://www.investors.com/etfs-and-funds/sectors/sp-500-stocks-more-than-a-third-get-kicked-out-in-nine-years/,2023-09-06 12:00:00,"Think you know the world's most-popular index: The S&P 500? It's very different from what it was just nine years ago - and more changes are coming. Nearly 180 stocks in the S&P 500, or roughly a third of the index, have been replaced since 2015, says data from S&P Dow Jones Indices.",PODD,0.169081,0.050492,Neutral
DexCom's  ( DXCM )  G6 CGM Connects With Omnipod 5 AID in Germany,https://www.zacks.com/stock/news/2144686/dexcoms-dxcm-g6-cgm-connects-with-omnipod-5-aid-in-germany,2023-09-05 11:29:00,DexCom's (DXCM) G6 CGM system and Omnipod 5 AID system can now simplify diabetes management and improve health outcomes in Germany.,PODD,0.208914,0.04784,Neutral
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio,https://www.zacks.com/stock/news/2143614/why-this-1-growth-stock-could-be-a-great-addition-to-your-portfolio,2023-09-01 13:45:08,"Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",PODD,0.329992,0.277065,Somewhat-Bullish
Wearable Injectors Market is Expected to Reach $11.5 billion | MarketsandMarkets.,https://www.benzinga.com/pressreleases/23/08/g34144103/wearable-injectors-market-is-expected-to-reach-11-5-billion-marketsandmarkets,2023-08-31 13:30:00,"Chicago, Aug. 31, 2023 ( GLOBE NEWSWIRE ) -- In the near future, the wearable injectors industry is poised to undergo a transformative evolution, redefining the landscape of medical treatment and patient care.",PODD,0.110293,0.021805,Neutral
Why Insulet Stock Rocked the Market Today,https://www.fool.com/investing/2023/08/30/why-insulet-stock-rocked-the-market-today/,2023-08-30 22:46:44,The company's leader signals a giant vote of confidence in its future.,PODD,0.52759,0.368849,Bullish
S&P 500 Hits 4500 As Odds Of Rate Pause Rise; Apple Offers Buy Point Ahead Of Key Event,https://www.investors.com/market-trend/stock-market-today/dow-jones-pares-gains-from-rise-on-rate-pause-hopes-apple-offers-buy-point-ahead-of-key-event/,2023-08-30 19:38:00,S&P 500 Hits 4500 As Odds Of Rate Pause Rise. Apple Offers Buy ... Investor's Business Daily ...,PODD,0.128478,0.321296,Somewhat-Bullish
"Stocks making the biggest moves midday: HP, Box, Brown-Forman, Insulet and more",https://www.cnbc.com/2023/08/30/stocks-making-the-biggest-moves-midday-hpq-box-bfb-podd.html,2023-08-30 16:21:04,These are the stocks posting the largest moves in midday trading.,PODD,0.061631,0.095013,Neutral
Insulet Unusual Options Activity - Insulet  ( NASDAQ:PODD ) ,https://www.benzinga.com/markets/options/23/08/34119125/insulet-unusual-options-activity,2023-08-30 15:46:23,"Someone with a lot of money to spend has taken a bearish stance on Insulet PODD. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",PODD,0.825544,0.05264,Neutral
President and CEO of Insulet Makes $1.01M Buy - Insulet  ( NASDAQ:PODD ) ,https://www.benzinga.com/news/23/08/34117701/president-and-ceo-of-insulet-makes-1-01m-buy,2023-08-30 15:03:11,"James Hollingshead, President and CEO at Insulet PODD, reported a large insider buy on August 29, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Hollingshead purchased 5,550 shares of Insulet.",PODD,0.522333,0.287097,Somewhat-Bullish
Stock Market Gives Back Gains After Payroll And GDP Numbers; AI Chip Stock Sinks After Lower Guidance,https://www.investors.com/market-trend/stock-market-today/stock-market-gives-back-gains-payroll-gdp-data-ai-chip-stock-sinks-on-lower-guidance/,2023-08-30 14:57:00,Stock Market Gives Back Gains After Payroll And GDP Numbers. AI ... Investor's Business Daily ...,PODD,0.113329,0.148616,Neutral
"Hovnanian Enterprises, LexinFintech Holdings And Other Big Stocks Moving Higher On Wednesday - AEON Biopharma  ( AMEX:AEON ) , Alkermes  ( NASDAQ:ALKS ) ",https://www.benzinga.com/news/23/08/34117041/hovnanian-enterprises-lexinfintech-holdings-and-other-big-stocks-moving-higher-on-wednesday,2023-08-30 14:37:22,"U.S. stocks traded mixed, with the Dow Jones falling around 10 points on Wednesday. Here are some big stocks recording gains in today's session. AEON Biopharma, Inc. AEON climbed 27% to $5.11.",PODD,0.47379,0.533114,Bullish
"$1M Bet On Lyft? Check Out These 4 Stocks Insiders Are Buying - Asana  ( NYSE:ASAN ) , Lyft  ( NASDAQ:LYFT ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/08/34114757/1m-bet-on-lyft-check-out-these-4-stocks-insiders-are-buying,2023-08-30 13:28:22,"Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.",PODD,0.396261,0.223112,Somewhat-Bullish
The Investing Club's top 10 things to watch in the stock market Wednesday,https://www.cnbc.com/2023/08/30/the-investing-clubs-top-10-things-to-watch-in-the-market-wednesday-.html,2023-08-30 13:19:44,"Stocks are poised to open slightly higher Wednesday, while Citigroup maintains a buy rating on Club name Apple (AAPL) ahead of its Sept. 12 product event.",PODD,0.113866,0.281147,Somewhat-Bullish
"Stocks making the biggest moves premarket: Box, Insulet, HP and more",https://www.cnbc.com/2023/08/30/stocks-making-the-biggest-moves-premarket-box-podd-hp.html,2023-08-30 12:08:10,These are the stocks posting the largest moves in premarket trading Wednesday.,PODD,0.17715,0.13152,Neutral
Insulet  ( PODD )  Launches Omnipod 5 AID System in Germany,https://www.zacks.com/stock/news/2142068/insulet-podd-launches-omnipod-5-aid-system-in-germany,2023-08-29 15:37:00,Insulet's (PODD) Omnipod 5 is available in the United States and the United Kingdom.,PODD,0.464844,0.400101,Bullish
Apple Taps Seasoned Executive To Head 'Secret' Team Developing Glucose Monitoring Device - Stocks To Watch - Apple  ( NASDAQ:AAPL ) ,https://www.benzinga.com/news/large-cap/23/09/34623127/apple-taps-seasoned-executive-to-head-secret-team-developing-glucose-monitoring-device-stocks-to-w,2023-09-15 17:46:53,"Apple Inc AAPL has appointed Tim Millet, a seasoned executive with a background in iPhone and Mac chip technology, to oversee its secretive team dedicated to developing a noninvasive blood sugar monitor, signaling a significant move in the company's health technology endeavors.",PODD,0.33628,0.261234,Somewhat-Bullish
"Stocks making the biggest moves midday: General Motors, Stellantis, Planet Fitness, Adobe and more",https://www.cnbc.com/2023/09/15/stocks-making-the-biggest-moves-midday-gm-stla-adbe-dash-and-more.html,2023-09-15 17:09:33,These are the stocks posting the largest moves in midday trading.,PODD,0.105604,0.076543,Neutral
Here's Why You Should Retain Insulet  ( PODD )  Stock for Now,https://www.zacks.com/stock/news/2149344/heres-why-you-should-retain-insulet-podd-stock-for-now,2023-09-15 12:21:00,Investors continue to be optimistic about Insulet (PODD) on the strength of the Omnipod 5 AID system.,PODD,0.355588,-0.057447,Neutral
Insulet  ( PODD )  Expands Omnipod 5 Even As Macro Woes Linger,https://www.zacks.com/stock/news/2147812/insulet-podd-expands-omnipod-5-even-as-macro-woes-linger,2023-09-12 14:10:00,Insulet's (PODD) international expansion efforts are aligned with its long-term growth profile.,PODD,0.504646,0.36625,Bullish
"Drug in Ozempic may enable patients with newly diagnosed type 1 diabetes to stave off insulin use, small study suggests",https://www.cnn.com/2023/09/08/health/ozempic-diabetes-semaglutide-study/index.html,2023-09-08 15:54:00,"A weekly dose of semaglutide, the key ingredient in blockbuster medications Ozempic and Wegovy, helped seven out of 10 patients newly diagnosed with type 1 diabetes stop taking insulin after three to six months in a small study.",PODD,0.049939,-0.034627,Neutral
"Zacks Investment Ideas feature highlights: Workday, Energy Transfer and Insulet",https://www.zacks.com/stock/news/2146548/zacks-investment-ideas-feature-highlights-workday-energy-transfer-and-insulet,2023-09-08 12:39:00,"Workday, Energy Transfer and Insulet are part of the Zacks Investment Ideas article.",PODD,0.33628,0.274595,Somewhat-Bullish
"September's Shakeout: S&P 500, Nasdaq 100 See Just 13% Of Stocks Above 50-Day Average",https://markets.businessinsider.com/news/etf/september-s-shakeout-s-p-500-nasdaq-100-see-just-13-of-stocks-above-50-day-average-1032660395,2023-09-27 16:04:52,"In a month marked by volatility, the stock market is sending out distress signals like never before. The S&P 500 and Nasdaq 100 have both hit yearly lows in terms of the percentage of stocks trading below their 50-day moving averages.",PODD,0.105604,-0.133425,Neutral
DexCom  ( DXCM )  Partners With RxFood for Automated Dietary Monitoring,https://www.zacks.com/stock/news/2156255/dexcom-dxcm-partners-with-rxfood-for-automated-dietary-monitoring,2023-09-27 13:16:00,"DexCom's (DXCM) CGM systems will make dietary assessment through AI-enabled RxFood app, which automatically interprets food images for calorie count in Canada.",PODD,0.157141,0.159438,Somewhat-Bullish
Will Insulet  ( PODD )  Stock Recover To Its Pre-Inflation Shock Highs Of $300?,https://www.forbes.com/sites/greatspeculations/2023/09/26/will-insulet-podd-stock-recover-to-its-pre-inflation-shock-highs-of-300/,2023-09-26 13:00:52,Returning to the pre-inflation shock level of $318 means that PODD stock will have to gain more than 100% from here.,PODD,0.68701,0.015369,Neutral
Analysts Predict A 19% S&P 500 Surge Soon - Lifted By 10 Stocks,https://www.investors.com/etfs-and-funds/sectors/sp-500-analysts-predict-a-19-surge-soon-lifted-by-stocks/,2023-09-25 12:00:00,It's been a rough half of the year for the S&P 500 - with it slipping nearly 3%. But that's not stopping analysts from calling for an amazing next 12 months.,PODD,0.272029,0.141792,Neutral
"Insulin Pump Market Size is Expected to Reach USD 12.18 Billion by 2028, With a 13.64% CAGR by 2028 | Brandessence Market Research",https://www.prnewswire.com/news-releases/insulin-pump-market-size-is-expected-to-reach-usd-12-18-billion-by-2028--with-a-13-64-cagr-by-2028--brandessence-market-research-301937087.html,2023-09-25 03:23:00,"Insulin Pump Market Size is Expected to Reach USD 12.18 Billion by 2028, With a 13.64% CAGR by 2028 ... PR ...",PODD,0.031241,0.0,Neutral
"Navigating The S&P 500 Landscape: Here Are The Stocks Analysts Believe Have The Highest Potential And Biggest Downside - Meta Platforms  ( NASDAQ:META ) , NVIDIA  ( NASDAQ:NVDA ) , SolarEdge Technologies  ( NASDAQ:SEDG ) , Expeditors Intl  ( NASDAQ:EXPD ) ",https://www.benzinga.com/markets/equities/23/09/34839781/navigating-the-s-p-500-landscape-here-are-the-stocks-analysts-believe-have-the-highest-potential,2023-09-24 14:01:18,"In the middle of the AI revolution and the Federal Reserve's steadfast stance on interest rates, the stock market has seen unexpected twists and turns. Despite hopes of the U.S. sidestepping a potential recession, the stock market's trajectory remains unpredictable.",PODD,0.121343,-0.047596,Neutral
The disruptive effect of weight loss drugs like Ozempic could have surprising impacts on the stock market. Here are potential winners and losers.,https://markets.businessinsider.com/news/stocks/ozempic-wegovy-glp1-weight-loss-drugs-stock-market-winners-losers-2023-9,2023-09-24 12:30:00,Weight Loss Drugs Like Ozempic Could Have Surprising Stock Market Effects - Markets Insider ...,PODD,0.076115,-0.01019,Neutral
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick,https://www.zacks.com/stock/news/2153669/are-you-a-growth-investor-this-1-stock-could-be-the-perfect-pick,2023-09-21 13:45:06,The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.,PODD,0.546745,0.384728,Bullish
Medtech Makers Are Real Losers From Obesity Drugs,https://www.barrons.com/articles/weight-loss-drugs-obesity-eli-lilly-novo-nordisk-bcd3dd6e,2023-09-21 05:00:00,Weight-Loss Drugs Are Bad News for Companies That Treat Obesity ... ...,PODD,0.414559,0.161174,Somewhat-Bullish
Why Insulet Stock Traded Lower - Insulet  ( NASDAQ:PODD ) ,https://www.benzinga.com/news/23/10/35116325/why-insulet-stock-traded-lower,2023-10-05 20:22:06,Insulet Corporation PODD shares traded lower Thursday. The stock has been under pressure this year amid the popularity of weight loss drugs.,PODD,0.919882,0.309109,Somewhat-Bullish
"Stocks That Hit 52-Week Lows On Thursday - PRA Group  ( NASDAQ:PRAA ) , Perimeter Solutions  ( NYSE:PRM ) ",https://www.benzinga.com/news/23/10/35111787/stocks-that-hit-52-week-lows-on-thursday,2023-10-05 17:22:02,"On Thursday, 369 companies hit new 52-week lows. The largest company in terms of market cap to set a new 52-week low was Coca-Cola KO. The smallest company by market cap to hit a new 52-week low was Neptune Wellness Solns NEPT.",PODD,0.013047,-0.110266,Neutral
"These diabetes stocks, pummeled by the Ozempic craze, now look like bargains, analysts say",https://www.marketwatch.com/story/these-diabetes-stocks-pummeled-by-the-ozempic-craze-now-look-like-bargains-analysts-say-30906b51,2023-10-05 13:31:00,"DexCom could be the first stock to break out of 'GLP jail,' analysts say, as market continues to punish device makers ...",PODD,0.260559,0.154043,Somewhat-Bullish
"Stocks making the biggest moves midday: Sunnova Energy, Cal-Maine Foods, Marathon Petroleum and more",https://www.cnbc.com/2023/10/04/stocks-making-the-biggest-moves-midday-sunnova-energy-cal-maine-foods-marathon-petroleum-and-more.html,2023-10-04 17:20:48,These are the stocks posting the largest moves in midday trading.,PODD,0.352223,-0.005119,Neutral
"Top Stories Wednesday, Oct 4: Palantir And PwC Team Up To Accelerate Data-Driven Operations, OpenAI Rival Secures Billions In Big Tech Backing, Six US States Brace For Healthcare Strike - Acuity Brands  ( NYSE:AYI ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/news/23/10/35091469/palantir-and-pwc-team-up-to-accelerate-data-driven-operations-openai-rival-secures-billions-in-big-t,2023-10-04 16:37:39,Palantir Technologies Inc PLTR is expanding its collaboration with PwC to combine its latest AI capabilities. The collaboration will combine Palantir's latest AI capabilities with PwC's industry experience to help clients realize value with data and AI-enabled operations.,PODD,0.082111,-0.028883,Neutral
"Tubeless Insulin Pump Technology Provider Insulet's CFO Resigns; Reaffirms Q3, FY23 Outlook - Insulet  ( NASDAQ:PODD ) ",https://www.benzinga.com/markets/equities/23/10/35082271/tubeless-insulin-pump-technology-provider-insulets-cfo-resigns-reaffirms-q3-fy23-outlook,2023-10-04 12:17:31,"Medical device company Insulet Corp PODD disclosed that Wayde McMillan has decided to resign as Executive Vice President, CFO, and Treasurer, effective October 20, 2023. McMillan will join 3M Company MMM as Chief Financial Officer of its Health Care business, which 3M has announced it plans to ...",PODD,0.82082,0.008266,Neutral
Insulet CFO to step down to join 3M's healthcare business,https://www.reuters.com/business/healthcare-pharmaceuticals/insulet-cfo-step-down-join-3ms-healthcare-business-2023-10-03/,2023-10-03 21:06:00,"The 3M logo is seen at its global headquarters in Maplewood, Minnesota, U.S. on March 4, 2020. The company has been contracted by the U.S. government to produce extra masks in response to the country's novel coronavirus outbreak. Picture taken March 4, 2020.",PODD,0.404563,0.290231,Somewhat-Bullish
"Stocks making the biggest moves midday: Sphere, Riot, Instacart, Insulet and more",https://www.cnbc.com/2023/10/02/stocks-making-biggest-midday-moves-sphere-instacart-riot-and-more.html,2023-10-02 16:22:44,These are the stocks posting the largest moves in midday trading.,PODD,0.074926,0.130333,Neutral
Stock Market Unsure To Start New Quarter; Tesla Deliveries Disappoint,https://www.investors.com/market-trend/stock-market-today/stock-market-unsure-to-start-new-quarter-tesla-deliveries-disappoint/,2023-10-02 14:51:00,Stock Market Unsure To Start New Quarter. Tesla Deliveries ... Investor's Business Daily ...,PODD,0.115787,0.064221,Neutral
"FedEx To Rally Around 19%? Here Are 10 Other Analyst Forecasts For Monday - Mr. Cooper Gr  ( NASDAQ:COOP ) , Datadog  ( NASDAQ:DDOG ) ",https://www.benzinga.com/news/23/10/35030601/fedex-to-rally-around-19-here-are-10-other-analyst-forecasts-for-monday,2023-10-02 12:58:56,"JP Morgan raised the price target for The Progressive Corporation PGR from $146 to $149. JP Morgan analyst Jimmy Bhullar maintained an Overweight rating. Progressive shares fell 0.8% to close at $139.30 on Friday. Barclays cut SolarEdge Technologies, Inc. SEDG price target from $274 to $152.",PODD,0.276909,0.223408,Somewhat-Bullish
"Stocks making the biggest moves premarket: Rivian, SolarEdge, Sphere Entertainment and more",https://www.cnbc.com/2023/10/02/stocks-making-the-biggest-moves-premarket-rivian-solaredge-sphere-entertainment-and-more.html,2023-10-02 12:11:39,These are the stocks posting the largest moves in early trading.,PODD,0.097854,0.308701,Somewhat-Bullish
Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks This Year?,https://www.fool.com/investing/2023/09/29/is-it-time-to-buy-the-sp-500s-4-worst-performing-s/,2023-09-29 12:17:00,The broad-market index is up but these stocks are down.,PODD,0.293741,0.037202,Neutral
"Down -20.51% in 4 Weeks, Here's Why Insulet  ( PODD )  Looks Ripe for a Turnaround",https://www.zacks.com/stock/news/2167107/down--2051-in-4-weeks-heres-why-insulet-podd-looks-ripe-for-a-turnaround,2023-10-17 13:35:06,"The heavy selling pressure might have exhausted for Insulet (PODD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.",PODD,0.485711,0.254565,Somewhat-Bullish
Intuitive Surgical  ( ISRG )  to Post Q3 Earnings: What's in Store?,https://www.zacks.com/stock/news/2167270/intuitive-surgical-isrg-to-post-q3-earnings-whats-in-store,2023-10-17 13:07:00,"Intuitive Surgical's (ISRG) third-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs might have hurt margins.",PODD,0.09495,0.0,Neutral
Here's Why You Should Invest in Insulet  ( PODD )  Stock for Now,https://www.zacks.com/stock/news/2166583/heres-why-you-should-invest-in-insulet-podd-stock-for-now,2023-10-16 14:39:00,Investors are optimistic about Insulet (PODD) on continued expansion in Omnipod's market access.,PODD,0.485711,0.092704,Neutral
"Down -21.98% in 4 Weeks, Here's Why Insulet  ( PODD )  Looks Ripe for a Turnaround",https://www.zacks.com/stock/news/2166397/down--2198-in-4-weeks-heres-why-insulet-podd-looks-ripe-for-a-turnaround,2023-10-16 13:35:06,"Insulet (PODD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.",PODD,0.485711,0.233792,Somewhat-Bullish
The stock market is getting Ozempic'ed,https://markets.businessinsider.com/news/stocks/stock-market-outlook-ozempic-wegovy-glp1-weight-loss-drugs-investing-2023-10,2023-10-14 09:02:00,How Weight-Loss Drugs Like Ozempic Will Alter the Stock Market's Outlook - Markets Insider ...,PODD,0.033052,-0.023285,Neutral
Why Insulet  ( PODD )  is a Top Growth Stock for the Long-Term,https://www.zacks.com/stock/news/2165570/why-insulet-podd-is-a-top-growth-stock-for-the-long-term,2023-10-13 13:45:06,The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.,PODD,0.47147,0.357101,Bullish
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings,https://www.zacks.com/stock/news/2165458/want-better-returns-dont-ignore-these-2-medical-stocks-set-to-beat-earnings,2023-10-13 12:50:07,Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.,PODD,0.318897,0.378256,Bullish
Why Shares of Insulet Dropped This Week,https://www.fool.com/investing/2023/10/12/why-shares-of-insulet-dropped-this-week/,2023-10-12 21:40:53,Positive news regarding diabetes therapy Ozempic worried investors.,PODD,0.59016,0.151349,Somewhat-Bullish
"Insulet  ( PODD )  Loses -24.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner",https://www.zacks.com/stock/news/2164847/insulet-podd-loses--246-in-4-weeks-heres-why-a-trend-reversal-may-be-around-the-corner,2023-10-12 13:35:06,"Insulet (PODD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.",PODD,0.496915,0.158004,Somewhat-Bullish
5 Medical Product Stocks to Buy Amid Industry Recovery,https://www.zacks.com/commentary/2164682/5-medical-product-stocks-to-buy-amid-industry-recovery,2023-10-12 12:14:00,"Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. SYK, BSX, ZBH, PODD and HAE are well-poised to gain from the favorable factors.",PODD,0.104409,-0.014522,Neutral
Novo drugs Ozempic and Wegovy are shaking up stock markets again,https://www.financialexpress.com/healthcare/pharma-healthcare/novo-drugs-ozempic-and-wegovy-are-shaking-up-stock-markets-again/3270796/,2023-10-12 10:51:54,"Novo Nordisk, the Danish company, now Europe's largest by market value, said late Tuesday it was halting a study that looked at the impact of its blockbuster Ozempic drug on kidney failure after it showed effectiveness surprisingly early. The news hit shares of the world's biggest kidney dialysis ...",PODD,0.104228,0.107321,Neutral
Will Insulet  ( PODD )  Beat Estimates Again in Its Next Earnings Report?,https://www.zacks.com/stock/news/2164473/will-insulet-podd-beat-estimates-again-in-its-next-earnings-report,2023-10-11 16:10:09,Insulet (PODD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,PODD,0.425746,0.483598,Bullish
What's in Store for Abbott Laboratories  ( ABT )  in Q3 Earnings?,https://www.zacks.com/stock/news/2163489/whats-in-store-for-abbott-laboratories-abt-in-q3-earnings,2023-10-10 14:09:00,Abbott Laboratories' (ABT) third-quarter 2023 results are likely to reflect solid underlying base business organic sales growth.,PODD,0.124809,0.047039,Neutral
"Down -17.48% in 4 Weeks, Here's Why Insulet  ( PODD )  Looks Ripe for a Turnaround",https://www.zacks.com/stock/news/2163371/down--1748-in-4-weeks-heres-why-insulet-podd-looks-ripe-for-a-turnaround,2023-10-10 13:35:05,"The heavy selling pressure might have exhausted for Insulet (PODD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.",PODD,0.485711,0.254565,Somewhat-Bullish
Insulet  ( PODD )  is an Incredible Growth Stock: 3 Reasons Why,https://www.zacks.com/stock/news/2162871/insulet-podd-is-an-incredible-growth-stock-3-reasons-why,2023-10-09 16:45:05,"Insulet (PODD) is well positioned to outperform the market, as it exhibits above-average growth in financials.",PODD,0.508878,0.394002,Bullish
DexCom  ( DXCM )  to Launch Latest CGM System G7 in Canada,https://www.zacks.com/stock/news/2162674/dexcom-dxcm-to-launch-latest-cgm-system-g7-in-canada,2023-10-09 13:02:00,"DexCom's (DXCM) G7 CGM System (launched in Canada) is expected to combine simplicity and power, thereby providing a better way to manage diabetes.",PODD,0.055492,0.022931,Neutral
Looking for Earnings Beat? 5 Top-Ranked Stocks to Play,https://www.zacks.com/stock/news/2162433/looking-for-earnings-beat-5-top-ranked-stocks-to-play,2023-10-09 10:56:00,"These top-ranked stocks are likely to beat on the bottom line in their upcoming releases. Tap NVIDIA (NVDA), Lamb Weston (LW), Insulet (PODD), Asure Software (ASUR) and Palo Alto Networks (PANW).",PODD,0.194554,0.146842,Neutral
"Bio-Rad  ( BIO )  Misses Q3 Earnings Estimates, Cuts 2023 View",https://www.zacks.com/stock/news/2173967/bio-rad-bio-misses-q3-earnings-estimates-cuts-2023-view,2023-10-27 15:59:00,The deterioration in biopharma and early biotech customer spending and a challenging macroeconomic environment in China impact Bio-Rad's (BIO) Q3 performance.,PODD,0.188928,0.078384,Neutral
Hologic  ( HOLX )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2173798/hologic-holx-to-report-q4-earnings-whats-in-the-cards,2023-10-27 13:03:00,Strength in Breast Health and GYN Surgical businesses will likely drive Hologic's (HOLX) Q4 revenues.,PODD,0.156207,0.054433,Neutral
"Diabetes stocks jump as obesity-drug recovery comes ahead of schedule, analysts say",https://www.marketwatch.com/story/diabetes-stocks-jump-as-obesity-drug-recovery-comes-ahead-of-schedule-analysts-say-11e9d470,2023-10-27 13:00:00,DexCom's strong quarterly results give device makers a boost.,PODD,0.391923,0.213962,Somewhat-Bullish
Weight-Loss Beating Continues For Devices Makers; Why It's Overdone,https://www.investors.com/news/technology/weight-loss-drugs-spook-medical-device-stocks-an-overreaction/,2023-10-27 13:00:00,Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors ... Investor's Business Daily ...,PODD,0.034907,0.099119,Neutral
"Chemed  ( CHE )  Q3 Earnings and Revenues Surpass, Margins Rise",https://www.zacks.com/stock/news/2173541/chemed-che-q3-earnings-and-revenues-surpass-margins-rise,2023-10-27 12:08:00,Chemed's (CHE) third-quarter 2023 performance reflects strength in the VITAS segment.,PODD,0.174272,0.076747,Neutral
"ResMed  ( RMD )  Q1 Earnings Surpass Estimates, Margins Down",https://www.zacks.com/stock/news/2173533/resmed-rmd-q1-earnings-surpass-estimates-margins-down,2023-10-27 12:01:00,ResMed's (RMD) solid revenue growth in the first quarter of fiscal 2024 reflects the strength of AirSense 10 and AirSense 11 sleep devices and robust growth in the mask product portfolio.,PODD,0.168785,0.075071,Neutral
"Boston Scientific  ( BSX )  Q3 Earnings Beat, Gross Margin Dips",https://www.zacks.com/stock/news/2173045/boston-scientific-bsx-q3-earnings-beat-gross-margin-dips,2023-10-26 16:06:00,Boston Scientific's (BSX) organic and operational revenues at its respective core business segments and geographies rise in the third quarter.,PODD,0.16117,0.038301,Neutral
"Edwards Lifesciences  ( EW )  Q3 Earnings Match Mark, Margins Dip",https://www.zacks.com/stock/news/2172966/edwards-lifesciences-ew-q3-earnings-match-mark-margins-dip,2023-10-26 15:17:00,Edwards Lifesciences (EW) TMTT performance benefits from the accelerated adoption of the differentiated PASCAL precision platform in the third quarter.,PODD,0.155201,0.036097,Neutral
"Labcorp  ( LH )  Q3 Earnings and Revenues Beat, Margins Fall",https://www.zacks.com/stock/news/2172927/labcorp-lh-q3-earnings-and-revenues-beat-margins-fall,2023-10-26 14:36:00,Labcorp (LH) delivers a strong performance in the third quarter of 2023 across the Diagnostics Laboratories and Biopharma Laboratory Services businesses.,PODD,0.16849,0.074982,Neutral
Insulet  ( PODD )  Expected to Beat Earnings Estimates: Can the Stock Move Higher?,https://www.zacks.com/stock/news/2172806/insulet-podd-expected-to-beat-earnings-estimates-can-the-stock-move-higher,2023-10-26 14:02:22,Insulet (PODD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,PODD,0.3007,0.179955,Somewhat-Bullish
"Integra's  ( IART )  Q3 Earnings Miss Estimates, 2023 View Cut",https://www.zacks.com/stock/news/2172560/integras-iart-q3-earnings-miss-estimates-2023-view-cut,2023-10-26 12:20:00,The impact of lost revenues and an increase in the return provision related to the Boston product recall dent Integra's (IART) Q3 revenues.,PODD,0.173958,0.07665,Neutral
"Amedisys'  ( AMED )  Q3 Earnings Miss Estimates, Margins Up",https://www.zacks.com/stock/news/2172557/amedisys-amed-q3-earnings-miss-estimates-margins-up,2023-10-26 12:19:00,"The continuous shortage of clinical labor, nursing in particular, is likely to have impacted Amedisys' (AMED) Q3 performance.",PODD,0.222327,0.088903,Neutral
Boston Scientific  ( BSX )  Tops Q3 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2172412/boston-scientific-bsx-tops-q3-earnings-and-revenue-estimates,2023-10-26 11:50:13,"Boston Scientific (BSX) delivered earnings and revenue surprises of 4.17% and 1.77%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?",PODD,0.137671,0.0,Neutral
Wearable Injectors Market Share Worth $13.88 Billion by 2027 - Exclusive Report by The Insight Partners,https://www.benzinga.com/pressreleases/23/10/g35435683/wearable-injectors-market-share-worth-13-88-billion-by-2027-exclusive-report-by-the-insight-partne,2023-10-26 11:18:47,"Pune, India, Oct. 26, 2023 ( GLOBE NEWSWIRE ) -- Wearable injectors are drug delivery devices that adhere to the body to deliver larger volumes of drugs subcutaneously. Several pharmaceutical and medical device companies have developed wearable injectors.",PODD,0.075516,0.089892,Neutral
"Align Technology  ( ALGN )  Q3 Earnings Miss, Operating Margin Up",https://www.zacks.com/stock/news/2172366/align-technology-algn-q3-earnings-miss-operating-margin-up,2023-10-26 11:14:00,Align Technology's (ALGN) Q3 fiscal 2023 performance reflects revenue growth across all regions.,PODD,0.149656,0.069505,Neutral
"Is Insulet  ( PODD )  a Solid Growth Stock? 3 Reasons to Think ""Yes""",https://www.zacks.com/stock/news/2171953/is-insulet-podd-a-solid-growth-stock-3-reasons-to-think-yes,2023-10-25 16:45:05,"Insulet (PODD) is well positioned to outperform the market, as it exhibits above-average growth in financials.",PODD,0.511734,0.395236,Bullish
"Thermo Fisher  ( TMO )  Q3 Earnings Top Estimates, Margins Up",https://www.zacks.com/stock/news/2171772/thermo-fisher-tmo-q3-earnings-top-estimates-margins-up,2023-10-25 13:12:00,Thermo Fisher's (TMO) PPI Business System and strong execution by its global team enabled the company to deliver strong financial performance for Q3.,PODD,0.215894,0.086852,Neutral
What's in Store for Canopy Growth  ( CGC )  in Q2 Earnings?,https://www.zacks.com/stock/news/2171342/whats-in-store-for-canopy-growth-cgc-in-q2-earnings,2023-10-25 12:18:00,"In the second quarter of fiscal 2024, Canopy Growth (CGS) is expected to demonstrate an improved performance in the Canadian cannabis business.",PODD,0.159569,0.055177,Neutral
"Quest Diagnostics  ( DGX )  Tops Q3 Earnings, Gross Margin Dips",https://www.zacks.com/stock/news/2170976/quest-diagnostics-dgx-tops-q3-earnings-gross-margin-dips,2023-10-24 15:42:00,"Quest Diagnostics' (DGX) base business growth reflects the company's ongoing efforts to partner with health plans, hospitals and physicians amid a continued return to care.",PODD,0.213988,0.086246,Neutral
EYE vs. PODD: Which Stock Is the Better Value Option?,https://www.zacks.com/stock/news/2170943/eye-vs-podd-which-stock-is-the-better-value-option,2023-10-24 15:40:07,Investors with an interest in Medical - Products stocks have likely encountered both National Vision ( EYE Quick QuoteEYE - ) and Insulet ( PODD Quick QuotePODD - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.,PODD,0.69701,0.638909,Bullish
InMode  ( INMD )  to Post Q3 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2170702/inmode-inmd-to-post-q3-earnings-whats-in-the-cards,2023-10-24 11:53:00,"InMode (INMD) is likely to register growth in Q3, backed by strong consumable and service revenues and ongoing global expansion.",PODD,0.256314,0.079031,Neutral
CVS Health  ( CVS )  to Report Q3 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2170688/cvs-health-cvs-to-report-q3-earnings-whats-in-the-cards,2023-10-24 11:48:00,CVS Health (CVS) Q3 revenues will likely benefit from growth in specialty pharmacy and brand inflation and increased prescription and front store volume.,PODD,0.152741,0.05368,Neutral
"Why Coke, others, may be spared, as a $100 billion opportunity in weight loss drugs unfolds says JPMorgan",https://www.marketwatch.com/story/the-weight-loss-drugs-are-coming-for-these-companies-but-heres-why-coke-others-may-be-spared-says-jpmorgan-c6c24538,2023-10-24 10:42:00,"JPMorgan says the weight-loss drug industry is now a ""$100 billion plus opportunity."" Coke is one of the stocks they say is likely to get hit less hard.",PODD,0.084722,0.211781,Somewhat-Bullish
"mHealth Market Size to Hit $410.39 Billion, Globally, by 2028 - Exclusive Report by The Insight Partners",https://www.benzinga.com/pressreleases/23/10/g35389192/mhealth-market-size-to-hit-410-39-billion-globally-by-2028-exclusive-report-by-the-insight-partner,2023-10-24 10:23:48,"Pune, India, Oct. 24, 2023 ( GLOBE NEWSWIRE ) -- Mobile health ( mHealth ) is a technique that includes the use of mobile commination devices, such as mobile phones, tablets, PDAs ( personal digital assistants ) and other wireless devices for distributing health services and information. mHealth ...",PODD,0.032164,0.16299,Somewhat-Bullish
Labcorp  ( LH )  to Report Q3 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2170090/labcorp-lh-to-report-q3-earnings-whats-in-the-cards,2023-10-23 10:26:00,Labcorp's (LH) third-quarter 2023 performance is likely to have witnessed strength in the Diagnostics Laboratories base business.,PODD,0.166455,0.056734,Neutral
IDEXX Laboratories  ( IDXX )  to Post Q3 Earnings: What's in Store?,https://www.zacks.com/stock/news/2170074/idexx-laboratories-idxx-to-post-q3-earnings-whats-in-store,2023-10-23 10:19:00,IDEXX Laboratories' (IDXX) third-quarter 2023 results are expected to reflect an impressive performance of the CAG segment.,PODD,0.173645,0.058403,Neutral
What's in Store for Option Care Health  ( OPCH )  in Q3 Earnings?,https://www.zacks.com/stock/news/2169774/whats-in-store-for-option-care-health-opch-in-q3-earnings,2023-10-20 15:47:00,Option Care Health's (OPCH) Q3 results are likely to be driven by sustained strong utilization.,PODD,0.186259,0.133391,Neutral
Insulet  ( PODD )  to Report Q3 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2169760/insulet-podd-to-report-q3-earnings-whats-in-the-cards,2023-10-20 15:41:00,Insulet's (PODD) global new customer starts are expected to have been strong in the third quarter.,PODD,0.351184,0.33384,Somewhat-Bullish
What's in Store for West Pharmaceutical  ( WST )  in Q3 Earnings?,https://www.zacks.com/stock/news/2169450/whats-in-store-for-west-pharmaceutical-wst-in-q3-earnings,2023-10-20 11:39:00,"West Pharmaceutical's (WST) third-quarter 2023 results are likely to reflect strength in the Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.",PODD,0.148731,0.0,Neutral
Corporate America weighs risks of the Ozempic effect,https://www.reuters.com/business/healthcare-pharmaceuticals/corporate-america-weighs-risks-ozempic-effect-2023-10-19/,2023-10-19 11:28:00,"Boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, is seen at a Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey/File Photo Acquire Licensing Rights",PODD,0.07913,-0.049676,Neutral
4 Medical Product Stocks Set to Outpace Q3 Earnings Estimates,https://www.zacks.com/stock/news/2168593/4-medical-product-stocks-set-to-outpace-q3-earnings-estimates,2023-10-19 10:54:00,"Medical Product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how EW, PODD, DXCM and IQV are poised ahead of their earnings release.",PODD,0.265666,0.048412,Neutral
Comparing DexCom With Industry Competitors In Health Care Equipment & Supplies Industry - DexCom  ( NASDAQ:DXCM ) ,https://www.benzinga.com/news/23/10/35312875/comparing-dexcom-with-industry-competitors-in-health-care-equipment-amp-supplies-industry,2023-10-18 16:00:43,"In today's rapidly changing and fiercely competitive business landscape, it is essential for investors and industry enthusiasts to thoroughly analyze companies. In this article, we will conduct a comprehensive industry comparison, evaluating DexCom DXCM against its key competitors in the Health ...",PODD,0.070935,0.0,Neutral
What's in Store for Thermo Fisher  ( TMO )  in Q3 Earnings?,https://www.zacks.com/stock/news/2168267/whats-in-store-for-thermo-fisher-tmo-in-q3-earnings,2023-10-18 15:00:00,Thermo Fisher (TMO) will likely gain from strong Analytical Instrument business performance and latest launches.,PODD,0.082393,0.0,Neutral
"Abbott  ( ABT )  Q3 Earnings and Revenues Surpass, Margins Dip",https://www.zacks.com/stock/news/2168143/abbott-abt-q3-earnings-and-revenues-surpass-margins-dip,2023-10-18 14:50:00,Abbott (ABT) reports solid underlying base business performance in the third quarter of 2023.,PODD,0.14069,0.067082,Neutral
5 Stocks That Powered S&P 500 ETF Last Week,https://www.zacks.com/stock/news/2179352/5-stocks-that-powered-sp-500-etf-last-week,2023-11-06 16:10:00,"After entering correction territory in the last week of October, the S&P 500 Index staged a solid comeback in the first week of November.",PODD,0.178459,0.112019,Neutral
"Insulet  ( PODD )  Q3 Earnings Beat, 2023 Sales Growth View Up",https://www.zacks.com/stock/news/2179256/insulet-podd-q3-earnings-beat-2023-sales-growth-view-up,2023-11-06 14:56:00,Insulet's (PODD) third-quarter 2023 revenues increase year over year as a result of continued high demand for Omnipod 5.,PODD,0.457157,0.313492,Somewhat-Bullish
Wall Street Analysts Think Insulet  ( PODD )  Could Surge 53.28%: Read This Before Placing a Bet,https://www.zacks.com/stock/news/2179259/wall-street-analysts-think-insulet-podd-could-surge-5328-read-this-before-placing-a-bet,2023-11-06 14:55:14,"The consensus price target hints at a 53.3% upside potential for Insulet (PODD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.",PODD,0.286193,0.305123,Somewhat-Bullish
Insulet  ( PODD )  Just Overtook the 50-Day Moving Average,https://www.zacks.com/stock/news/2179155/insulet-podd-just-overtook-the-50-day-moving-average,2023-11-06 14:30:06,Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?,PODD,0.800175,0.676908,Bullish
"QIAGEN's  ( QGEN )  Molecular Diagnostics Gains Share, FX Woe Stays",https://www.zacks.com/stock/news/2179016/qiagens-qgen-molecular-diagnostics-gains-share-fx-woe-stays,2023-11-06 13:35:00,QIAGEN (QGEN) continues to see a very healthy conversion trend from the tuberculin skin test.,PODD,0.133593,0.132213,Neutral
"Barron's Weekend Stock Picks: Chevron, Apple, Disney And Insulet's Stock Increase - Apple  ( NASDAQ:AAPL ) , BILL Holdings  ( NYSE:BILL ) ",https://www.benzinga.com/news/23/11/35607199/barrons-weekend-stock-picks-chevron-apple-disney-and-insulets-stock-increase,2023-11-04 20:37:44,"Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read. In ""Buy Chevron Stock.",PODD,0.355588,0.469012,Bullish
Dow Jones Soars On Job Data Surprise; Warren Buffett's Berkshire Hathaway Earnings Loom,https://www.investors.com/market-trend/stock-market-today/dow-jones-soars-on-jobs-data-surprise-warren-buffetts-berkshire-hathaway-earnings-loom/,2023-11-03 19:20:15,Dow Jones Soars On Job Data Surprise. Warren Buffett's Berkshire ... Investor's Business Daily ...,PODD,0.136888,0.28421,Somewhat-Bullish
Diabetes Stock Rockets 15% After Eye-Popping Profit Wallops Estimates,https://www.investors.com/news/technology/podd-stock-surges-after-eye-popping-profit-wallops-expectations/,2023-11-03 16:53:50,PODD Stock Surges After Eye-Popping Profit Wallops Expectations Investor's Business Daily ...,PODD,0.659096,0.555881,Bullish
"Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday - Allogene Therapeutics  ( NASDAQ:ALLO ) , AMC Networks  ( NASDAQ:AMCX ) ",https://www.benzinga.com/news/23/11/35594375/expedia-group-gartner-cloudflare-cardinal-health-and-other-big-stocks-moving-higher-on-friday,2023-11-03 15:30:22,"U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today's session. Cooper-Standard Holdings Inc. CPS shares shares gained 41% to $17.94 following better-than-expected third-quarter results. Udemy, Inc.",PODD,0.109206,0.300205,Somewhat-Bullish
"Teleflex  ( TFX )  Q3 Earnings Top Estimates, 2023 Outlook Up",https://www.zacks.com/stock/news/2178266/teleflex-tfx-q3-earnings-top-estimates-2023-outlook-up,2023-11-03 14:59:00,Teleflex's (TFX) year-over-year revenue growth was driven by all global product categories in Q3.,PODD,0.16849,0.031951,Neutral
"Haemonetics  ( HAE )  Q2 Earnings Top Estimates, 2024 View Up",https://www.zacks.com/stock/news/2178247/haemonetics-hae-q2-earnings-top-estimates-2024-view-up,2023-11-03 14:31:00,The robust volume growth and price benefits in the Plasma business driven by strong momentum in U.S. collections and price benefit Haemonetics' (HAE) fiscal second-quarter results.,PODD,0.132611,0.0,Neutral
Why Insulet Corp  ( PODD )  Stock Is Soaring Today - Insulet  ( NASDAQ:PODD ) ,https://www.benzinga.com/news/earnings/23/11/35587621/omnipod-insulin-pump-working-well-for-insulet-lifts-annual-forecast,2023-11-03 13:57:29,"Insulet Corporation PODD reported Q3 sales of $432.7 million, up 27.0%, or 25.1% in constant currency, beating the consensus of $414.383 million. Total Omnipod revenue of $422 million marked a year-over-year increase of 29.4%.",PODD,0.779232,0.146484,Neutral
"Envista  ( NVST )  Q3 Earnings Miss Estimates, Gross Margin Down",https://www.zacks.com/stock/news/2177463/envista-nvst-q3-earnings-miss-estimates-gross-margin-down,2023-11-02 14:24:00,Envista's (NVST) Q3 performance is impacted by the negative impact of Russia and the weakness of higher-end specialty procedures in developed markets.,PODD,0.20537,0.086676,Neutral
3 Medical Products Stocks to Consider as Earnings Approach,https://www.zacks.com/commentary/2176738/3-medical-products-stocks-to-consider-as-earnings-approach,2023-11-01 22:27:00,"These top-rated Zacks Medical sector stocks are very attractive ahead of their quarterly reports on Thursday, November 2 with now looking like an ideal time to invest.",PODD,0.439026,0.438233,Bullish
Analyzing DexCom In Comparison To Competitors In Health Care Equipment & Supplies Industry - DexCom  ( NASDAQ:DXCM ) ,https://www.benzinga.com/news/23/11/35542089/analyzing-dexcom-in-comparison-to-competitors-in-health-care-equipment-amp-supplies-industry,2023-11-01 16:00:59,"In today's fast-paced and highly competitive business world, it is crucial for investors and industry followers to conduct comprehensive company evaluations. In this article, we will delve into an extensive industry comparison, evaluating DexCom DXCM in relation to its major competitors in the ...",PODD,0.07423,0.0,Neutral
Lantheus  ( LNTH )  to Report Q3 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2176580/lantheus-lnth-to-report-q3-earnings-whats-in-the-cards,2023-11-01 15:59:00,Lantheus' (LNTH) third-quarter results are likely to reflect solid top-line performance on the back of robust product adoption.,PODD,0.158868,0.081346,Neutral
"IDEXX  ( IDXX )  Q3 Earnings Top Estimates, '23 Sales View Down",https://www.zacks.com/stock/news/2176357/idexx-idxx-q3-earnings-top-estimates-23-sales-view-down,2023-11-01 13:53:00,IDEXX (IDXX) delivers better-than-expected earnings in the third quarter of 2023.,PODD,0.164468,0.073775,Neutral
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises,https://www.zacks.com/stock/news/2176145/how-to-find-strong-medical-stocks-slated-for-positive-earnings-surprises,2023-11-01 12:50:07,Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.,PODD,0.38489,0.396447,Bullish
STERIS  ( STE )  Set to Post Q2 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2175759/steris-ste-set-to-post-q2-earnings-whats-in-the-cards,2023-10-31 15:28:00,STERIS' (STE) second-quarter fiscal 2024 results are likely to reflect an impressive performance across the Healthcare and AST segments.,PODD,0.177802,0.059386,Neutral
Zimmer Biomet  ( ZBH )  Reports Next Week: Wall Street Expects Earnings Growth,https://www.zacks.com/stock/news/2175532/zimmer-biomet-zbh-reports-next-week-wall-street-expects-earnings-growth,2023-10-31 14:01:33,Zimmer (ZBH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,PODD,0.17618,0.047731,Neutral
"QIAGEN  ( QGEN )  Q3 Earnings and Revenues Beat, Margins Down",https://www.zacks.com/stock/news/2175126/qiagen-qgen-q3-earnings-and-revenues-beat-margins-down,2023-10-31 11:37:00,"In an increasingly challenging macro environment, QIAGEN (QGEN) surpasses the earnings and revenue outlook in the third quarter of 2023.",PODD,0.144275,0.068034,Neutral
Will Zimmer Biomet  ( ZBH )  Beat Estimates This Earnings Season?,https://www.zacks.com/stock/news/2174652/will-zimmer-biomet-zbh-beat-estimates-this-earnings-season,2023-10-30 15:31:00,Zimmer Biomet (ZBH) is expected to have witnessed strong performance across Avenir Complete hip.,PODD,0.162802,0.055902,Neutral
Hologic  ( HOLX )  Q4 Earnings Might Rise on 7.7% Breast Health Growth,https://www.zacks.com/stock/news/2174620/hologic-holx-q4-earnings-might-rise-on-77-breast-health-growth,2023-10-30 14:03:00,Strength in Breast Health and growing Panther instrument installed base will likely benefit Hologic's (HOLX) Q4 performance.,PODD,0.201523,0.065181,Neutral
Here's Why Insulet  ( PODD )  is a Strong Growth Stock,https://www.zacks.com/stock/news/2174484/heres-why-insulet-podd-is-a-strong-growth-stock,2023-10-30 13:45:06,The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.,PODD,0.347614,0.255412,Somewhat-Bullish
Henry Schein  ( HSIC )  Set to Post Q3 Earnings: What Awaits?,https://www.zacks.com/stock/news/2174298/henry-schein-hsic-set-to-post-q3-earnings-what-awaits,2023-10-30 12:41:00,Henry Schein's (HSIC) third-quarter 2023 results are likely to reflect the strong fundamentals of the Dental business.,PODD,0.134214,0.049907,Neutral
Paragon 28  ( FNA )  New Staple System Expands Ankle Device Line,https://www.zacks.com/stock/news/2185482/paragon-28-fna-new-staple-system-expands-ankle-device-line,2023-11-16 16:31:00,Paragon 28's (FNA) JAWS Great White Staple System is claimed to have 400 times greater fatigue life compared to competitors under similar load conditions.,PODD,0.204647,0.069111,Neutral
Omnicell's  ( OMCL )  Portfolio Expansion Aids Amid Macro Woes,https://www.zacks.com/stock/news/2185461/omnicells-omcl-portfolio-expansion-aids-amid-macro-woes,2023-11-16 16:19:00,Omnicell (OMCL) accelerates its shift to cloud-based solutions and tech-enabled services through the launch of Inventory Optimization Service and Central Pharmacy Dispensing Services.,PODD,0.166551,0.059468,Neutral
Industry Comparison: Evaluating DexCom Against Competitors In Health Care Equipment & Supplies Industry - DexCom  ( NASDAQ:DXCM ) ,https://www.benzinga.com/news/23/11/35831044/industry-comparison-evaluating-dexcom-against-competitors-in-health-care-equipment-amp-supplies-indu,2023-11-16 16:00:47,"In today's rapidly changing and fiercely competitive business landscape, it is vital for investors and industry enthusiasts to carefully evaluate companies. In this article, we will perform a comprehensive industry comparison, evaluating DexCom DXCM against its key competitors in the Health Care ...",PODD,0.070105,0.0,Neutral
Here's Why You Should Retain Omnicell  ( OMCL )  Stock Now,https://www.zacks.com/stock/news/2185113/heres-why-you-should-retain-omnicell-omcl-stock-now,2023-11-16 11:53:00,Investors are optimistic about Omnicell (OMCL) due to its technology and innovative solutions.,PODD,0.140896,0.031241,Neutral
Illumina  ( ILMN )  Launches Initiative on Pathogen Sequencing,https://www.zacks.com/stock/news/2185110/illumina-ilmn-launches-initiative-on-pathogen-sequencing,2023-11-16 11:49:00,Illumina (ILMN) introduces a new initiative to drive more equitable access to genomics globally.,PODD,0.140896,0.053661,Neutral
Encompass Health  ( EHC )  Opens Hospital to Boost Presence in Texas,https://www.zacks.com/stock/news/2184828/encompass-health-ehc-opens-hospital-to-boost-presence-in-texas,2023-11-15 17:39:00,Encompass Health (EHC) opens an inpatient rehabilitation hospital in Prosper to address the diversified needs of the greater Dallas area residents. It marks EHC's 160th nationwide facility.,PODD,0.234119,0.152566,Somewhat-Bullish
"Prestige Consumer's  ( PBH )  Brand Building, Innovation Aid Growth",https://www.zacks.com/stock/news/2184695/prestige-consumers-pbh-brand-building-innovation-aid-growth,2023-11-15 15:20:00,"Prestige Consumer's (PBH) long-term brand-building efforts, efficient marketing, channel development and innovation help the company to continually hold a leading market share position.",PODD,0.172507,0.065083,Neutral
QIAGEN  ( QGEN )  Launches QIAcuity Kits and Software Update,https://www.zacks.com/stock/news/2184368/qiagen-qgen-launches-qiacuity-kits-and-software-update,2023-11-15 11:32:00,QIAGEN's (QGEN) new QIAcuity kits are likely to expand application areas and foster digital PCR adoption.,PODD,0.159569,0.057814,Neutral
Behind the Scenes of DexCom's Latest Options Trends - DexCom  ( NASDAQ:DXCM ) ,https://www.benzinga.com/markets/options/23/11/35780189/behind-the-scenes-of-dexcoms-latest-options-trends,2023-11-14 15:45:53,"Deep-pocketed investors have adopted a bullish approach towards DexCom DXCM, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",PODD,0.087824,0.0,Neutral
Here's Why Investors Should Buy Alcon  ( ALC )  Stock Right Now,https://www.zacks.com/stock/news/2183772/heres-why-investors-should-buy-alcon-alc-stock-right-now,2023-11-14 12:25:00,"Investors continue to be optimistic about Alcon (ALC), backed by a competitive product portfolio and strong commercial execution.",PODD,0.145437,0.030539,Neutral
Medical device makers rise on relief after Wegovy obesity trial data,https://www.reuters.com/business/healthcare-pharmaceuticals/medical-device-makers-rise-relief-after-wegovy-obesity-trial-data-2023-11-13/,2023-11-13 15:21:00,"A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights",PODD,0.147818,0.317247,Somewhat-Bullish
IDEXX's  ( IDXX )  Upcoming Launch to Detect Canine Leishmaniosis,https://www.zacks.com/stock/news/2183048/idexxs-idxx-upcoming-launch-to-detect-canine-leishmaniosis,2023-11-13 11:10:00,IDEXX (IDXX) expands the SNAP franchise with a comprehensive solution for detecting canine leishmaniosis.,PODD,0.145437,0.05463,Neutral
3 Reasons Why Growth Investors Shouldn't Overlook Insulet  ( PODD ) ,https://www.zacks.com/stock/news/2182525/3-reasons-why-growth-investors-shouldnt-overlook-insulet-podd,2023-11-10 17:45:06,Insulet (PODD) could produce exceptional returns because of its solid growth attributes.,PODD,0.50746,0.370017,Bullish
This Is What Whales Are Betting On DexCom - DexCom  ( NASDAQ:DXCM ) ,https://www.benzinga.com/markets/options/23/11/35709498/this-is-what-whales-are-betting-on-dexcom,2023-11-09 19:17:10,"Investors with a lot of money to spend have taken a bearish stance on DexCom DXCM. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",PODD,0.08687,0.0,Neutral
Here's Why You Should Invest in IDEXX  ( IDXX )  Stock Right Now,https://www.zacks.com/stock/news/2181457/heres-why-you-should-invest-in-idexx-idxx-stock-right-now,2023-11-09 12:48:00,"Investors continue to be optimistic about IDEXX (IDXX), backed by the strength of the CAG Diagnostics business and momentum in ProCyte One expansion.",PODD,0.13637,0.030678,Neutral
Corporate America weighs business impact of new weight-loss drugs,https://www.reuters.com/business/healthcare-pharmaceuticals/corporate-america-weighs-business-impact-new-weight-loss-drugs-2023-11-08/,2023-11-08 18:19:00,"[1/3] A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights",PODD,0.054114,-0.048816,Neutral
Surging Earnings Estimates Signal Upside for Insulet  ( PODD )  Stock,https://www.zacks.com/stock/news/2181076/surging-earnings-estimates-signal-upside-for-insulet-podd-stock,2023-11-08 17:20:05,"Insulet (PODD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.",PODD,0.606706,0.656788,Bullish
"Chemed's  ( CHE )  VITAS Performance Aids, Macro Issues Linger",https://www.zacks.com/stock/news/2180967/chemeds-che-vitas-performance-aids-macro-issues-linger,2023-11-08 15:33:00,Chemed (CHE) believes Roto-Rooter is well-positioned for growth and anticipates continued expansion of the segment's market share.,PODD,0.245959,0.181664,Somewhat-Bullish
How to Find Strong Buy Medical Stocks Using the Zacks Rank,https://www.zacks.com/stock/news/2179979/how-to-find-strong-buy-medical-stocks-using-the-zacks-rank,2023-11-07 14:00:05,"Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.",PODD,0.29176,0.264597,Somewhat-Bullish
Here's How Much a $1000 Investment in Insulet Made 10 Years Ago Would Be Worth Today,https://www.zacks.com/stock/news/2179915/heres-how-much-a-1000-investment-in-insulet-made-10-years-ago-would-be-worth-today,2023-11-07 13:30:03,"Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",PODD,0.603745,0.331374,Somewhat-Bullish
Insulet  ( PODD )  Banks on Omnipod for Consistent Market Share Gain,https://www.zacks.com/stock/news/2179888/insulet-podd-banks-on-omnipod-for-consistent-market-share-gain,2023-11-07 13:00:00,Insulet's (PODD) Omnipod 5 continues to be a driving force behind U.S. and international growth.,PODD,0.682689,0.188292,Somewhat-Bullish
QIAGEN  ( QGEN )  Launches Workflow to Boost Microbiome Research,https://www.zacks.com/stock/news/2179834/qiagen-qgen-launches-workflow-to-boost-microbiome-research,2023-11-07 12:01:00,QIAGEN (QGEN) expands the Microbiome solutions portfolio with the launch of Microbiome WGS SeqSets.,PODD,0.143415,0.054195,Neutral
Here's Why You Should Retain Tandem Diabetes  ( TNDM )  Now,https://www.zacks.com/stock/news/2179816/heres-why-you-should-retain-tandem-diabetes-tndm-now,2023-11-07 11:53:00,"Investors remain optimistic about Tandem Diabetes (TNDM), backed by upcoming innovative launches, including Mobi and the new integrated CGM offering.",PODD,0.137934,0.03087,Neutral
"Orthofix  ( OFIX )  Q3 Earnings Top Estimates, 2023 Sales View Cut",https://www.zacks.com/stock/news/2189267/orthofix-ofix-q3-earnings-top-estimates-2023-sales-view-cut,2023-11-24 17:28:00,Orthofix (OFIX) saw very strong growth across multiple business segments and product lines in Q3.,PODD,0.149038,0.059211,Neutral
Labcorp  ( LH )  Closes the Legacy Health Asset Acquisition Deal,https://www.zacks.com/stock/news/2188867/labcorp-lh-closes-the-legacy-health-asset-acquisition-deal,2023-11-24 12:21:00,Labcorp (LH) finalizes the comprehensive laboratory relationship with Legacy Health.,PODD,0.170878,0.060516,Neutral
Insulet  ( PODD )  Up 31.5% Since Q3 Earnings: What's Driving It?,https://www.zacks.com/stock/news/2188619/insulet-podd-up-315-since-q3-earnings-whats-driving-it,2023-11-23 16:46:00,Insulet (PODD) continues to gain from the strong adoption of Ommipod 5 and market expansion.,PODD,0.46898,0.325986,Somewhat-Bullish
This Top Medical Stock is a #1  ( Strong Buy ) : Why It Should Be on Your Radar,https://www.zacks.com/stock/news/2188344/this-top-medical-stock-is-a-strong-buy-why-it-should-be-on-your-radar,2023-11-23 14:00:09,"Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.",PODD,0.2872,0.322401,Somewhat-Bullish
"EssilorLuxottica  ( ESLOY ) , Moncler Ink Luxury Eyewear Deal",https://www.zacks.com/stock/news/2188322/essilorluxottica-esloy-moncler-ink-luxury-eyewear-deal,2023-11-23 13:49:00,The first Moncler Lunettes collection produced with EssilorLuxottica (ESLOY) is called Fall-Winter 2024.,PODD,0.237358,0.077774,Neutral
"If You Invested $1000 in Insulet a Decade Ago, This is How Much It'd Be Worth Now",https://www.zacks.com/stock/news/2188302/if-you-invested-1000-in-insulet-a-decade-ago-this-is-how-much-itd-be-worth-now,2023-11-23 13:30:05,"Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",PODD,0.600121,0.330417,Somewhat-Bullish
Here's Why You Should Retain Edward Lifesciences  ( EW )  Stock Now,https://www.zacks.com/stock/news/2188215/heres-why-you-should-retain-edward-lifesciences-ew-stock-now,2023-11-23 11:06:00,Investors remain optimistic about Edward Lifesciences (EW) due to Surgical's differentiated portfolio and TMTT franchise.,PODD,0.13459,0.030461,Neutral
Dow Jones Up As Microsoft Pops On Sam Altman Return; Cathie Wood Sells This Leader Up 250%,https://www.investors.com/market-trend/stock-market-today/dow-jones-up-as-microsoft-stock-pops-on-sam-altman-return-cathie-wood-sells-this-leader-up-250-nvidia-stock-tesla-stock/,2023-11-22 20:19:00,Dow Jones Up As Microsoft Pops On Sam Altman Return. Cathie ... Investor's Business Daily ...,PODD,0.090645,0.114916,Neutral
Quest Diagnostics'  ( DGX )  New Pact to Advance Cancer Screening,https://www.zacks.com/stock/news/2187944/quest-diagnostics-dgx-new-pact-to-advance-cancer-screening,2023-11-22 15:38:00,"Quest Diagnostics' (DGX) latest partnership will increase the likelihood that Americans will eventually have an easy, reliable and accessible way to check for colorectal cancer.",PODD,0.149966,0.055624,Neutral
Abbott  ( ABT )  Benefits From Innovation Amid FX Headwinds,https://www.zacks.com/stock/news/2187790/abbott-abt-benefits-from-innovation-amid-fx-headwinds,2023-11-22 14:10:00,"Abbott's (ABT) mAbxience collaboration is likely to help introduce cutting-edge medicines in the areas of oncology, women's health and respiratory diseases.",PODD,0.190667,0.065481,Neutral
Teleflex  ( TFX )  Enrolls First Patient in ACCESS-MANTA Registry,https://www.zacks.com/stock/news/2187672/teleflex-tfx-enrolls-first-patient-in-access-manta-registry,2023-11-22 12:25:00,Teleflex's (TFX) ACCESS-MANTA Registry is likely to examine the contemporary on-label use of the MANTA VCD.,PODD,0.148426,0.055282,Neutral
"Medtronic  ( MDT )  Q2 Earnings Beat Estimates, 2024 View Up",https://www.zacks.com/stock/news/2187364/medtronic-mdt-q2-earnings-beat-estimates-2024-view-up,2023-11-21 16:02:00,"Medtronic (MDT) Q2 results reflect broad strength across businesses and geographies, benefiting from durable fundamentals.",PODD,0.129983,0.047943,Neutral
Here's Why You Should Retain Myriad Genetics  ( MYGN )  Stock Now,https://www.zacks.com/stock/news/2187353/heres-why-you-should-retain-myriad-genetics-mygn-stock-now,2023-11-21 15:54:00,Investors are optimistic about Myriad Genetics (MYGN) on recent partnerships and growth in testing volumes.,PODD,0.142284,0.055185,Neutral
"Zimmer Biomet's  ( ZBH )  Knee Sales Robust, Macro Woes Hurt",https://www.zacks.com/stock/news/2187140/zimmer-biomets-zbh-knee-sales-robust-macro-woes-hurt,2023-11-21 13:52:00,Zimmer Biomet (ZBH) is working to strengthen its foothold in emerging markets that provide long-term opportunities for growth.,PODD,0.125242,0.050572,Neutral
Boston Scientific  ( BSX )  Closes the Relievant Medsystems Buyout,https://www.zacks.com/stock/news/2187043/boston-scientific-bsx-closes-the-relievant-medsystems-buyout,2023-11-21 11:56:00,Boston Scientific (BSX) expands the neuromodulation portfolio with the acquisition of Relievant Medsystems.,PODD,0.146321,0.054821,Neutral
Here's Why Investors Should Retain STERIS  ( STE )  Stock for Now,https://www.zacks.com/stock/news/2187041/heres-why-investors-should-retain-steris-ste-stock-for-now,2023-11-21 11:52:00,STERIS' (STE) Healthcare segment continues to benefit from procedure volume recovery.,PODD,0.132611,0.030223,Neutral
"National Vision's  ( EYE )  Market Expansion Aids, Inflation Ails",https://www.zacks.com/stock/news/2186766/national-visions-eye-market-expansion-aids-inflation-ails,2023-11-20 16:32:00,National Vision (EYE) is expanding sales by the continued rollout of its remote medicine technology.,PODD,0.134339,0.052317,Neutral
Myriad Genetics  ( MYGN )  Expands Pharma Services With New Pact,https://www.zacks.com/stock/news/2186741/myriad-genetics-mygn-expands-pharma-services-with-new-pact,2023-11-20 16:18:00,Myriad Genetics (MYGN) will market the Personalis ImmunoID NeXT ultra-comprehensive biomarker discovery platform to its pharmaceutical partners with a new collaboration.,PODD,0.191675,0.067239,Neutral
Medtronic's  ( MDT )  Symplicity Spyral RDN System Gets FDA Boost,https://www.zacks.com/stock/news/2186720/medtronics-mdt-symplicity-spyral-rdn-system-gets-fda-boost,2023-11-20 15:47:00,Medtronic (MDT) receives the FDA approval for Symplicity blood pressure procedure for the treatment of hypertension.,PODD,0.153145,0.056337,Neutral
Paragon 28  ( FNA )  BEAST Cortical Fibers Launch Boosts Biologics,https://www.zacks.com/stock/news/2186709/paragon-28-fna-beast-cortical-fibers-launch-boosts-biologics,2023-11-20 15:34:00,Paragon 28's (FNA) BEAST Cortical Fibers' advanced processing capability ensures the preservation of native bone morphogenic proteins and other growth factors crucial for bone formation.,PODD,0.200134,0.069479,Neutral
Nemaura  ( NMRD )  to Expand in UK With Metabolic Health Program,https://www.zacks.com/stock/news/2186133/nemaura-nmrd-to-expand-in-uk-with-metabolic-health-program,2023-11-17 16:41:00,"The latest program leverages Nemaura's (NMRD) world-first daily wear non-invasive CGM technology, providing individuals with real-time insights into their body's glucose dynamics.",PODD,0.195814,0.066808,Neutral
"Neogen's  ( NEOG )  Innovation Aids, Currency Headwind Stays",https://www.zacks.com/stock/news/2186126/neogens-neog-innovation-aids-currency-headwind-stays,2023-11-17 16:23:00,Neogen (NEOG) is progressing well in terms of picking the right growth markets and gaining a bigger share of those markets.,PODD,0.175009,0.06153,Neutral
Charles River  ( CRL )  Widens CliniPrime GMP Suite With New Launch,https://www.zacks.com/stock/news/2185867/charles-river-crl-widens-cliniprime-gmp-suite-with-new-launch,2023-11-17 13:40:00,Charles River (CRL) brings CliniPrime Cryopreserved Leukopaks for cell therapy development and manufacturing.,PODD,0.165031,0.059104,Neutral
"Omnicell's  ( OMCL )  Global Expansion Strong, Macro Issues Ail",https://www.zacks.com/stock/news/2194093/omnicells-omcl-global-expansion-strong-macro-issues-ail,2023-12-06 14:25:00,Omnicell (OMCL) accelerates a shift to cloud-based solutions and tech-enabled services through the launches of Inventory Optimization Service and Central Pharmacy Dispensing Services.,PODD,0.146916,0.054951,Neutral
Neogen  ( NEOG )  to Offer Biosecurity Products With New Pact,https://www.zacks.com/stock/news/2194003/neogen-neog-to-offer-biosecurity-products-with-new-pact,2023-12-06 13:16:00,"Neogen will be able to highlight its biosecurity and horse health products, like the COMPANION range of cleansers and disinfection solutions, through the latest collaboration.",PODD,0.207571,0.071471,Neutral
Here's Why You Should Retain Align Technology  ( ALGN )  Stock Now,https://www.zacks.com/stock/news/2193991/heres-why-you-should-retain-align-technology-algn-stock-now,2023-12-06 13:08:00,Investors are optimistic about Align Technology (ALGN) on global expansion and strategic alliance.,PODD,0.145437,0.055876,Neutral
Teleflex  ( TFX )  Signs Peripheral Access Purchasing Deal With PINC,https://www.zacks.com/stock/news/2193974/teleflex-tfx-signs-peripheral-access-purchasing-deal-with-pinc,2023-12-06 12:48:00,"Teleflex (TFX) secures the Peripheral Access purchasing agreement with Premier, Inc.",PODD,0.147818,0.065218,Neutral
Market Whales and Their Recent Bets on DXCM Options - DexCom  ( NASDAQ:DXCM ) ,https://www.benzinga.com/markets/options/23/12/36100418/market-whales-and-their-recent-bets-on-dxcm-options,2023-12-05 20:15:57,"High-rolling investors have positioned themselves bearish on DexCom DXCM, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data.",PODD,0.093653,0.0,Neutral
"Integra Gains From New Product Launches, Mounting Costs Ail",https://www.zacks.com/stock/news/2193456/integra-gains-from-new-product-launches-mounting-costs-ail,2023-12-05 13:35:00,"Integra expands the international reach of the CUSA platform and registers DuraGen, DuraSeal, Mayfield and Duo LED lighting in the EMEA and Latin America.",PODD,0.170475,0.060418,Neutral
"Boston Scientific  ( BSX )  Gains From Global Expansion, FX Woe Ails",https://www.zacks.com/stock/news/2193448/boston-scientific-bsx-gains-from-global-expansion-fx-woe-ails,2023-12-05 13:30:00,Boston Scientific's (BSX) Endoscopy business within MedSurg benefits from strong worldwide demand for its broad range of GI and pulmonary treatment options.,PODD,0.134841,0.052418,Neutral
Henry Schein's  ( HSIC )  Zahn Dental and Myerson Enter New Deal,https://www.zacks.com/stock/news/2193401/henry-scheins-hsic-zahn-dental-and-myerson-enter-new-deal,2023-12-05 12:37:00,"Henry Schein's (HSIC) dental laboratory business, Zahn Dental, is set to exclusively distribute Myerson's New Trusana 3D Premium Denture System.",PODD,0.146321,0.054821,Neutral
Here's Why You Should Retain Charles River  ( CRL )  Stock Now,https://www.zacks.com/stock/news/2193393/heres-why-you-should-retain-charles-river-crl-stock-now,2023-12-05 12:29:00,"Charles River's (CRL) share price is likely to grow, backed by the strength of the DSA segment.",PODD,0.125025,0.029346,Neutral
"The Zacks Analyst Blog Highlights NVIDIA, Vertiv Holdings, Copart, Insulet and Constellation Energy",https://www.zacks.com/stock/news/2193323/the-zacks-analyst-blog-highlights-nvidia-vertiv-holdings-copart-insulet-and-constellation-energy,2023-12-05 10:01:00,"NVIDIA, Vertiv Holdings, Copart, Insulet and Constellation Energy are included in this Analyst Blog.",PODD,0.334573,0.357868,Bullish
Exact Sciences  ( EXAS )  Up 35.4% YTD: Will the Rally Continue?,https://www.zacks.com/stock/news/2193144/exact-sciences-exas-up-354-ytd-will-the-rally-continue,2023-12-04 17:13:00,"Investors are optimistic about Exact Sciences (EXAS), driven by growth in Screening and Precision Oncology segments.",PODD,0.160633,0.059387,Neutral
Top 5 Momentum Picks for December After Rejuvenated November,https://www.zacks.com/stock/news/2192791/top-5-momentum-picks-for-december-after-rejuvenated-november,2023-12-04 12:49:00,"Five momentum stocks for December are: NVDA, VRT, CPRT, CEG, PODD.",PODD,0.311406,0.486941,Bullish
Thermo Fisher  ( TMO )  Advances Health Equity via New Partnership,https://www.zacks.com/stock/news/2192709/thermo-fisher-tmo-advances-health-equity-via-new-partnership,2023-12-04 11:15:00,Thermo Fisher (TMO) announces a collaboration with Project HOPE to improve health outcomes by enabling expanded access to HIV testing and support services in Nigeria.,PODD,0.135857,0.052622,Neutral
4 Best Stocks to Invest in for Solid Earnings Growth,https://www.zacks.com/stock/news/2192705/4-best-stocks-to-invest-in-for-solid-earnings-growth,2023-12-04 11:03:00,"Invest in stocks such as Insulet (PODD), W.R. Berkley (WRB), Invitation Home (INVH) and VICI Properties (VICI) for superb earnings growth.",PODD,0.106541,0.145432,Neutral
BiomX  ( PHGE )  Reports Positive Pulmonary Infection Treatment Data,https://www.zacks.com/stock/news/2192692/biomx-phge-reports-positive-pulmonary-infection-treatment-data,2023-12-04 10:38:00,BiomX's (PHGE) BX004 showcases an impressive 14% conversion to a negative P. aeruginosa sputum culture at the end of treatment.,PODD,0.175859,0.061741,Neutral
Neogen  ( NEOG )  Unveils New Assay for Walnut Allergens Detection,https://www.zacks.com/stock/news/2192294/neogen-neog-unveils-new-assay-for-walnut-allergens-detection,2023-12-01 16:01:00,Neogen's (NEOG) Veratox VIP for Walnut allergy test displays robust performance across sample types while keeping the Veratox product line's simple testing approach.,PODD,0.182967,0.063519,Neutral
"CVS Health's  ( CVS )  Digital Focus Aids Growth, Macro Issues Ail",https://www.zacks.com/stock/news/2192251/cvs-healths-cvs-digital-focus-aids-growth-macro-issues-ail,2023-12-01 14:54:00,CVS Health's (CVS) Health Care Benefits segment demonstrates value to consumers and clients by successfully managing drug cost trends and bringing innovative clinical solutions to the market.,PODD,0.162073,0.058402,Neutral
Walgreens  ( WBA )  Launches Rx Savings Finder Digital Tool,https://www.zacks.com/stock/news/2191998/walgreens-wba-launches-rx-savings-finder-digital-tool,2023-12-01 12:04:00,Walgreens (WBA) introduces Rx Savings Finder to help patients save on prescription medications.,PODD,0.131643,0.051785,Neutral
Thermo Fisher  ( TMO )  Extends Partnership With Flagship Pioneering,https://www.zacks.com/stock/news/2191700/thermo-fisher-tmo-extends-partnership-with-flagship-pioneering,2023-11-30 16:51:00,Thermo Fisher's (TMO) in-depth knowledge of the life sciences sector will be combined with Flagship Pioneering to create revolutionary capabilities for the ecosystem.,PODD,0.158173,0.0588,Neutral
Charles River  ( CRL )  Gains on Price & Volume Growth Amid FX Woe,https://www.zacks.com/stock/news/2191596/charles-river-crl-gains-on-price-volume-growth-amid-fx-woe,2023-11-30 16:17:00,"At present, Charles River (CRL) is the largest provider of outsourced drug discovery, non-clinical development and regulated safety testing services worldwide.",PODD,0.144275,0.054379,Neutral
Inspira  ( IINN )  Expands in Life Support Space With New Deal,https://www.zacks.com/stock/news/2191591/inspira-iinn-expands-in-life-support-space-with-new-deal,2023-11-30 16:04:00,"According to Inspira (IINN), the integration of its technology to oxygenate blood combined with Ennocure's infection prevention solutions is likely to help improve patient outcomes in ICUs.",PODD,0.236588,0.07757,Neutral
"11 Stocks Turn $10,000 Into $230,769 In 11 Months",https://www.investors.com/etfs-and-funds/sectors/sp500-stocks-turn-10000-into-in-11-months/,2023-11-30 13:00:00,Hope you didn't bail out of S&P 500 stocks after three straight months of losses. November turned into a big moneymaker for patient investors.,PODD,0.099683,0.160428,Somewhat-Bullish
Penumbra  ( PEN )  Enrolls First Patient in Landmark STORM-PE Trial,https://www.zacks.com/stock/news/2191307/penumbra-pen-enrolls-first-patient-in-landmark-storm-pe-trial,2023-11-30 12:37:00,Penumbra (PEN) achieves an important milestone by enrolling the first patient in STORM-PE RCT.,PODD,0.166169,0.062085,Neutral
Reasons to Retain Quest Diagnostics  ( DGX )  Stock for Now,https://www.zacks.com/stock/news/2191302/reasons-to-retain-quest-diagnostics-dgx-stock-for-now,2023-11-30 12:28:00,Investors are optimistic about Quest Diagnostics (DGX) on the strength of the base business.,PODD,0.118064,0.028592,Neutral
Here's Why You Should Retain Zimmer Biomet  ( ZBH )  for Now,https://www.zacks.com/stock/news/2190999/heres-why-you-should-retain-zimmer-biomet-zbh-for-now,2023-11-29 16:34:00,"Investors are optimistic about Zimmer Biomet (ZBH), driven by a recovery in business and an expanding global footprint.",PODD,0.1437,0.055494,Neutral
Quest Diagnostics'  ( DGX )  New Pact to Scale Precision Medicine,https://www.zacks.com/stock/news/2191001/quest-diagnostics-dgx-new-pact-to-scale-precision-medicine,2023-11-29 16:33:00,Quest Diagnostics' (DGX) will supply next-generation sequencing and enhanced RNA extraction services for Scipher's PrismRA test through a new collaboration.,PODD,0.147516,0.056339,Neutral
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick,https://www.zacks.com/stock/news/2190882/are-you-a-growth-investor-this-1-stock-could-be-the-perfect-pick,2023-11-29 14:45:07,"Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",PODD,0.446742,0.345425,Somewhat-Bullish
Accelerate Diagnostics  ( AXDX )  Expands in In Vitro Diagnostics,https://www.zacks.com/stock/news/2190753/accelerate-diagnostics-axdx-expands-in-in-vitro-diagnostics,2023-11-29 13:43:00,"Accelerate Diagnostics' (AXDX) Arc system eliminates the need for overnight culture incubation, drastically reducing the wait time for identification results.",PODD,0.238913,0.095981,Neutral
Charles River  ( CRL )  Backs the Quest to Cure SPG56 via New Deal,https://www.zacks.com/stock/news/2190717/charles-river-crl-backs-the-quest-to-cure-spg56-via-new-deal,2023-11-29 12:57:00,Charles River (CRL) and GC4K announce a gene therapy manufacturing collaboration.,PODD,0.148121,0.055215,Neutral
Smith & Nephew  ( SNN )  New Buyout Expands Sports Medicine Suite,https://www.zacks.com/stock/news/2190443/smith-nephew-snn-new-buyout-expands-sports-medicine-suite,2023-11-28 16:31:00,"Smith & Nephew (SNN) will pay an initial cash consideration of $180 million at closure, with an additional $150 million based on financial performance to acquire CartiHeal.",PODD,0.158868,0.05765,Neutral
"Penumbra's  ( PEN )  Expansion Moves, New Launches Aid Growth",https://www.zacks.com/stock/news/2190374/penumbras-pen-expansion-moves-new-launches-aid-growth,2023-11-28 14:54:00,Penumbra (PEN) expects to materially increase both revenues and profitability of the international business in the next three years and beyond.,PODD,0.148426,0.055282,Neutral
Here's Why You Should Retain Teleflex  ( TFX )  Stock for Now,https://www.zacks.com/stock/news/2190140/heres-why-you-should-retain-teleflex-tfx-stock-for-now,2023-11-28 12:41:00,Investors remain optimistic about Teleflex (TFX) on the strength of the Vascular and Interventional businesses.,PODD,0.1331,0.030282,Neutral
PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer,https://www.globenewswire.com/news-release/2023/11/28/2786835/37149/en/PDS-Biotech-Appoints-Lars-Boesgaard-as-Chief-Financial-Officer.html,2023-11-28 12:30:00,"PRINCETON, N.J., Nov. 28, 2023 ( GLOBE NEWSWIRE ) -- PDS Biotechnology Corporation ( Nasdaq: PDSB ) ( ""PDS Biotech"" or the ""Company"" ) , a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines based on the Company's ...",PODD,0.029691,0.016766,Neutral
3 Reasons Why Growth Investors Shouldn't Overlook Insulet  ( PODD ) ,https://www.zacks.com/stock/news/2189934/3-reasons-why-growth-investors-shouldnt-overlook-insulet-podd,2023-11-27 17:45:05,"Insulet (PODD) possesses solid growth attributes, which could help it handily outperform the market.",PODD,0.497733,0.366068,Bullish
Here's Why Investors Should Retain Labcorp  ( LH )  Stock for Now,https://www.zacks.com/stock/news/2189584/heres-why-investors-should-retain-labcorp-lh-stock-for-now,2023-11-27 13:35:00,Investors are increasingly optimistic about Labcorp (LH) due to development in targeted high-growth areas.,PODD,0.126119,0.029469,Neutral
Big Players' Recent Trades in PODD Options - Insulet  ( NASDAQ:PODD ) ,https://www.benzinga.com/markets/options/23/12/36264235/big-players-recent-trades-in-podd-options,2023-12-15 19:31:05,"Whales with a lot of money to spend have taken a noticeably bullish stance on Insulet. Looking at options history for Insulet PODD we detected 11 trades. If we consider the specifics of each trade, it is accurate to state that 54% of the investors opened trades with bullish expectations and 45% ...",PODD,0.671304,0.305025,Somewhat-Bullish
Here's Why You Should Retain Globus Medical  ( GMED )  Stock Now,https://www.zacks.com/stock/news/2198889/heres-why-you-should-retain-globus-medical-gmed-stock-now,2023-12-15 17:14:00,Investors are optimistic about Globus Medical (GMED) on growing demand for musculoskeletal devices and its strong solvency position.,PODD,0.147516,0.056339,Neutral
Neogen  ( NEOG )  to Advance Feline DNA Testing With New Pact,https://www.zacks.com/stock/news/2198888/neogen-neog-to-advance-feline-dna-testing-with-new-pact,2023-12-15 17:13:00,Neogen's (NEOG) strategic alliance will expand feline DNA testing and strengthen its relationship with the kitty community.,PODD,0.163909,0.064206,Neutral
"Align's  ( ALGN )  New Launches Aid, Macroeconomic Woes Linger",https://www.zacks.com/stock/news/2198721/aligns-algn-new-launches-aid-macroeconomic-woes-linger,2023-12-15 14:52:00,"Align Technology (ALGN) performs digital treatment planning and interpretation for restorative cases worldwide, including Costa Rica, China, Germany, Spain, Poland and Japan, among others.",PODD,0.127908,0.051068,Neutral
Align Technologies  ( ALGN )  Secures Updated Medical Device License,https://www.zacks.com/stock/news/2198549/align-technologies-algn-secures-updated-medical-device-license,2023-12-15 14:02:00,Align Technologies' (ALGN) Invisalign Palatal Expander system receives an updated medical device license from Health Canada.,PODD,0.136113,0.052674,Neutral
Here's Why You Should Buy Neogen  ( NEOG )  Stock Now,https://www.zacks.com/stock/news/2198536/heres-why-you-should-buy-neogen-neog-stock-now,2023-12-15 13:55:00,"Investors are optimistic about Neogen (NEOG), owing to product launches and the performance of segments.",PODD,0.134841,-0.008645,Neutral
Tandem Diabetes  ( TNDM )  Avails Tandem Source in the United States,https://www.zacks.com/stock/news/2198106/tandem-diabetes-tndm-avails-tandem-source-in-the-united-states,2023-12-14 16:23:00,"Tandem Diabetes (TNDM) announces the full U.S. launch of Tandem Source, a new diabetes management platform for customers and healthcare providers.",PODD,0.152499,0.057473,Neutral
Integra  ( IART )  to Advance ENT Division With New Buyout Deal,https://www.zacks.com/stock/news/2198095/integra-iart-to-advance-ent-division-with-new-buyout-deal,2023-12-14 16:14:00,Integra (IART) will be among the top suppliers of ENT products and technologies following the Acclarent acquisition.,PODD,0.158519,0.057569,Neutral
Myriad Genetics'  ( MYGN )  New Partnerships Aid Amid FX Woes,https://www.zacks.com/stock/news/2197835/myriad-genetics-mygn-new-partnerships-aid-amid-fx-woes,2023-12-14 13:22:00,"Myriad Genetics (MYGN) continues to record strong revenue growth from companion diagnostics, including significant revenue share from its proprietary myChoiceCDx test.",PODD,0.142005,0.053895,Neutral
Medtronic  ( MDT )  Expands AI-Driven Care With New Partnership,https://www.zacks.com/stock/news/2197563/medtronic-mdt-expands-ai-driven-care-with-new-partnership,2023-12-13 17:52:00,Medtronic's (MDT) expanded collaboration with Cosmo Pharmaceuticals is a strategic step forward in its quest to use AI to improve patient care.,PODD,0.149346,0.055486,Neutral
Here's Why You Should Retain Exact Sciences  ( EXAS )  Stock Now,https://www.zacks.com/stock/news/2197564/heres-why-you-should-retain-exact-sciences-exas-stock-now,2023-12-13 17:52:00,Investors are optimistic about Exact Sciences (EXAS) on strong Cologuard adoption and raised guidance.,PODD,0.144853,0.054504,Neutral
"Is Insulet  ( PODD )  a Solid Growth Stock? 3 Reasons to Think ""Yes""",https://www.zacks.com/stock/news/2197560/is-insulet-podd-a-solid-growth-stock-3-reasons-to-think-yes,2023-12-13 17:45:05,"Insulet (PODD) possesses solid growth attributes, which could help it handily outperform the market.",PODD,0.508878,0.334271,Somewhat-Bullish
QIAGEN's  ( QGEN )  Strategic Alliances Aid Amid Macro Woes,https://www.zacks.com/stock/news/2197534/qiagens-qgen-strategic-alliances-aid-amid-macro-woes,2023-12-13 17:19:00,QIAGEN (QGEN) aims to expand the NGS platform by rapidly scaling up the new Enterprise Genomics Services.,PODD,0.138464,0.053155,Neutral
Terumo  ( TRUMY )  Launches AZUR HydroPack in Embolotherapy Space,https://www.zacks.com/stock/news/2197507/terumo-trumy-launches-azur-hydropack-in-embolotherapy-space,2023-12-13 17:11:00,"Terumo's (TRUMY) coil system boasts a soft, universal-shaped platinum and hydrogel composition, which sets it apart in the peripheral coil market.",PODD,0.211191,0.070831,Neutral
Charles River  ( CRL )  Expands 3D In Vitro Services Via New Deal,https://www.zacks.com/stock/news/2197217/charles-river-crl-expands-3d-in-vitro-services-via-new-deal,2023-12-13 13:29:00,"Charles River (CRL) finalizes agreement with service-based biotechnology company, CELLphenomics.",PODD,0.14573,0.054693,Neutral
Here's Why Investors Should Retain ResMed  ( RMD )  Stock for Now,https://www.zacks.com/stock/news/2196711/heres-why-investors-should-retain-resmed-rmd-stock-for-now,2023-12-12 14:19:00,Investors continue to be optimistic about ResMed (RMD) due to the sustained growth in the SaaS business.,PODD,0.118647,-0.008117,Neutral
Thermo Fisher  ( TMO )  Launches New Solutions for Clinical Labs,https://www.zacks.com/stock/news/2196649/thermo-fisher-tmo-launches-new-solutions-for-clinical-labs,2023-12-12 13:52:00,Thermo Fisher (TMO) introduces the KingFisher Apex Dx system and Applied Biosystems MagMAX Dx Isolation Kit to improve preanalytical workflows for clinical laboratories.,PODD,0.152499,0.056191,Neutral
Edwards Lifesciences  ( EW )  Forwards Growth Strategy and Outlook,https://www.zacks.com/stock/news/2196357/edwards-lifesciences-ew-forwards-growth-strategy-and-outlook,2023-12-11 17:27:00,"Edwards Lifesciences' (EW) TAVR remains strong, driven by greater awareness, patient activation and advances in new technologies such as RESILIA.",PODD,0.145145,0.118155,Neutral
Illumina  ( ILMN )  Expands Globally Despite Macroeconomic Woes,https://www.zacks.com/stock/news/2196086/illumina-ilmn-expands-globally-despite-macroeconomic-woes,2023-12-11 14:13:00,The NovaSeq X launch strengthens Illumina's (ILMN) competitive position in high-throughput sequencing.,PODD,0.120834,0.049781,Neutral
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks,https://www.zacks.com/stock/news/2196079/the-zacks-rank-explained-how-to-find-strong-buy-medical-stocks,2023-12-11 14:00:04,"Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.",PODD,0.286082,0.260646,Somewhat-Bullish
"If You Invested $1000 in Insulet a Decade Ago, This is How Much It'd Be Worth Now",https://www.zacks.com/stock/news/2196021/if-you-invested-1000-in-insulet-a-decade-ago-this-is-how-much-itd-be-worth-now,2023-12-11 13:30:03,"Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",PODD,0.597724,0.34874,Somewhat-Bullish
Walgreens'  ( WBA )  AllianceRx Pharmacy Will Now Distribute XDEMVY,https://www.zacks.com/stock/news/2196004/walgreens-wba-alliancerx-pharmacy-will-now-distribute-xdemvy,2023-12-11 13:02:00,"Walgreens' (WBA) subsidiary, AllianceRx Walgreens Pharmacy, is one of the four specialty pharmacies selected to distribute XDEMVY.",PODD,0.129749,0.051418,Neutral
Centene's  ( CNC )  Ambetter Enhances Offerings With Broward Health,https://www.zacks.com/stock/news/2195538/centenes-cnc-ambetter-enhances-offerings-with-broward-health,2023-12-08 15:37:00,Centene's (CNC) Health Insurance Marketplace brand Ambetter strengthens its provider network with Broward Health.,PODD,0.21686,0.151346,Somewhat-Bullish
BrainsWay  ( BWAY )  Strengthens South Korean Foothold With Deep TMS,https://www.zacks.com/stock/news/2195323/brainsway-bway-strengthens-south-korean-foothold-with-deep-tms,2023-12-08 13:16:00,"BrainsWay's (BWAY) Deep TMS targets affected brain structures with a magnetic field, stimulating crucial neural networks.",PODD,0.195287,0.069712,Neutral
Quest Diagnostics  ( DGX )  & CDC to Assess Hepatitis C Burden,https://www.zacks.com/stock/news/2195277/quest-diagnostics-dgx-cdc-to-assess-hepatitis-c-burden,2023-12-08 12:25:00,Quest Diagnostics (DGX) and CDC expand research collaboration to better understand the Hepatitis C burden in the United States.,PODD,0.139804,0.053433,Neutral
Here's Why You Should Retain Boston Scientific  ( BSX )  Now,https://www.zacks.com/stock/news/2195111/heres-why-you-should-retain-boston-scientific-bsx-now,2023-12-07 20:14:00,Investors are optimistic about Boston Scientific (BSX) on strong worldwide demand for its GI and pulmonary treatment options and traction in Europe for its next-generation WATCHMAN FLX.,PODD,0.148731,0.05535,Neutral
"Centene  ( CNC ) , Mindoula to Address Mental Health Issues in Indiana",https://www.zacks.com/stock/news/2194922/centene-cnc-mindoula-to-address-mental-health-issues-in-indiana,2023-12-07 16:36:00,"Centene's (CNC) unit, MHS, collaborates with Mindoula to enhance mental health support for Hoosiers and attract more customers to opt for CNC's Medicaid plans.",PODD,0.211191,0.212352,Somewhat-Bullish
"Globus Medical  ( GMED )  Gains From NuVasive Deal, Macro Woes Stay",https://www.zacks.com/stock/news/2194719/globus-medical-gmed-gains-from-nuvasive-deal-macro-woes-stay,2023-12-07 14:20:00,"Globus Medical (GMED) witnesses notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings.",PODD,0.149966,0.055624,Neutral
OrthoPediatrics  ( KIDS )  Introduces Unit for Non-Surgical Bracing,https://www.zacks.com/stock/news/2194705/orthopediatrics-kids-introduces-unit-for-non-surgical-bracing,2023-12-07 14:10:00,OrthoPediatrics (KIDS) continues to diversify its non-surgical offerings with the introduction of the DF2 Brace.,PODD,0.194242,0.066402,Neutral
Here's Why You Should Retain National Vision  ( EYE )  Stock Now,https://www.zacks.com/stock/news/2194602/heres-why-you-should-retain-national-vision-eye-stock-now,2023-12-07 11:59:00,"Investors are optimistic about National Vision's (EYE) stock, banking on comparable store sales growth and a favorable liquidity structure.",PODD,0.124164,0.02925,Neutral
Tandem Diabetes  ( TNDM )  Launches Dexcom G7 Integrated t:slim X2,https://www.zacks.com/stock/news/2194597/tandem-diabetes-tndm-launches-dexcom-g7-integrated-tslim-x2,2023-12-07 11:55:00,Tandem Diabetes' (TNDM) t:slim X2 is the first AID system in the world to feature Dexcom's most advanced CGM technology.,PODD,0.135602,0.052571,Neutral
Thermo Fisher  ( TMO )  Unveils CorEvitas Pharmacovigilance Platform,https://www.zacks.com/stock/news/2202037/thermo-fisher-tmo-unveils-corevitas-pharmacovigilance-platform,2023-12-26 12:08:00,Thermo Fisher (TMO) introduces the CorEvitas pharmacovigilance platform for clinical research registries.,PODD,0.1568,0.057172,Neutral
Penumbra  ( PEN )  Stock Up 16.2% YTD: Will the Rally Continue?,https://www.zacks.com/stock/news/2201524/penumbra-pen-stock-up-162-ytd-will-the-rally-continue,2023-12-22 14:37:00,"Investors are optimistic about Penumbra (PEN), driven by growth in the vascular segments and upbeat guidance.",PODD,0.16849,0.059936,Neutral
Thermo Fisher's  ( TMO )  PPD Business Backs BARDA's Clinical Trial,https://www.zacks.com/stock/news/2201462/thermo-fishers-tmo-ppd-business-backs-bardas-clinical-trial,2023-12-22 13:56:00,Thermo Fisher's (TMO) PPD clinical research business is selected by BARDA to support the Phase II platform clinical trial to treat ARDS.,PODD,0.136629,0.052779,Neutral
Here are the big health sector themes to watch next year,https://www.cnbc.com/2023/12/22/health-sector-themes-to-watch-in-2024.html,2023-12-22 13:41:09,"The health-care sector has seen a big rebound this month, and analysts say some beaten-down names will continue to have positive momentum in 2024.",PODD,0.050679,0.083415,Neutral
Universal Health  ( UHS )  Up 17% in 3 Months: More Growth Ahead?,https://www.zacks.com/stock/news/2201204/universal-health-uhs-up-17-in-3-months-more-growth-ahead,2023-12-21 17:33:00,"Universal Health (UHS) is well-poised for growth on the back of the resumption of elective procedures, acquisitions and solid operating cash flows.",PODD,0.201523,0.163044,Somewhat-Bullish
Henry Schein  ( HSIC )  Enters Orthopedic Market With New Buyout,https://www.zacks.com/stock/news/2201157/henry-schein-hsic-enters-orthopedic-market-with-new-buyout,2023-12-21 16:39:00,"Henry Schein's (HSIC) recent deals will position it as a prominent producer and supplier in the orthopedic market's Foot and Ankle, Hand and Wrist extremity sectors.",PODD,0.158173,0.0588,Neutral
"Exact Sciences'  ( EXAS )  Solid Cologuard Sales, Innovation Aid",https://www.zacks.com/stock/news/2201042/exact-sciences-exas-solid-cologuard-sales-innovation-aid,2023-12-21 14:43:00,"Following the acquisitions of Paradigm and Ashion, Exact Sciences (EXAS) is offering therapy selection tests for patients with advanced cancer.",PODD,0.133346,0.053309,Neutral
Myriad Genetics'  ( MYGN )  New Platform to Advance Cancer Care,https://www.zacks.com/stock/news/2201001/myriad-genetics-mygn-new-platform-to-advance-cancer-care,2023-12-21 14:17:00,Myriad Genetics' (MYGN) new MCRR platform advances patient care by combining structured clinical data with genetic and genomic results.,PODD,0.146618,0.054886,Neutral
"Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Thursday - argenx  ( NASDAQ:ARGX ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/news/23/12/36341410/amazon-com-to-rally-over-38-here-are-10-top-analyst-forecasts-for-thursday,2023-12-21 12:36:23,"Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Morgan Stanley boosted Regency Centers Corporation REG price target from $62 to $75.",PODD,0.246999,0.295634,Somewhat-Bullish
DexCom's Options Frenzy: What You Need to Know - DexCom  ( NASDAQ:DXCM ) ,https://www.benzinga.com/markets/options/23/12/36328765/dexcoms-options-frenzy-what-you-need-to-know,2023-12-20 16:45:47,"Whales with a lot of money to spend have taken a noticeably bearish stance on DexCom. Looking at options history for DexCom DXCM we detected 11 trades. If we consider the specifics of each trade, it is accurate to state that 27% of the investors opened trades with bullish expectations and 72% ...",PODD,0.098255,0.0,Neutral
Bruker  ( BRKR )  Installs First 1.2 GHz NMR at Ohio University,https://www.zacks.com/stock/news/2200633/bruker-brkr-installs-first-12-ghz-nmr-at-ohio-university,2023-12-20 16:32:00,Bruker (BRKR) 1.2 GHz AVANCE NMR spectrometer is cutting-edge equipment capable of performing high-resolution liquid and solid-state NMR studies.,PODD,0.159569,0.059133,Neutral
"Bio-Rad  ( BIO )  Faces Soft Industry-wide Demand, Macro Woes",https://www.zacks.com/stock/news/2200595/bio-rad-bio-faces-soft-industry-wide-demand-macro-woes,2023-12-20 16:03:00,"Bio-Rad's (BIO) margin performance suffers due to elevated raw material costs, increased logistics costs and higher employee-related expenses.",PODD,0.148121,0.055215,Neutral
Venus Concept  ( VERO )  Expands Global Reach With New Partnerships,https://www.zacks.com/stock/news/2200464/venus-concept-vero-expands-global-reach-with-new-partnerships,2023-12-20 13:49:00,Venus Concept (VERO) expects its deals to fetch continued success in both the United Kingdom and India.,PODD,0.166551,0.059468,Neutral
Quest Diagnostics  ( DGX )  Unveils the 88-Compound NPS Test Panel,https://www.zacks.com/stock/news/2200390/quest-diagnostics-dgx-unveils-the-88-compound-nps-test-panel,2023-12-20 12:01:00,Quest Diagnostics (DGX) launches the new 88-Compound NPS test panel to address the changing drug epidemic.,PODD,0.137148,0.052885,Neutral
How to Find the Best Top-Ranked Stocks to Buy in 2024,https://www.zacks.com/commentary/2200181/how-to-find-the-best-top-ranked-stocks-to-buy-in-2024,2023-12-19 20:36:00,Here is how to utilize the Filtered Zacks Rank 5 Stock Screen to help find potentially winning stocks to buy to close out December and throughout 2024.,PODD,0.423606,0.15825,Somewhat-Bullish
DexCom's  ( DXCM )  G7 CGM Connects With Tandem's Insulin Pump,https://www.zacks.com/stock/news/2200159/dexcoms-dxcm-g7-cgm-connects-with-tandems-insulin-pump,2023-12-19 18:27:00,"Dexcom's (DXCM) G7 integrates with Tandem's t:slim X2, revolutionizing diabetes care. A perfect combination of accuracy and innovation, this synergy sets a new standard in continuous glucose monitoring.",PODD,0.051774,0.0,Neutral
Here's Why You Should Invest in Penumbra  ( PEN )  Stock Now,https://www.zacks.com/stock/news/2200052/heres-why-you-should-invest-in-penumbra-pen-stock-now,2023-12-19 15:30:00,"Investors are optimistic about Penumbra (PEN), which is led by growth in vascular and neuro businesses.",PODD,0.155786,0.060836,Neutral
Align's  ( ALGN )  Invisalign Palatal Expander System Gets FDA Nod,https://www.zacks.com/stock/news/2200045/aligns-algn-invisalign-palatal-expander-system-gets-fda-nod,2023-12-19 15:24:00,"Align's (ALGN) Invisalign Palatal Expander is the company's first direct 3D-printed orthodontic device. It offers a safe, pleasant and clinically effective alternative to traditional palatal expanders.",PODD,0.155451,0.058159,Neutral
"CVS Health  ( CVS )  New Opportunities Drive Growth, Macro Woes Stay",https://www.zacks.com/stock/news/2199865/cvs-health-cvs-new-opportunities-drive-growth-macro-woes-stay,2023-12-19 13:25:00,"CVS Health's (CVS) restructuring plan poises it well, along with its strategic buyouts.",PODD,0.114865,0.048774,Neutral
SenesTech  ( SNES )  Likely to Expand Into China With New Deal,https://www.zacks.com/stock/news/2199856/senestech-snes-likely-to-expand-into-china-with-new-deal,2023-12-19 13:20:00,"This partnership provides SenesTech (SNES) with a gateway into one of the largest pest control markets globally, with the support and expertise of Fruit Tree.",PODD,0.183895,0.063754,Neutral
5 Nasdaq Composite Laggards Likely to Gather Pace in 2024,https://www.zacks.com/stock/news/2199840/5-nasdaq-composite-laggards-likely-to-gather-pace-in-2024,2023-12-19 13:02:00,"We have narrowed our search to five Nasdaq Composite listed laggards of 2023 with strong potential for 2024. These are: PEP, KHC, WMG, PODD, BGNE.",PODD,0.25255,0.443416,Bullish
Charles River's  ( CRL )  Memphis Site Achieves Crucial Approval,https://www.zacks.com/stock/news/2199833/charles-rivers-crl-memphis-site-achieves-crucial-approval,2023-12-19 13:01:00,Charles River (CRL) reaches an important milestone in cell therapy manufacturing collaboration with Vertex Pharmaceuticals.,PODD,0.143415,0.054195,Neutral
Here's Why You Should Retain Tandem Diabetes  ( TNDM )  Now,https://www.zacks.com/stock/news/2199822/heres-why-you-should-retain-tandem-diabetes-tndm-now,2023-12-19 12:50:00,"Investors remain optimistic about Tandem Diabetes (TNDM), backed by the impressive spree of product introductions.",PODD,0.136888,0.030741,Neutral
Abbott  ( ABT )  Gains From Global Expansion Amid Macro Woes,https://www.zacks.com/stock/news/2199328/abbott-abt-gains-from-global-expansion-amid-macro-woes,2023-12-18 14:08:00,Abbott's (ABT) EPD business continues to witness low double-digit growth. It has successfully positioned itself as one of the best-positioned large healthcare companies in emerging markets.,PODD,0.146618,0.054886,Neutral
Thermo Fisher  ( TMO )  to Allocate IFA Testing Kits With New Pact,https://www.zacks.com/stock/news/2199299/thermo-fisher-tmo-to-allocate-ifa-testing-kits-with-new-pact,2023-12-18 13:45:00,Thermo Fisher (TMO) will continue to meet the evolving needs of laboratories and healthcare professionals by expanding its immunology product portfolio of EliA autoimmune diagnostics.,PODD,0.167322,0.059653,Neutral
Quest Diagnostics'  ( DGX )  Haystack Oncology Inks New Deal,https://www.zacks.com/stock/news/2199231/quest-diagnostics-dgx-haystack-oncology-inks-new-deal,2023-12-18 12:47:00,"Quest Diagnostics' (DGX) wholly owned subsidiary, Haystack Oncology, partners with the Rutgers Cancer Institute of New Jersey.",PODD,0.142005,0.055124,Neutral
Here's Why You Should Invest in IDEXX  ( IDXX )  Stock Right Now,https://www.zacks.com/stock/news/2199228/heres-why-you-should-invest-in-idexx-idxx-stock-right-now,2023-12-18 12:40:00,"Investors continue to be optimistic about IDEXX (IDXX), backed by the strength of the CAG Diagnostics business.",PODD,0.121241,0.02893,Neutral
Here's Why You Should Retain Hologic  ( HOLX )  Stock for Now,https://www.zacks.com/stock/news/2199227/heres-why-you-should-retain-hologic-holx-stock-for-now,2023-12-18 12:39:00,"Investors are optimistic about Hologic (HOLX), which is led by growth with recovery in procedural volumes and acceleration from new business lines.",PODD,0.138464,0.054367,Neutral
Why Insulet  ( PODD )  is a Top Growth Stock for the Long-Term,https://www.zacks.com/stock/news/2206299/why-insulet-podd-is-a-top-growth-stock-for-the-long-term,2024-01-05 14:45:07,"Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",PODD,0.575055,0.352211,Bullish
"Alcon  ( ALC )  Business Hurt by Macroeconomic Woes, Competition",https://www.zacks.com/stock/news/2205673/alcon-alc-business-hurt-by-macroeconomic-woes-competition,2024-01-04 14:44:00,"In the surgical business, Alcon (ALC) faces a mix of competitors, ranging from large manufacturers with multiple business lines to small manufacturers.",PODD,0.176717,0.060541,Neutral
Ozempic and other weight-loss drugs' popularity set these stocks up for big gains,https://www.marketwatch.com/story/ozempic-and-other-weight-loss-drugs-popularity-set-these-stocks-up-for-big-gains-fa2a3f33,2024-01-04 12:10:00,Gut-punch to medical technology and processed-food stocks is temporary.,PODD,0.176933,0.02006,Neutral
FluidForm Bio™ Welcomes New Executive Leadership,https://www.prnewswire.com/news-releases/fluidform-bio-welcomes-new-executive-leadership-302025374.html,2024-01-03 16:07:00,"WALTHAM, Mass., Jan. 3, 2024 /PRNewswire/ -- FluidForm Bio™ announced that it has named Jonathan Paris as general counsel and head of corporate strategy, Naomi Phaneuf as chief marketing officer, and Alex Lenz as vice president of people & business operations.",PODD,0.07446,0.06999,Neutral
Thermo Fisher  ( TMO )  End Markets Drive Growth Amid Macro Woes,https://www.zacks.com/stock/news/2205062/thermo-fisher-tmo-end-markets-drive-growth-amid-macro-woes,2024-01-03 15:09:00,"In the academic and government end markets, Thermo Fisher (TMO) is delivering strong growth in the electron microscopy, chromatography and mass spectrometry businesses.",PODD,0.146321,0.057323,Neutral
DexCom Unusual Options Activity - DexCom  ( NASDAQ:DXCM ) ,https://www.benzinga.com/markets/options/24/01/36457531/dexcom-unusual-options-activity,2024-01-02 19:00:46,"Investors with a lot of money to spend have taken a bullish stance on DexCom DXCM. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",PODD,0.085629,0.0,Neutral
Here's Why You Should Retain Medtronic  ( MDT )  Stock for Now,https://www.zacks.com/stock/news/2204570/heres-why-you-should-retain-medtronic-mdt-stock-for-now,2024-01-02 17:10:00,Investors are optimistic about Medtronic's (MDT) expansion in global markets and stable solvency position.,PODD,0.143987,0.055556,Neutral
Omnicell  ( OMCL )  Gains From Innovation Amid Cost Pressure,https://www.zacks.com/stock/news/2204346/omnicell-omcl-gains-from-innovation-amid-cost-pressure,2024-01-02 12:58:00,Omnicell (OMCL) plans to focus on integrating customer success functions into its broader organizational structure.,PODD,0.135347,0.051322,Neutral
Here's Why You Should Retain Teleflex  ( TFX )  Stock for Now,https://www.zacks.com/stock/news/2204317/heres-why-you-should-retain-teleflex-tfx-stock-for-now,2024-01-02 12:24:00,"Investors remain optimistic about Teleflex (TFX), backed by the strong prospects of the Interventional business and stable solvency.",PODD,0.128822,0.029778,Neutral
Boston Scientific  ( BSX )  Initiates AVANT GUARD Clinical Trial,https://www.zacks.com/stock/news/2204314/boston-scientific-bsx-initiates-avant-guard-clinical-trial,2024-01-02 12:18:00,Boston Scientific's (BSX) AVANT GUARD clinical trial is set to evaluate the FARAPULSE PFA System as the first-line treatment for persistent AF.,PODD,0.138198,0.0531,Neutral
XORTX Welcomes New Member to the Board of Directors,https://www.globenewswire.com/news-release/2024/01/02/2802570/0/en/XORTX-Welcomes-New-Member-to-the-Board-of-Directors.html,2024-01-02 12:00:00,"CALGARY, Alberta, Jan. 02, 2024 ( GLOBE NEWSWIRE ) -- XORTX Therapeutics Inc. ( ""XORTX"" or the ""Company"" ) ( NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU ) , a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, welcomes Mr. ...",PODD,0.052918,0.052981,Neutral
3 Reasons Why Growth Investors Shouldn't Overlook Insulet  ( PODD ) ,https://www.zacks.com/stock/news/2203851/3-reasons-why-growth-investors-shouldnt-overlook-insulet-podd,2023-12-29 17:45:03,"Insulet (PODD) is well positioned to outperform the market, as it exhibits above-average growth in financials.",PODD,0.497733,0.363936,Bullish
Globus Medical  ( GMED )  Gains From Innovation Amid Macro Issues,https://www.zacks.com/stock/news/2203657/globus-medical-gmed-gains-from-innovation-amid-macro-issues,2023-12-29 14:33:00,"Globus Medical (GMED) is particularly seeing notable gains in expandables, biologics, MIS screws, 3D printed implants and cervical offerings.",PODD,0.159922,0.057896,Neutral
Walgreens  ( WBA )  to Report Q1 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2203640/walgreens-wba-to-report-q1-earnings-whats-in-the-cards,2023-12-29 14:24:00,Strength in U.S. Healthcare and International businesses is likely to drive Walgreens' (WBA) first-quarter 2024 performance.,PODD,0.083541,0.0,Neutral
Here's Why Investors Should Retain Labcorp  ( LH )  Stock for Now,https://www.zacks.com/stock/news/2203637/heres-why-investors-should-retain-labcorp-lh-stock-for-now,2023-12-29 14:23:00,Investors remain optimistic about Labcorp (LH) due to impressive partnerships and expansion efforts in targeted high-growth areas.,PODD,0.127231,0.080036,Neutral
5 Impressive MedTech Industry Growth Stocks to Buy for 2024,https://www.zacks.com/stock/news/2203633/5-impressive-medtech-industry-growth-stocks-to-buy-for-2024,2023-12-29 14:19:00,"Stocks such as HAE, PEN, EXAS, PODD and CAH are set to garner remarkable growth for investors.",PODD,0.185781,0.18291,Somewhat-Bullish
Here's Why You Should Invest in Insulet  ( PODD )  Stock for Now,https://www.zacks.com/stock/news/2203323/heres-why-you-should-invest-in-insulet-podd-stock-for-now,2023-12-28 18:13:00,"Investors are optimistic about Insulet (PODD), led by the strong adoption of Omnipod 5 and its strong solvency position.",PODD,0.46898,0.318497,Somewhat-Bullish
Here's Why You Should Retain Illumina  ( ILMN )  Stock for Now,https://www.zacks.com/stock/news/2203319/heres-why-you-should-retain-illumina-ilmn-stock-for-now,2023-12-28 18:02:00,Investors are optimistic about Illumina's (ILMN) strength in the genomics market and strong solvency position.,PODD,0.137934,0.054256,Neutral
Ensign Group  ( ENSG )  Rises 23% in 3 Months: More Room to Run?,https://www.zacks.com/stock/news/2203320/ensign-group-ensg-rises-23-in-3-months-more-room-to-run,2023-12-28 18:01:00,"Ensign Group (ENSG) remains well-poised for growth, courtesy of an extensive treatment network, higher rental revenues and uninterrupted dividend hikes.",PODD,0.155954,0.068681,Neutral
"National Vision  ( EYE )  Store Openings Aid, Macro Issues Stay",https://www.zacks.com/stock/news/2203215/national-vision-eye-store-openings-aid-macro-issues-stay,2023-12-28 16:07:00,"In terms of store expansion, National Vision (EYE) continues to see sizable new opportunities for many years to come.",PODD,0.157827,0.057409,Neutral
Bull of the Day: Insulet  ( PODD ) ,https://www.zacks.com/commentary/2202837/bull-of-the-day-insulet-podd,2023-12-28 14:01:00,A big earnings beat at the perfect time has this stock up over 50% in short order.,PODD,0.497391,0.427628,Bullish
Here's Why You Should Retain QIAGEN  ( QGEN )  Stock for Now,https://www.zacks.com/stock/news/2203003/heres-why-you-should-retain-qiagen-qgen-stock-for-now,2023-12-28 12:25:00,"Investors remain optimistic about QIAGEN (QGEN), backed by strategic alliances and potential in the Molecular Diagnostics arena.",PODD,0.121241,0.078322,Neutral
Reasons to Buy Prestige Consumer  ( PBH )  Stock for Now,https://www.zacks.com/stock/news/2203002/reasons-to-buy-prestige-consumer-pbh-stock-for-now,2023-12-28 12:20:00,"Investors remain optimistic about Prestige Consumer (PBH), backed by the robust strength of its consumer brands portfolio.",PODD,0.129516,0.079542,Neutral
"Top Stock Picks for Week of December 25, 2023",https://www.zacks.com/stock/news/2202804/top-stock-picks-for-week-of-december-25-2023,2023-12-27 17:52:00,An Interesting Bet for Trend Investors and a Leading Medical Products Stock for Your Review ...,PODD,0.579393,0.681131,Bullish
Align Technology  ( ALGN )  Up 30% YTD: Will the Rally Continue?,https://www.zacks.com/stock/news/2202708/align-technology-algn-up-30-ytd-will-the-rally-continue,2023-12-27 16:02:00,"Investors are optimistic about Align Technology (ALGN), driven by recent strategic alliance and geographic expansion.",PODD,0.149656,0.059357,Neutral
Here's Why You Should Retain CVS Health  ( CVS )  Stock for Now,https://www.zacks.com/stock/news/2202694/heres-why-you-should-retain-cvs-health-cvs-stock-for-now,2023-12-27 15:35:00,Investors are optimistic about CVS Health (CVS) on its strong segmental performance and impressive restructuring plan.,PODD,0.146025,0.056006,Neutral
"Henry Schein  ( HSIC )  Sales Hurt by Cyber Attack, Macro Woes",https://www.zacks.com/stock/news/2202660/henry-schein-hsic-sales-hurt-by-cyber-attack-macro-woes,2023-12-27 15:09:00,Henry Schein's (HSIC) financial operations are being affected by the current macroeconomic environment.,PODD,0.130453,0.051554,Neutral
Orthofix  ( OFIX )  Releases New Data for Spinal Fusion Procedures,https://www.zacks.com/stock/news/2202514/orthofix-ofix-releases-new-data-for-spinal-fusion-procedures,2023-12-27 13:45:00,"According to Orthofix (OFIX), this data highlights the noninvasive and cost-effective nature of SpinalStim, enabling patients to continue their healing in the comfort of their homes.",PODD,0.167322,0.061014,Neutral
Here's How Much a $1000 Investment in Insulet Made 10 Years Ago Would Be Worth Today,https://www.zacks.com/stock/news/2202502/heres-how-much-a-1000-investment-in-insulet-made-10-years-ago-would-be-worth-today,2023-12-27 13:30:03,"Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.",PODD,0.603745,0.331412,Somewhat-Bullish
Here's Why Investors Should Retain Bruker  ( BRKR )  Stock Now,https://www.zacks.com/stock/news/2202464/heres-why-investors-should-retain-bruker-brkr-stock-now,2023-12-27 12:34:00,Investors remain optimistic about Bruker (BRKR) due to the strength of the BSI BioSpin and CALID groups.,PODD,0.11787,0.077406,Neutral
A Closer Look at DexCom's Options Market Dynamics - DexCom  ( NASDAQ:DXCM ) ,https://www.benzinga.com/markets/options/24/01/36539678/a-closer-look-at-dexcoms-options-market-dynamics,2024-01-08 17:31:09,"Whales with a lot of money to spend have taken a noticeably bullish stance on DexCom. Looking at options history for DexCom DXCM we detected 12 trades. If we consider the specifics of each trade, it is accurate to state that 66% of the investors opened trades with bullish expectations and 33% ...",PODD,0.105604,0.0,Neutral
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio,https://www.zacks.com/stock/news/2206987/why-this-1-momentum-stock-could-be-a-great-addition-to-your-portfolio,2024-01-08 14:50:08,The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.,PODD,0.464633,0.206676,Somewhat-Bullish
"Implantable Drug Delivery Devices Global Market to Exhibit Growth at a Considerable CAGR of ~6% by 2028, Assesses DelveInsight",https://www.prnewswire.com/news-releases/implantable-drug-delivery-devices-global-market-to-exhibit-growth-at-a-considerable-cagr-of-6-by-2028-assesses-delveinsight-302041477.html,2024-01-23 22:31:00,Implantable Drug Delivery Devices Global Market to Exhibit Growth at a Considerable CAGR of ~6% by 2028 ... PR ...,PODD,0.027103,-0.01558,Neutral
Universal Health  ( UHS )  Up 5.3% in 6 Months: More Room to Run?,https://www.zacks.com/stock/news/2214379/universal-health-uhs-up-53-in-6-months-more-room-to-run,2024-01-23 16:46:00,Universal Health's (UHS) rising patient volumes and better pricing position the company well for growth.,PODD,0.150906,0.109455,Neutral
Insulet Unusual Options Activity For January 22 - Insulet  ( NASDAQ:PODD ) ,https://www.benzinga.com/insights/options/24/01/36722954/insulet-unusual-options-activity-for-january-22,2024-01-22 19:30:57,"Whales with a lot of money to spend have taken a noticeably bullish stance on Insulet. Looking at options history for Insulet PODD we detected 8 trades. If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 50% ...",PODD,0.664604,0.340928,Somewhat-Bullish
Here's Why Insulet  ( PODD )  is a Strong Growth Stock,https://www.zacks.com/stock/news/2213427/heres-why-insulet-podd-is-a-strong-growth-stock,2024-01-22 14:45:07,The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.,PODD,0.406526,0.287439,Somewhat-Bullish
Wearable Injectors Market Surges Towards US$ 19.4 Billion by 2033 with 10.2% CAGR | Persistence Market Research,https://www.benzinga.com/pressreleases/24/01/g36711531/wearable-injectors-market-surges-towards-us-19-4-billion-by-2033-with-10-2-cagr-persistence-market,2024-01-22 09:00:00,"New York, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The Wearable Injectors Market has witnessed remarkable growth in recent years, driven by a combination of technological advancements and the growing demand for convenient and patient-centric drug delivery solutions.",PODD,0.029381,0.207221,Somewhat-Bullish
DexCom's  ( DXCM )  G7 Links With Tandem's Insulin Pump in Europe,https://www.zacks.com/stock/news/2212038/dexcoms-dxcm-g7-links-with-tandems-insulin-pump-in-europe,2024-01-18 14:09:00,"Dexcom's (DXCM) G7 integrates with Tandem's t:slim X2, revolutionizing diabetes care. A perfect combination of accuracy and innovation, this synergy sets a new standard in continuous glucose monitoring.",PODD,0.049629,0.0,Neutral
aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor - aTyr Pharma  ( NASDAQ:LIFE ) ,https://www.benzinga.com/pressreleases/24/01/g36675973/atyr-pharma-announces-howard-university-president-emeritus-dr-wayne-a-i-frederick-as-advisor,2024-01-18 13:00:00,"SAN DIEGO, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- aTyr Pharma, Inc. LIFE ( aTyr or ""the Company"" ) , a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced the appointment of Wayne A.",PODD,0.034087,-0.05823,Neutral
Boston Scientific's  ( BSX )  FARAPULSE PFA System Gets FDA Nod,https://www.zacks.com/stock/news/2220088/boston-scientifics-bsx-farapulse-pfa-system-gets-fda-nod,2024-02-02 13:09:00,Boston Scientific (BSX) secures FDA approval for the FARAPULSE PFA system.,PODD,0.091162,0.05288,Neutral
"Insulet  ( PODD )  Gains From Product Innovation, Global Expansion",https://www.zacks.com/stock/news/2219642/insulet-podd-gains-from-product-innovation-global-expansion,2024-02-01 15:26:00,Insulet's (PODD) Omnipod 5 continues to be a driving force behind U.S. and international growth.,PODD,0.626173,0.374728,Bullish
Thermo Fisher  ( TMO )  End Market Growth Strong Despite Macro Woes,https://www.zacks.com/stock/news/2218890/thermo-fisher-tmo-end-market-growth-strong-despite-macro-woes,2024-01-31 16:23:00,"Thermo Fisher's (TMO) electron microscopy, chromatography and mass spectrometry businesses are delivering strong growth in the academic and government end market.",PODD,0.163539,0.057409,Neutral
QIAGEN  ( QGEN )  Forges Alliance to Advance Microbiome Sciences,https://www.zacks.com/stock/news/2218502/qiagen-qgen-forges-alliance-to-advance-microbiome-sciences,2024-01-31 12:35:00,"QIAGEN (QGEN) announces a first-in-kind collaboration with Penn State University to help shape research, education and outreach in microbiomes.",PODD,0.13637,0.051524,Neutral
Here's Why You Should Invest in IDEXX  ( IDXX )  Stock Right Now,https://www.zacks.com/stock/news/2218498/heres-why-you-should-invest-in-idexx-idxx-stock-right-now,2024-01-31 12:29:00,"Investors continue to be optimistic about IDEXX (IDXX), backed by the strength of the CAG Diagnostics business.",PODD,0.121037,0.078266,Neutral
